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The aim of this thesis was to investigate a novel prototype supercritical fluid chromatography 
instrumentation optimized to exploit the theoretical benefits of sub-2 µm particle stationary 
phases and determine the benefits of its applied use towards the discovery and early drug 
development of new chemical entities found in natural products.  The protoype supercritical 
instrument was designed to reduce the system and extra-column volumes in order to reach the 
theoretical efficiencies of a sub-2 µm particle stationary phase.  The system was also 
designed to decrease baseline noise and drift via design improvements of the CO2 solvent 
delivery by the pump, updated backpressure regulator needle and seat designs, and 
optimization of UV detector design that accounts for CO2 refractive indices rather than 
typical liquid mobile phases used in reversed phase liquid chromatography. The prototype 
instrument was also designed to improve the sample introduction to the flow stream, thus to 
improve the applied use of the instrument allowing the analyst to attain highly reproducible 
results that would be required for improved qualitative separations, semi-quantitative 
statistical profiling, and quantitative commercial use determinations.  Supercritical fluid 
chromatography utilizes CO2-based mobile phases with unique properties associated with 
improving solvation, lowering mobile phase viscosity and exploring a wide range of polarity 
of solutes. Natural products have a complexity of compounds varying in polarity requiring a 
variety of analytical techniques resulting in numerous chromatographic profiles.  The goal of 
this research is to prove the benefits of this novel technology to natural product research, 
specifically in the field of discovering new molecular entities and drug discovery workflows.  
Establishing the usefulness of a new technology and its potential impact to new therapeutic 
discovery requires a large gap of experimentation and education to be filled prior to any 




The thesis will study four distinct requirements to validate the benefits of a new technology:  
Review of the theory and past challenges with SFC, Investigate the proof-of-principle 
attributes of the prototype instrumentation, assess the practicality of its use relative to 
analytical scientist’s needs when working in a commercial industry, and applicability towards 
drug discovery and early development workflows when derived from natural products.  The 
proof-of-principle attributes study the theoretical promise of sub-2 µm particle columns when 
employed with an optimized SFC instrument and overall system performance.  The 
practicality of the novel instrumentation will investigate methodology variables affecting 
chromatography and approaches interfacing with mass spectrometry.  The knowledge gained 
from these preliminary studies combined with a review of previous research enable the 
applied use of the novel technology towards the drug discovery workflow as it pertains to 
necessary lead discovery, lead optimization, process development, and early analytical 
method development.   The applied approaches investigated within this thesis include 
reaction monitoring of candidate drug substance synthesises’ and comprehensive profiling of 
natural products as these are critical activities in the discovery and early development of 
commercialized drug products. 
 In this thesis, insight was provided regarding SFC theory, previous uses, instrument 
design and reasons why researchers found limitations in terms of performance hindering the 
progress of their research to be adopted for commercial use.  The discussions and studies 
regarding the new design combined with the results presented in Chapters 1 and 2.  They 
illustrate the key points to these past challenges and how they were addressed with the 
prototype instrument.  The preliminary studies exploring the new designs use with sub-2 um 
particle size columns indicated good reproducibility for a mixture of 18 analytes.  The 
preliminary investigation efficiency, retention and peak shape attributes were affected by a 
multitude of properties related to mobile phase homogeneity, density variations and 
vii 
 
insolubility.  Two parameters of which are related to instrument design and performance, 
whereas insolubility is due mostly in part of the analysts knowledge of the analyte solubility.  
All of which require the necessary education on part of the user in order to increase their 
success in using a supercritical fluid chromatographic approach.  In some comparisons, the 
results from an optimized instrument design to those previously published with a non-
optimized instrument design place into question the conclusions from their results. 
 Instrument design is important to understand and defines a basis for general 
expectations of the results to come once it’s employed for analytical determinations. The 
practicality of the instrument design can be better understood when methodology variables 
are taken into consideration.  In chapters 3 and 4, one factor at a time (OFAT) and 
multivariate approaches are explored to determine the variables that effect chromatographic 
separations, information rich data, and interfacing with mass spectrometry.  In addition, these 
chapters highlight the importance of troubleshooting techniques that help distinguish system 
related effects versus chemistry related effects based on experimental observations and 
reason that could cause retention time drift, peak splitting, peak distortion, and ionization 
efficiency.  More importantly, evidence of the various retention mechanisms affecting the 
selectivity, retention and resolution of analytes; but more specifically, structurally related 
small molecule (>1500 Da) analytes analogous to those observed in natural product profiling 
and reaction monitoring and process optimization syntheses.  The examples show how the 
column choice can greatly impact the selectivity of a mixture of structurally related 
impurities and the retention behaviour of biologically related molecules such as differing 
lipid classes and lipid species found in natural product sources. 
Natural products have numerous structural analogues with a wide variety of polarity.  The 
discovery and eventual commercialization of any natural product synthetically derived 
chemical entities require reaction synthesis and process optimization which is monitored 
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analytically.  In the final chapters, the technology is applied to these application areas of 
chemical substituent profiling and synthesis monitoring.  One of the applications is focused 
on the typical procedures and workflows practiced in the lead optimization and process 
development groups employed in the pharmaceutical or chemical material industry.  The 
application investigates the reaction synthesis monitoring of three small molecules chosen 
either for their unique stereochemical properties and relationship to derived natural product 
entities.  The reasoning for this investigation was due in part of proving the sustainability of 
the technique and novel technology design improvements for use by the industry in terms of 
post discovery of a new chemical entity.  The examples in this chapter show the benefit of a 
high efficiency separation using the SFC approach when compared to UHPLC, the 
effectiveness to determine recovery values, the ability to troubleshoot synthetic route issues, 
and an approach to streamline chiral and achiral screening on a single chromatographic 
system.  One of the highlights demonstrates the optimized SFC instrument as a tool for a 
column agnostic screening approach to aid process optimization of a synthetic reaction during 
the clopidogrel experiments.   
 The final applied approach explores the chemical profiling of two species of 
chamomile and multivariate analysis of a collection of chamomile commercially available 
products.  Chamomile was chosen due to its long history of being used as a medicinal plant. 
Chamomile has been reported to contain therapeutic compound classes ranging in polarity 
and derivatives of sesquiterpenes, flavonoids, polyacetylenes, terpenoids, and coumarins,  
Due to chamomiles diversity and amount of published content related to the characterization 
of composition, it was deemed as an appropriate representative test case to use to investigate 
this new SFC technology and compare to other chromatographic techniques.   The chapter 
highlights the sub 2um SFC technology and the benefits of identification of 6 new chemical 
entities with the aid of multivariate statistical analysis the separation profile.  This was 
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achieved by the enhanced selectivity benefits of a SFC approach.   The results also concluded 
the use single quadrupole detector was capable to distinguish between authentic and 
adulterated chamomile commercial products. 
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1 Introduction to Natural Products, Liquid Chromatography and 
Supercritical Fluids.  
 
1.1 Natural Product Research 
Natural products and their derivatives have been employed as therapeutic treatments of 
ailments and diseases for thousands of years.  Early medicines were based on tree-bark, 
leaves and fruit.  Many well-known and commonly used therapeutics have their origins in 
natures remedies, Aspirin and digitalis being two common examples.  Natural products have 
been used as the basis of consumer products, are the basis of Traditional Chinese Medicines 
(TCM), antibiotics, and as the starting synthesis point for the development of blockbuster 
drugs.  More recently these natural compounds have been the starting point for specifically 
designed Antibody Drug Conjugate (ADCs) ‘warheads’ [1].  Natural product profiling and 
characterization has also led to the betterment of food genomics improving quality attributes, 
environmental resilience, and drought resistance [2]. The practice of natural product research 
requires collaborative knowledge of analytical, organic, and biological chemistry.  Natural 
products are a decoction of multiple components, some active and some inactive others acting 
symbiotically.  Due to the complexity and diversity of biological moieties, understanding the 
chemical dynamics of a natural product require data interpretation from biosynthesis, 
biology, taxonomy, pharmacology, spectroscopy, and separation sciences.   
 
The idea of discovering natural products with therapeutic relevance may seem like a semi-




the FDA proved otherwise.  An analysis performed on NME approvals between 1981 and 
2010 by Newman and Cragg showed of the 1355 approved NMEs, 50.63% are natural 
products or natural product derived semi-synthetics [10].  For the 30 year period, NMEs 
originating from natural products and natural products derivatives have been predominately 
developed for the treatments of anticancer and antibacterial indications.  Antiviral medicines 
are dominated by the discovery and development of vaccine-based new chemical entities, 
which are derived from nature by definition [10, 11].  Further review notes a slight decline of 
approved small molecules between 1981 and 2010 specifically in the 1990s, however natural 
product , natural product botanicals, and natural product derived NMEs accounted for a 
median of 35.2% of the total FDA approved NME’s during the 30 year period.  The analysis 
did not conclude any clear and indicative trend of natural products representation from year 
to year positive or negative, yet subsequent articles suggested a slight decline has occurred 
[6-8]. Additionally, the decline does not coincide with the FDA’s claims to refute the public 
perception of the Agency approving fewer drugs in recent years [12].  The small molecule 
approval rate is in the range of 20 to 30 molecules per year.  The NME approval rate has not 
necessarily declined, but the Center for Drug Evaluation and Research (CDER) analysis did 
indicate fewer NME applications have been submitted.  From a natural product NME 
perspective, drilling down into the data indicates a maximum representation of 50% NME in 
2010 and a minimum representation of 12.2% in 1997 have natural products origins [10].  
Interestingly, the percentage of NMEs from plant based origins decline steadily as the years 
progress, yet shift to a greater percentage of NMEs derived from bacterial and fungi origins 
spanning from 1931 to 2013, thus indicating an inclusion of research diversity in the 
discovery of NME from natural products [8]. In many of the closing remarks and response 
articles focused on natural product research, the recognition of natural products significant 




research for chemically diverse compounds exploration within marine life species [1, 3, 5, 7, 
8, 10, 11, 13, 14]. 
 Role of Natural Products in Drug Discovery 1.1.1
Natural products are produced by nature; eukaryotic and prokaryotic, which are extracted 
from cells, tissues, microorganisms, plants and animals [3].  The environmental and 
biological diversity found in nature contributes to the novelty of the compounds extracted 
from the biological source.  The natural products used for medicinal purposes are a result of 
pharmacognostic studies; Pharmacognosy.  Pharmacognosy is the study of natural products 
molecules that are useful for their medicinal, ecological, gustatory, or other functional 
properties that allow for the identification, selection, and processing of the primary and 
secondary metabolites found in natural products to be bioactive towards a targeted disease[4].  
These metabolites may evolve to the role of a “lead” candidate for a new pharmaceutical 
drug.  Examples of natural products used as medicines such as aspirin, morphine, quinine, 
and pilocarpine were derived from plants [5].  Therapeutic natural products are broadly 
defined as any of the following [6, 7]:   
 Unregulated organisms or natural materials;   
 FDA-regulated, unmodified natural materials or compounds;  
 Naturally occurring compounds that have been chemically modified and referred to as 
“semisynthetic”;  and  
 Purely synthetic medicinal compounds inspired by a natural compound.   
 
The analysis of natural products requires intensive investments in time and resources due to 
the effort needed to isolate and identify the active substances within a comprehensive sample 
profile [8].  The identification of these components normally employs a combination of 




bioactive compound from a natural product starts early within the pharmaceutical drug 
discovery process.   The process of discovering new molecular entities (NME) follows a “hit 
to lead” (H2L) scheme within the pharmaceutical discovery process.  A “hit” is the result of a 
high throughput screening (HTS) exercise discovering bioactivity specific to the target 
disease.  The “hit” is determined a “lead” drug candidate after subsequent structural activity 
relationship (SAR) testing and generation of pharmacodynamics / pharmacokinetic (PD/PK) 
information.  The progression of a natural product NME from discovery to development 
highlighting the amount of material required to fulfill the needs of each stage of testing is 
depicted in Figure 1.1.   
 
Figure 1.1 Chemical process for natural product discovery [7] 
 
The process begins with the natural product being extracted from its source (plant leaves etc), 
concentrated, fractionated and purified; yielding essentially a single chemical compound. 




1) The rapid identification of known compounds (dereplication) - to avoid the 
duplication of effort. This step has been greatly facilitated by the availability of 
reliable HPLC-mass spectrometer (LC/MS) systems, and the general availability 
of natural-product databases. The correlation of both molecular mass and 
ultraviolet light (UV) absorption data with known compounds by database 
searching is ordinarily sufficient to classify sets of compounds [9].   
 
2) The de novo structure determination of NMEs - this area has been revolutionized 
by many advances in high-resolution mass spectrometry and high field NMR 
spectroscopy.  In those cases in which the biological activity profile meets criteria 
for potency and selectivity, preliminary SAR studies are conducted and the 
process is scaled up. Once the feasibility of modulating biological response 
through synthetic modification is established, the hit is declared a lead and 
proceeds onwards for additional optimization by traditional medicinal chemistry.  
 
 
3) Efficient techniques and capabilities to isolate and purify targets - Utilization of 
analytical and purification scale liquid chromatographic techniques provide the 
tools to monitor reactions and isolate constituents of interest such as isomeric 
compounds.   The purification step in the process is rate-limiting and potentially 
hindered by supply of the source material.  Additionally, one must correlate the 
biological signal of interest with the bioactive compounds.   As it can be assumed 
by this description, a strong basis of knowledge, equipment, techniques, and a hint 
of luck are required to discover natural products for medicinal purposes. 
 
 Impact of Combinatorial Chemistry 1.1.2
The perceived decline of natural product drug discovery has also been attributed to a number 
of factors circumstantiating from the advent of combinatorial chemistry, lack of focus on 
molecular targets as a result of competitive first-to-market timelines, and commercially 
driven philosophies steering away from treatments for infectious diseases, which are the 




combinatorial chemistry and failure to produce a high success of leads in the 1990s ultimately 
resulted in the disillusionment of combinatorial effectiveness.  
 
Combinatorial chemistry, is an approach facilitated by the use of high throughput screening 
(HTS) of compound libraries consisting of hundreds of thousands to millions of synthetic 
compounds designed on the basis of chemical accessibility and maximum achievable size 
[10].  Although the perception has been acknowledged as a contributed factor to the decline 
of natural product drug discovery, the HTS approach was regarded as a useful approach to 
optimizing the development of natural product lead candidates rather than lead identification.  
In a 2014 review by Butler et al, they recognized the counterintuitive mindset of not utilizing 
HTS for natural product lead identification due to their significant role in drug development.  
Only one de novo natural product drug was cited as a result of a combinatorial screening Hit 
to Lead (H2L) identification campaign, the antitumor compound known as sorafenib from 
Bayer [11].   Since the turn of the millennium, the pharmaceutical industry has recognized the 
lack of diversity within their synthetically developed chemical libraries evident by the recent 
shift to “focused” or “targeted” library screening.   
 
Advances in cheminformatic tools such as Instant JChem (ChemAxon), Spotfire (TIBCO), 
Vortex (Dotmatics) and “CLEVER’1 freeware facilitate the visualizing, management and in 
silico techniques of vast chemical libraries to produce smaller (200 to 3000) chemically 
relevant screening libraries designed to target a disease.  Multivariate statistical analysis of 
natural products and synthetic drugs shows discretely different molecular descriptors in terms 
                                                 
1
 Chemical Library Editing, Visualizing and Enumerating Resources (A*STAR Agency for Science, 




of the aromatic atoms, solvated hydrogen donors and accepters, molecular rigidity, mass, 
octanol-water partition coefficients (KOW or logPoct/wat; expressed by Equation 1.1), number of 
chiral centers, and number of specific elements such as oxygen, nitrogen, sulphur, and 
halogens.  
log 𝑃𝑜𝑐𝑡/𝑤𝑎𝑡 =  log (
[𝑠𝑜𝑙𝑢𝑡𝑒]𝑢𝑛 − 𝑖𝑜𝑛𝑖𝑧𝑒𝑑 𝑜𝑐𝑡𝑎𝑛𝑜𝑙
[𝑠𝑜𝑙𝑢𝑡𝑒]𝑢𝑛 − 𝑖𝑜𝑛𝑖𝑧𝑒𝑑 𝑤𝑎𝑡𝑒𝑟
) 
Equation 1.1: Partition coefficient represented by the logarithmic concentration of the 
hydrophobic phase divided by the logarithmic concentration of the hydrophilic phase. 
 
In respect to building focused natural product libraries, the following criteria can be followed 
[12-14]:  
1. Lower ratios of aromatic ring atoms to total heavy atoms,  
2. Greater number of chiral centers,  
3. Increased stearic complexity,  
4. Greater amount of oxygen atoms,  
5. Greater number of solvated hydrogen-bond donors and accepters and  
6. Greater molecular rigidity.  
 
The cheminformatic advancements allow the discovery organizations to customize inclusive 
of the typical Lipinski rule of five “drug likeliness”; which natural products structures that 
violate two or more rules is less than 10%, but additionally design libraries based attributes 
such as scaffold architecture and pharmacophore properties [14-16].  
 
The purpose of the targeted or focused library approach seeks to elaborate structural 
modifications onto existing bioactive natural-product scaffolds in a parallel, systematic 




performed either by semi-synthetic modification of the parent molecule, or by fully synthetic 
natural product inspired methods. This strategy was put into practice by Waldmann et al., 
who recently developed potent, selective inhibitors against the TIE2 receptor tyrosine kinase 
by parallel synthesis of a small (74 member) focused library based on nakijiquinone [17].  
Although diverse focused libraries can be designed, there is still a requirement to efficiently 
screen, separate, isolate, and interpret the resulting complexity from any natural product 
research campaign. 
 
In order to gain a better understanding of how best to address the aspects of natural product 
research, it has already been identified in the previous sections regarding the significant role 
of chromatography and mass spectrometry.  Additionally, the concepts of supercritical fluids 
must be reviewed as they present a unique opportunity for topics such as: (i) Sample 
preparation; by providing selectivity and specificity to discrete analytes of interest. (ii) 
throughput; by resulting in lower mobile phase viscosity thus reducing compromises and 
limitations set by system pressure thresholds, and  (iii) chromatographic flexibility; by 
simplifying eluent configurations which are unique for particular stationary phase use. 
 
1.2  Liquid Chromatography and Their Principles of Measurement 
This history and invention of chromatography traces back to 1906 to Mikhail Tsvet, an 
Russian-Italian botanist researching plant pigments.  Tsvet successfully utilized liquid-
adsorption chromatography to separate chlorophylls and carotenoids, interestingly a natural 
product application, thus connecting natural product research to the origin of 
chromatography. Chromatography is the field in which separation techniques allow for an 




Chromatography also refers to the analytes affinity to migrate at different velocities [18]. The 
phases typically consist of a stationary phase and mobile phase, with the exception of 
countercurrent chromatography which uses two mobile phases in opposite directions.  
Generally, the stationary phase is a solid and the mobile phase is a liquid, gas, or supercritical 
fluid
2
.  As it can be expected, when the mobile phase is a gas, it is referred to as gas 
chromatography (GC). When the mobile phase is a liquid, it is referred to as liquid 
chromatography (LC) and thus for supercritical fluids it is referred to as supercritical fluid 
chromatography (SFC).  The general types of chromatography can elute solutes by either one 
or a combination of the following mechanisms: (i) Adsorption, (ii) Partition, (iii) Ion 
Exchange, (iv) Molecular (size) Exclusion, and (v) Affinity.  Basically, the separation 
mechanisms are driven by polarity, electrical charge, or molecular size.  
 
Liquid chromatography or High Performance Liquid Chromatography (HPLC) is the most 
common technique employed today. HPLC uses a variety of separation mechanisms as 
outlined in Table 1.1.  Each chromatographic approach has a unique function and practical 
purpose in regards to effectively achieving a separation of analytes.  For example, 
Hydrophilic Interaction Liquid Chromatography (HILIC) is very useful for highly polar 
molecules often found in the pharmaceutical industry such as the separation of Metformin 
and its related substances[19, 20].  Ion-exchange chromatography (IEX) leverages the ionic 
strength of buffers for the separation of proteins and biomolecules for the biopharmaceutical 
industry. Size exclusion chromatography (SEC) utilizes stationary pore size to achieve 
effective separations of oligomers and larger polymers required in plastics and materials 
industries.  
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Table 1.1: Summary table of Liquid Chromatography Modes 
LC Mode Stationary phase (SP) Mobile Phase 
(MP) 
Targeted mechanism 
Normal Phase LC 
(NPLC) 






Adsorption.    
 
Interaction of polar 
functional groups of 
analyte with polar 
functional groups of SP 
Reversed Phase LC 
(RPLC) 




chains, Si-C18, SI- 
C8,) 
Polar eluents 
(water, acetonitrile , 
methanol 




the SP surface and 
hydrophobic 














Water or dilute buffer Adsorbed to SP with 
concentrated buffer and 
eluted with lower 
concentrated buffer 








Polar sorbent  
(silica, polar ligand 
bonded silica) 
Aqueous Eluents Partition driven.  Thin 
aqueous (aq.) film on 
SP surface and analytes 
equilibrate between 




Cation (+) or Anion (-) 
charged SP surfaces 
via acidic or basic 
functionality attached 
to silica or polymer 
particles 
Strong and weak pka 
buffers 
Ion-exchange, 
Primarily based on 
charge, whereas 
opposite charges attract 











Sieving by analyte size 
relative to SP pore size; 







As discussed earlier, HPLC is the dominant separation technique, however the opportunity 
for supercritical fluid chromatography lends to a hypothetical expansion of capabilities that 
will be discussed in later sections.  Gas chromatography is used during natural product 
research for the analysis of small aliphatic hydrocarbons, essential oils, and natural product 
lipids research.  However, gas chromatography often requires derivatization and is limited to 
volatile compounds.   Since SFC is a form of liquid chromatography derived from Normal 
Phase Liquid Chromatography (NPLC), many of the same LC measurement principles are 
utilized and deemed essential to best understand and characterize separations of simple and 
complex mixtures. Therefore, the basics of chromatographic principles and systems are 
reviewed in this section to better identify, understand the similarities and differences between 
general LC and SFC.   This information will be used to design experimental procedures 
appropriate for natural product analysis appropriate for use in pharmaceutical drug discovery 
and development. 
 
 Stationary Phases and Chromatography Columns  1.2.1
The stationary phase particles are the driving influence on the chromatographic separation.  
The particles can be non-porous, porous, or a combination thereof known as pellicular 
particles or more recently referred to as superficially porous-based particles[21].  Stationary 
phase particles can be composed of silica, organo-silica hybrids of different polarity, chiral 
functionalized, graphite particles, and polymeric particles. Each type has particular uses, 
benefits and compromises to separation needs and performance. The stationary phase 
particles are packed into cylindrical tubes called ‘columns’ using processes developed to 
increase column stability and lifetime during use.  There are other manufacturing processes 
where the silica is ‘grown’ as tubular formations known as monolith columns.  In general, 




external connection details. All of which should be considered when connecting to a 
chromatographic system.   
 
 Liquid Chromatography System Components 1.2.2
A modern day liquid chromatograph system (Figure 1.2) consists of a pump (B) which 
siphons, compresses, meters, mixes, degases and delivers the mobile phase (A) throughout 
the fluidic path of the system (blue arrows).  The pump typically has the capability to deliver 
the mobile phase isocratically (constant composition) or with gradient elution (varying 
composition) at a constant flow rate. The autosampler (C) consists of an injection mechanism 
that will collect and aspirate the contents of a sample into the flowing mobile phase stream.  
The samples are typically located in vials or a well within a sample plate and located in the 
autosampler.  Many autosamplers have the capacity for 2 or more plates.  The sample is 
carried in the flowing stream to a column (1 or 2) of appropriate stationary phase packing 
material held within the column heating or column management module (D).  The column 
compartment module has two main functions.  The primary function regulates the 
temperature of the column to mitigate solute retention irreproducibility from injection to 
injection caused by environmental temperature inconsistencies.  A secondary function is to 
manage column selection if a selection valve is installed.  The solutes migrate and separate on 
the column via one or a combination of the modes described in Error! Reference source not 
found., at the exit of the column they travel through a transfer line to a detector(s) configured 
either in series or parallel if multiple detectors are used.  Different forms of detectors can be 
chosen based on solute properties.  Solutes with chromophores can be detected by UV 
detection. Solute fluorescence can be detected using a fluorescence detector.  Other forms of 
detectors include corona charged aerosol detector (CAD), evaporative light scattering 




nitrogen detector (CLND) and a mass spectrometer.   In Figure 1.2, a schematic illustrates an 
ultraviolet light detector (E) and mass spectrometer (F) configured in series with the flow 
typically split after the UV detector to maximize ionization efficiency of the MS detector.  
The signal from the detection modules are converted to graphs that are collected, processed 
and stored by chromatographic software installed on a computer (G). Eluent waste is 
collected in a sealed container or certified waste collection system (H) for safe disposal.  In 
larger chromatographic laboratories, the waste eluent can either be recycled or piped to an 
external containment area [22, 23]. 
 
 
Figure 1.2: Schematic of a modern liquid chromatograph system configured with ultraviolet 















  Nomenclature of a Chromatogram 1.2.3
A chromatogram is the representation of the chemical separation in terms of peak response 
versus elution time.  The chromatogram displays numerous parameters that can used to 
qualitatively and quantitatively assess the solutes separation results and evaluate system 
performance.  An example of the basic parameters and nomenclature for a chromatogram are 
described in Figure 1.3.   
 
 
Figure 1.3: Nomenclature of a chromatogram. Adapted from Ettre [24]. 
 
The baseline is any part of the chromatogram, which represents detection of only the mobile 
phase.  An unretained solute is either represented by time or volume.  The ‘dead point’ is the 
position of the peak maximum of an unretained solute.  Dead time or void time (t0) is the time 
elapsed between the point of injection and the apex of the unretained solute.  Dead volume 
0 5 10 15
Dead time (t0)
Or Dead volume (V0)
Retention time (t)r Or Retention volume (V)r
Peak Height (h)
Corrected Retention time (t’)r Or Corrected Retention volume (V’)r






(V0) represents the amount of mobile phase passed through the column from the point of 
injection and the apex of the unretained solute.  The retention time (tr) is a characteristic 
property of the solute measured from the injection point to the peak apex.  Retention volume 
(Vr) is the volume of mobile phase passed through the column between the point of injection 
and the peak apex.  The corrected retention time (t’r) is the time spent by the solute on the 
stationary phase calculated from measurement of the unretained solute and the apex of the 
eluted solute. The same determinations can be calculated for the functions of volume. The 
peak height (h) is the distance from the baseline to the peak apex.  The peak width (w) is the 
distance between each side of a peak measured at 0.607 of the peak height representing two 
standard deviations (2σ) of the Gaussian curve.  The peak width at half height (w0.5) is the 
distance measured between each side of the peak at half its maximum height.  The peak width 
at the base (w) is the distance between the intersections of the tangents geometrically drawn 
to the sides of the solute peak and to the peak baseline.  The wB is representative to four 
standard deviations (4σ) of the Gaussian curve. 
 
 Retention Factor (k) 1.2.4
The retention factor (k) is a measurement, which is used to determine the solutes affinity to 
the stationary phase relative to an unretained solute. Retention factors can be calculated from 
functions of retention times or volumes.  The retention factor is defined by the following 
equation [18, 22, 25]: 
𝒌  =   
𝒕𝒓 − 𝒕𝟎
𝒕𝟎










Solutes with retention factors, which are between 2 and 5, are used as probes when 
determining optimum column efficiency for van Deemter plots [18].  The United States 
Pharmacopoeia (USP) does not accept chromatographic methods as valid it the k is less than 
2.  Retention factors are also used to troubleshoot shifts in solute retention.  Chromatographic 
comparisons resulting in a solutes retention factor varying from injection to injection are 
typically attributed to column issues. Chromatographic comparisons resulting in constant 
values of k for a solute can be attributed to system issues. 
 
 Selectivity Factor (α) 1.2.5
The selectivity factor is a measure of the difference in retention of two eluting solutes in a 
separation.  The selectivity is a function of column packing material.  Method parameters 
such as mobile phase composition, mobile phase pH, and column temperature can all affect 
selectivity.  A selectivity value equal to 1 represents no separation between the solutes. 
Selectivity can be calculated as a function of times, volumes or capacity factors as described 
by the following equation [18, 22, 25] : 
𝛼 =
𝑡2 − 𝑡𝑜
𝑡1  − 𝑡𝑜
  =  
 𝑣2 − 𝑣0
𝑣1 − 𝑣0




Equation 1.3: Definition of selectivity 
 
Where 𝑣2 𝑎𝑛𝑑 𝑣1  represents the retention volume of the respective solute peaks.  





 Resolution (Rs) 1.2.6
The measurement describing the degree of separation between two adjacent peaks is 
calculated as resolution (Rs) using the following equation [18, 22, 25]: 




Equation 1.4: Definition of resolution 
 
Where ∆𝑡𝑟 is the difference of the retention times between two adjacent peaks and wb, (x) are 
the widths at the peak base for each adjacent peak. Instrument vendors will also report 
values calculated using widths at various standard deviations and half height when defining 
instrument specifications and qualification procedures.   
 
The resolution equation can also be represented by the Purnell equation using values of 
efficiency (N), selectivity (α) and retention factor (k) and represented by Equation 1.5. 
 
Equation 1.5: Purnell Equation for resolution between two adjacent peaks highlighting the 
physical and chemical aspects of the equation influencing resolution under isocratic conditions 
 
The Purnell equation can be split to determine the physical or chemical influence on 
resolution.  By breaking down the equation, the ‘physical’ parameters are limited by 





parameters can be due to poor column packing, gaps within the connecting fluidic hardware 
and system volume contributions such as higher volume detector flow cells.  These physical 
limiting factors make it difficult to benefit from the theoretical efficiency provided for 
example, by the use of sub-2µm particle stationary phases 
 
The ‘chemical’ influence of the equation is addressed with the introduction of new hybrid 
stationary phases which are stable at high pH and higher pressures.  Factors such as mobile 
phase composition, pH, and column physiochemical properties will affect selectivity (α) and 
retention factors (k) 
 
A similar equation can be derived for gradient elution chromatography (Equation 1.6) 







Equation 1.6: Resolution equation as it pertains to gradient elution[18]. 
 Chromatographic Efficiency (N)   1.2.7
Column efficiency is measured and reported as a number of theoretical plates (N) calculated 
by Equation 1.7.  Peak width and retention time are key features of the concentration profile 
that determine the efficiency of a column to resolve two solutes under isocratic conditions.   
𝑁 =  
𝐿
𝐻
     
Equation 1.7: Theoretical representation of efficiency  
 
Where L is the length of a column and H is the height equivalent of a theoretical plate, also 
referred to as HETP.   The practical determination of column efficiency is calculated from the 















Equation 1.8: Practical calculation of column efficiency.  
 
The concepts of quantitating column efficiency are used to communicate two major theories, 
plate theory and rate theory. 
 
 Peak Capacity (Pc) 1.2.8
During gradient elution, the solute band is focused at the front of the column and the peak 
fidelity is as adversely affected by diffusion as the solute migrates across the length of the 
column as with an isocratic method.  The separating power of a column under a gradient 
elution profile is determined by a different form of measurement aimed at determining the 
number of discretely resolved peaks that are eluted per unit time.  The efficiency of the 
column measured from a gradient elution experiment is dependent upon the capacity factor of 
the last eluting peak (𝑘𝑚𝑎𝑥 ) and defined by Equation 1.9 [26].   
𝑃𝑐  =   1 +
√𝑁
4𝑅𝑠
 ln(1 + 𝑘𝑚𝑎𝑥) 
Equation 1.9: Calculation of peak capacity under isocratic conditions. 
 
 
When using a gradient elution, peak capacity can be calculated by the following Equation 
1.10 where tg = time for the gradient and w is the width of the chromatographic peak  








 Plate Theory 1.2.9
The theoretical plate model assumes a column of fixed length is equally segregated into a 
large number of divisions across the column with each division representing a theoretical 
plate (Figure 1.4).  Plate theory assumes the solute is in equilibrium with the stationary phase 
and mobile phase as it migrates through the column from one plate to the next.  A larger 
number of theoretical plates (N) translate to a more efficient column.  
 
Figure 1.4: Conceptual representation of a theoretical plate and division within in a column 
 
Unfortunately, plate theory does not account for additional phenomena occurring within the 
column affecting the rate of elution and solute band fidelity as it travels the length of the 
column, hence why the Rate Theory is widely adopted. 
 
 Rate Theory 1.2.10
Rate theories consider the contribution of flow hydrodynamics and their effect on peak 
dispersion.  The Height Equivalent to the Theoretical Plate (HETP) is the theoretical link 
between Plate Theory and Rate Theory representing a numerical value equal to the variance 
per unit length of the column. The HETP is a function of the representative of the properties 
of the column and the solute. If Equation 1.7 was solved for HETP (H) to yield Equation 






resolution. HETP determinations provide a good measure for dispersion within the column 
when plotted versus linear velocity.   
𝐻𝐸𝑇𝑃 (𝐻)  =  
𝐿
𝑁
     
Equation 1.11: Calculation determining the height equivalent theoretical plate 
 
A number of equations have been used to represent the efficiency, flow and peak width 
dispersion relationship such as the van Deemter equation, the Giddings equation and the 
Knox equation.  The van Deemter equation is the most commonly used and simplest to apply 
practically to a set of empirical data where the linear velocity (u) is known [18].   




Equation 1.12:  The van Deemter equation 
 
The van Deemter equation (Equation 1.12) is composed of three independent contributions, 
which additively represent a curved relationship when plotted (Figure 1.5).  The three terms 
are generally represented by A, B and C.   
 The A term represents the contribution of solute eddy diffusion that occurs as a result 
of varying size and distribution of inter-particle channels in the column.  The A term 
is independent of linear velocity and solely dependent on the column packing.  Solute 
band broadening as a result of eddy diffusion can be minimised by using small 






 The B term captures the molecular longitudinal diffusion (axial) and is indirectly 
proportional to the linear velocity.   The B term dominates band broadening at low 
velocities.  However, in liquid chromatography where diffusion coefficients are small, 
the contribution of Hmd  to the overall plate height is often negligible. 
 
 
 The C term considers the resistance to all mass transfer contributions as it pertains to 
the mobile phase and stationary phase interactions inclusive of any adsorption 
kinetics.  The C term increases within increasing linear velocity and increasing 
particle diameter.   
 
The three terms plotted together indicate a minimum dispersion whereas the optimum linear 
velocity, or flow rate can be determined to achieve the maximum efficiency (or minimum 
HETP) for a particular column.  This information is essential when developing and 
optimizing chromatographic method conditions, column vendor selection, and method 
validation activities. Methods operating in the robust regime of the maximum efficiency 







Figure 1.5: van Deemter Plot showing contribution of A, B, and C terms on HETP. Figure 
courtesy of Waters Corporation 
 
 Extra-column volume and Band Broadening 1.2.11
Measuring the efficiency of columns using any of the rate theories is an excellent approach to 
making decisions regarding column choice.  An analytical scientist can make assumptions on 
how well a vendor can control their column manufacturing process and provide a quality 
column with the least occurrence of bandspreading factors adversely affecting overall column 
efficiency.  With that said, the factors affecting column efficiency within the column are 
controlled by the vendor or the individual choosing to pack stationary phase in the column.  
Factor controlling those aspects of efficiency are more or less out of the control of the 
everyday analysts.  There are factors that an everyday analyst can control related to the 
chromatographic systems, which can contribute to decreases in observed efficiency.  These 
extra-column effects are easily controlled and easily identified via system level 





Extra-column volume effects are found within the connections of the fluidic path of the 
chromatographic system.  They are typically identified at the column connections due to the 
frequent interchanging use of columns.  They are also found at valve connections, flow 
splitters, and detection interfaces. In some instances, improper fittings are causing other 
complications such as sample carryover from injection to injection in addition to the 
contribution to dispersion (Figure 1.6). 
 
Figure 1.6:  Illustration of a sample loop fitting within the injection valve of a chromatographic 
system highlighting the ‘gap’ contributing to dispersion and sample carryover. 
 
  











All of the aforementioned extra-column dispersion effects are independent and therefore 
additive variance (σ) contributions affecting overall observed separation efficiency 
represented by the following equation: 
𝜎𝑡
2  =   𝜎𝑖
2 +  𝜎𝑓
2 + 𝜎𝑐
2 +  𝜎𝑑
2 
Equation 1.13: Equation for dispersion variance 
 
Where (t) is the total variance calculated from the additive contributions from the injector (i), 
the fluidic path and tubing quality (f), the column internal dispersion (c), and the detector (d).   
 
 Specific Permeability and Diffusion Coefficient 1.2.12
Solute permeability and diffusion provide an insight into quality when comparing columns 
with different packing attributes.  Derivations of permeability and diffusion coefficient 
equations allow for theoretical equations focused to measure separation impedance [27] or 
quality of the separation medium [18].  They can also help predict theoretical plate 
assumptions regarding column efficiency comparisons when using mobile phases with 
different viscosities.   
 
Diffusion coefficients for a solute in the mobile phase must be known to predict HETP or 
optimal linear velocities.  Based on the van Deemter plots, the slope of C term is predicted to 
decrease as a result of the indirect proportional relationship of the increased diffusion 
coefficient (D) to the viscosity of the mobile phase ().  The diffusion coefficient can be 









Equation 1.14:  Wilke-Chang equation for diffusion 
 
Where T is the temperature in Kelvin, M2 is the molecular weight of the solvent, V1 is the 
molar volume of the solute in milliliters, and η is the viscosity in centipoise, and ψ2 is the 
association factor for the solvent.  An association factor for non-polar solvents would be 1, 
1.9 for methanol, and 2.6 for water [25]. 
 
If a mobile phase of lower viscosity is used, the “resistance to mass transfer” decreases, and 
the slope of the C term decreases allowing for a larger range of optimal linear velocity.  
Dissecting this statement further, the influence of specific permeability (B0) relating to the 
packing density and flow through properties of the column/particle morphology, can be 
related to that of the mobile phase viscosity.  Permeability is useful to know when exploring 
the kinetic capabilities of a packing morphology combined with instruments limitations [28-





Equation 1.15: Equation for specific permeability 
Where ∆p is the pressure drop along a column, r is radius of the column and F is the flow 
rate.  
 
The A term of the van Deemter equation is more or less fixed by the quality of the column 




diffusion coefficient and specific permeability have influence on the B and C terms of the van 
Deemter and therefore influence the point of optimal flow rate. 
 
1.3 Supercritical Fluids  
Supercritical fluids have been primarily a subject of physical chemistry research over the past 
century [31], specifically with natural products. Particular discoveries have allowed increased 
capabilities for analytical chemistry, provided profitable improvements when implemented by 
industry, and heightened the awareness as a viable environmental friendly solution addressing 
the worldwide initiatives for sustainability.  The industry has used supercritical fluid CO2 to 
extract essential oils from hops for use in beer brewing.  The hop extracts obtained by 
supercritical extraction (SFE) can solve many industrial problems associated with 
evaporation during storage.  The use of the hops extracts instead of the raw hops would 
eliminate the need for cooled storage essentially reducing energy costs [32].  Saul Katz from 
the General Foods Corporation developed a method extracting caffeine from green coffee 
beans resulting in a more efficient process for batch processing of decaffeinated coffee [33].  
Although these are only a few examples, the applicability for supercritical fluid CO2 are 
widespread for practical purposes throughout pharmaceutical, food, environmental, and 
consumer needs industries. 
 





 centuries, experimentation designed to explore the behavior of fluids in 
presence of high temperature and high pressure was heightened with Denis Papin’s invention 
of the “steam digester” in 1679.   The steam digester, otherwise known as the Papin Digester, 




extract fat from bones or reduce bone to bone meal [34].  The Papin digester was one of 
many devices used for experiments exploring liquefaction of gases in the late 1700s by 
Antoine-Laurent de Lavoisier [35] which stemmed from the interest of French baron Charles 
Cagniard de La Tour. Cagniard de La Tour’s experimentation in 1822 using the Papin 
digester, a quartz ball, and alcohol marking the first reports of an acoustical difference 
projected by the ball when rolled in the digester as the state of phase was changed with 
increasing temperature [36].  Further research with a glass tube visually confirmed his 
hypothesis of a homogeneous mixture and cited observations of a diminished meniscus 
between the two layers where the gas and liquid meet.  He called this phenomena the “ѐtat 
particulier” [37].  Later, Mendeleev referred to it as the “absolute boiling point” in 1861 [38].  
Cagniard de La Tour’s discovery initiated further interest from Michael Faraday years later 
who began a search for a term to call this continuity behavior [39, 40].  Thomas Andrews 
studied the pressure-volume curve of carbonic acid homogenous fluid and published his 
works using the term we currently use today – “the critical point” [41].   
 
Historically, supercritical fluids have been defined as substances that are above their critical 
temperature (TC) and above their critical pressure (PC).  Recent theoretical research 
highlighted in section 1.4 of this chapter discusses extensions of this historical definition.  
Once a substance is above the TC and PC, equilibrium of vapor and liquids, a common 
homogenous substance can be observed.  Phase diagrams generally are constructed to 
describe the three states of matter for a substance; solid, liquid, and gas, yet provide a visual 
aid to defining the supercritical nature of that substance.   For the example of carbon dioxide 
(CO2), the phase diagram in Figure 1.7 highlights the boundaries of each of the three states of 
matter whereas convergence to the triple point indicates a state of equilibrium for all three 




gas states of matter, distinctions regarding the substance density can be observed until a 
convergence of the densities occurs.  The convergence point results in a homogeneous 
solution occurring beyond the boiling point boundary and is defined as the critical point, or 
Cagnaird de La Tour’s “ѐtat particulier”.  Changes in temperature or pressure above the 




Figure 1.7: Phase diagram illustration for carbon dioxide 
 
 Properties of Supercritical fluids 1.3.2
Supercritical fluids have been pictorially described in phase diagrams, however supercritical 
fluid is not an additional or new state of matter such as the known states of matter, which are 
solids, liquids, and gases.  The properties of supercritical fluids allow defined changes in the 

























to the properties of a liquid.  The critical temperatures and critical pressures of many 
substances are listed in Error! Reference source not found..  A gas to liquid state transition 
is determined by intra-molecular forces.  The motional energies of gaseous molecules can 
overcome the attractive forces that lead to a liquid state when the critical temperatures and 
critical pressures are reached [43].  An increase in pressure of a gas in a closed container 
forces the molecules to exist in close proximity to each other which results in frequent 
molecular collisions.  Although a gas, the density approaches that of a liquid.  The increased 
molecular collision rate allows the supercritical fluid to increase the solvating properties; 
hence it’s applicability as an extraction solvent. Hannay and Hogarth published the first 
account of the solvating properties in 1879 and 1880 [44-46]. Hannay’s findings were 
summarized as stating the solvating property was related to the increased density of the gas 
and increases in volume would result in decreased solvent action [46]. For example, 
appropriate manipulations of temperature and pressure of supercritical carbon dioxide (CO2) 
can extract complex mixtures from food, pharmaceuticals, chemicals, fossil fuels and plastics 





Table 1.2: Critical temperatures and critical pressures of various substances 
Substance Tc (
0
C) Pc (psi) 
Propane 97 616 
Ammonia 132 1691 
Carbon Dioxide 31 1132 
Hydrogen - 242 294 
Nitrogen -149 514 
Oxygen -118 735  
Helium -268 33 
Water 374 3200 
Phosphine 51 947 
Argon -122 705 
Propane 97 617 
Hydrogen Sulfide 102 1306 
 
 
Interestingly, decreasing the density of the supercritical fluid can result in separation of the 
solute and from the supercritical fluid if there is a solubility mismatch and the solute and 
crash out of solution.  The reduction in viscosity and increase in diffusivity; where diffusivity 
refers to the supercritical fluid’s ability to pass through a substance at a measured rate,  
when applied to separation techniques, potentially increases the applicability of the 
supercritical fluid for chromatography but it must be balanced for analyte solubility [48].  
The diffusivity and viscosity properties of a gas, a liquid and a supercritical fluid are 
compared in Table 1.3Error! Reference source not found..  In terms of a practical 




packed column chromatographic applications, as first suggested by Lovelock in 1958 [49, 
50].   





































The most commonly used supercritical fluid is carbon dioxide (CO2).  CO2 is chemically 
pure, non-polar, and stable.  The physical state of CO2 can be easily manipulated by 
commercial instrumentation due to the achievable critical pressure and critical temperature.  
The use of CO2 is considered environmentally benign.  The waste removal is residue-free, 
non-toxic (relative to handling of organic solvents), and non-flammable.  CO2 is considered a 
renewable feedstock.  The majority of CO2 collection is produced and collected in processes 
from the effluent of ammonia plants or derived from naturally occurring deposits [51].  It is 
also a by-product from commercial processes fermenting sugars from beer and wine making, 
yet there is no published reference of collection from beer of wine manufacturers for mass 





1.4 Supercritical Fluid Chromatography 
Supercritical fluid chromatography has been researched extensively since the 1960s.  The 
inclines and plateaus of research activity have cycled approximately each decade.  During 
this time frame, three review articles have been published and when read collectively, cover 
an extremely in-depth overview of the history, theoretical principles, instrumentation 
innovations, and practical applications.  Roger Smith’s 1999 review “Supercritical Fluids in 
Separation Science – the dreams, the reality and the future” is a concise compilation of the 20 
years prior to publication and candid perspective on the future direction of supercritical fluid 
chromatography [31].  Larry Taylor’s 2009 review compared the capillary and packed 
column approaches while highlighting current trends moving forward with SFC [52].  
Guiochon and Tarafder’s 2011 review, focuses on the main fundamental issues that need to 
be studied and understood in order to reach a level of knowledge of SFC similar to the one 
now achieved in preparative GC and HPLC [53].  Lesellier’s review in 2009 “Retention 
mechanisms in super/subcritical fluid chromatography on packed columns” provides a 
concise general overview, however the review lacks a comprehensive citation diversity of 
work performed by the scientific community. Berger and Lesellier account for greater than 
55% of the bibliography [54].  It should be noted, a more comprehensive review based on 
packed column SFC providing an overview of theoretical and novel developments in recent 
years was finally published in 2015 during the writing of this thesis [55].  The 2015 Lesellier 
and West review provides a new foundation for industry to expand upon and develop new 
pragmatic uses of packed column SFC.  
 
 Historical Application of Supercritical Fluid Chromatography 1.4.1
Klesper et al. has been credited in the majority of publications as pioneering supercritical 




an apparatus using chloroflouroalkanes as a mobile phase due to their inertness and low 
flammability to separate etioporphyrin II, Ni etioporphyrin II, and NI mesoporphyrin IX 
dimethylester.  The porphyrin colored bands was observed to elute down the path of the 
polyethylene glycol stationary phase lined glass column.  They referred to this technique as 
“High Pressure Gas Chromatography above Critical temperatures”. 
 
In the late 1960s, Sie and Rijinders published novel approaches using supercritical CO2, gas-
liquid and gas-solid separations, and instrument designs for sample introduction and detection 
[57-60]. They were the first to coin the term supercritical fluid chromatography as they 
investigated the rapid analysis of compounds deemed heavy for ordinary gas 
chromatography, using n-pentane and isopropanol as mobile phase fluids under supercritical 
conditions [61].  In the same decade (1969), J. Calvin Giddings et al. expanded on this 
research by utilizing pressures greater than 2000 bar and reported it “Dense Gas 
Chromatography” [62].  Giddings insights sparked the ideology transferring the nomenclature 
from supercritical chromatography to evolve as “Unified Chromatography”.  He stated “One 
of the most interesting features of ultra-high-pressure gas chromatography would be its 
convergence with classical liquid chromatography…” predicting “there ought to be only one 
theory, or at least one true theory, of chromatography”.  20 years after Giddings findings,  
Martire and Boehm’s theories link GC, SFC, and LC with a set of general equations reducing 
the retention expressions with assumptions [63].  They came to the recognition of certain 
similarities among the equations describing supercritical fluid chromatography (SFC) and 
several previously derived expressions (based on kindred models) for gas and liquid 
chromatography (GC and LC, respectively).  The end result of this realization is a unified 
theory of chromatography, encompassing all three types of mobile phases.  In further 




forming a “unified molecular theory of chromatography” however, the research was focused 
mostly on the capillary approaches [64, 65].   Based on similar findings, Ishii and Takeuchi 
introduced the term “unified fluid chromatography” in which they envisioned changing the 
separation mode between GC, SFC, and LC by changing temperature and pressure [66].  
Chester published unified chromatography theories redefining the representation of the 
supercritical fluid region specified above the critical point on the phase diagram concepts in 
Figure 1.8 [67].  The change in perception of the supercritical region is consistent with recent 
theoretical research by Tarafder and Guiochon whereas the isopycnic plots were constructed 
to determine how the role of density dictates operating conditions for SFC [68-74]. 
 
 
Figure 1.8: Two dimensional phase diagram representing a unified region derived from Chester 




















  ‘Open Tubular’ versus ‘Packed Column’ Supercritical Fluid Chromatography  1.4.2
Supercritical fluid chromatography can be performed with open tubular capillary columns 
(cSFC), packed capillary columns (pcSFC) or with packed columns (pSFC).  The techniques 
are compared most appropriately in terms of maximum number of plates assuming the 
pressure drop per theoretical plate can be compared and the maximum pressure drop 
allowable across a column can be determined [75].  Schoenmakers reports an equation 
(Equation 1.16) seemingly derived from the specific permeability equation and Kozeny-
Carmen equations to summarize a comparison of Open, Packed, and Packed-capillary 
columns: 
[𝐵0𝜂𝑛ℎ𝑟?̅?𝐷𝑀]𝑐  =  [𝐵0𝜂𝑛ℎ𝑟?̅?𝐷𝑀]𝑝 
Equation 1.16:  Efficiency relationship equation for the comparison of open, packed, and 
packed capillary columns when assuming maximum achievable theoretical plates 
 
Where (η) is the viscosity of the mobile phase (Pa.s), (hr) is the reduced plate height,  (v̅) is 





), Bo is the specific permeability coefficient (m
-2
).  For capillary columns Bo = 32/dc
2,  
hr = 4.5 and v̅ = 45.  For packed columns Bo = 1000/dp
2 , hr = 3, and  v̅ = 10. 
 











Schoenmakers summarizes example values in a table within the chapter concluding that very 
high plates counts are achievable by capillary column SFC, but they come with a cost of a 
very high run time (i.e. for a 50 µm ID column, a maximum theoretical plate count of 
9,260,000, but a 77,000 minute run time) [75].  
 
Open tubular columns are designed with a film of stationary phase coated on the inside walls 
of the column.  Successful implementations of an open tubular SFC are based on three critical 
parameters:   
1. The system must include the column and the detector within the same pressurized 
value,   
2. The system must minimize the contributions to band broadening, and  
3. The internal stationary phase films must be optimized to resist long term bleed, yet 
provide minimal resistance for mass transfer.   
 
This technique was pioneered by Novotny et al. premised on the early concern that packed 
columns produce a pressure drop along the column significantly reducing the 
chromatographic efficiency of a pSFC approach [76].  Open tubular capillary columns 
progressed initially in the 1980s based on research focusing on highly efficient separations of 
non-polar hydrocarbons and flame ionization detection capability.  Their internal diameters 
were typically 50 µm to 100 µm.  Unfortunately, enthusiasm dwindled due to lack of 
reproducibility, blockages due to adiabatic expansion of the CO2, low sample “loadability” 
leading to poor techniques introducing the solute in small amounts (nL), limited solute 
applicability (i.e. poor for polar solutes), and lack of commitment from vendors to innovate 





Packed column SFC (pSFC) research began to expand once the limitations of open tubular 
SFC were realized.  The benefits of packed column SFC was realized in terms of improved 
separation performance, solute flexibility and instrumentation ease of use.  Typically, packed 
columns, which are commonly used for liquid chromatography, with particle sizes ranging 
from 3 µm – 10 µm, lengths ranging from 50 mm – 300 mm and internal diameters ranging 
from 3.9 mm – 4.6 mm have been used.  The range of usable stationary phases includes 
normal phase, chiral and reversed-phase columns.  The first reports of packed column SFC 
was performed by Gere et al. by modifying a commercial (Hewlett-Packard) HPLC system 
by adding backpressure regulation, a high pressure UV flow cell, and external chilling [77].  
They successfully constructed van Deemter plots comparing packed column SFC and HPLC 
for columns with 3 µm and 5 µm particle stationary phases, and the results showed that pSFC 
combined with small particles provide greater chromatographic efficiency and speed.  The 
importance of their findings negated the disputes regarding the effect of the pressure drop on 
performance for small particle stationary phases from previous reports [61, 76]. 
 
The main advantage of packed capillary column SFC (pcSFC) is the higher specific 
permeability (Bo) resulting in a higher number of theoretical plates obtained when compared 
to a conventional packed column with the same pressure drop.  The decreased internal 
column diameters would require reduced instrument extra-column volumes. For this reason, 
the reduced internal diameters would be a challenge for detector flow cell design and sample 
injection designs.   In comparison to open tubular capillary SFC, the benefits of packed 





 Role of Density for Solute Retention in SFC 1.4.3
The role of density and its impact on supercritical fluid chromatography was first explored by 
Van Wasen and Scheider where they plotted capacity factors in respect to density rather than 
pressure, thus concluding isothermal curves were more appropriate to use [78].  Peaden and 
Lee used open tubular supercritical chromatography to determine similar relationships 
between the retention factors and density [79].  This lead to a general expression for column 
efficiency derived from the relationship of the solute retention and mobile phase density by 
Poe and Martire [80].   
 
Understanding the role of pressure, temperature and more notably density were determined to 
be controlling mechanisms for solute retention.  However, the factors they controlled were 
determined to be mobile phase viscosity, solute diffusivity, and solubility.  Lou et al. plotted 
the effect of changing temperature and pressure on solute solubility [81].  Lou et al. 
developed methodology to measure the vapor pressure of acenapthene, anthracene, and 
chrysene using FID.  They measured inflection points suggesting retention factors are 
inversely proportional to solubility and directly proportional to the affinity for the solute with 
the stationary phase.  The experiments allowed Lou et al. to derive an equation to estimate 
the solute affinity to the stationary phase with changes in temperature.  Solubility has also 
been plotted as a function of pressure, however it was observed by many that trends were 
difficult to determine [82, 83].  The solubility of different analytes with respect to pressure 
gave rise to different slopes resulting in crossover points.  Yet, the author plots the same data 
as a function of density and the author observes the solubility to have clear and specific 
trends [73].  Solubility increases with increasing density under isothermal conditions and 




Mobile phase viscosity changes with particular flow rates and directly affects the pressure 
drop along a column. Due to these changes in pressure, density gradients occur along the 
column.  Scientists have modeled these viscosity changes in CO2 with a wide range of 
pressure and temperature values [84, 85].  The National Institute of Standards and 
Technology (NIST) uses the equations derived from Vesovic et al. experimentation and 
provides them to researchers learning to understand supercritical fluids through modeling 
[84].  Together with the NIST values and REFROP software, Tarafder et al. [73] derived an 
equation based on the dependence of retention on density and temperature.  Tarafder reduced 
the equation, Equation 1.18, which resembled the solubility equation derived by Chrastil [86].   
ln(𝑘𝑖) =  −(𝜆𝑖 +  1)  ln(𝜌) +  ln( 𝑓𝑖(𝑇)) 
Equation 1.18: Tarafder's reduced equation for retention dependency on density and 
temperature 
 
Where ki is the retention factor of component i, where λ is a coefficient depending on the 
experimental conditions,  ρ is the density of the mobile phase and T is the temperature.   
 
Although the solute solubility has a dependence on temperature and density, it was the 
opinion of Tarafder et al.; stating later in section 1.4.5, that the solute diffusivity dependence 
was strongly influenced by the mobile phase density alone. 
 
  Column Efficiency in SFC 1.4.4
Density plays a critical role in SFC, in terms of solubility, diffusivity, viscosity, pressure drop 
across a column, and therefore it can be expected that density plays a major role in 




determinations of column efficiency in terms of height equivalent to a theoretical plate 
(HETP) was performed by Bartmann and Schneider [87].  Their Equation 1.19 is divided into 














Equation 1.19: Bartmann and Schneider efficiency equation when accounting for the role of 
density in SFC 
   
Therefore:    
𝐼𝑓 𝜌 ↓ ,     𝑡ℎ𝑒𝑛  ?̅? ↑   𝐷𝑚 ↑   𝜂 ↓   𝑘 ↑  𝑎𝑛𝑑 𝐻 ↓ 
(whereas k remains an integer greater than 2 and changes in density are a function of changes in 
pressure while maintaining constant temperature above the critical point) 
 
The loss of efficiency, specifically in particular regions of low pressure and low temperature 
where the mobile phase has a low viscosity and high molecular diffusivity, has been studied 
and hypothesized for decades.  The earliest investigations hypothesized that the loss of 
efficiency was due to large pressure drops across the column[61, 76].   This theory was later 
confirmed by various authors, suggesting the low efficiency is attributed to large density 
gradients [88-90]. A commonality was observed throughout many literature citations, where 
for the general operating values of 373 K and 80 bar, scientists repeatedly generated low 
efficiency “poor” chromatograms.  Rajendran et al. performed experiments near this critical 
region speculating that the poor chromatographic efficiency was due to adiabatic cooling 
[91].  Poe and Schroden [92]  expanded on this concept and determined the occurrence of 
radial temperature gradients along the column in which Kaczmarski et al. [93] calculated the 
axial and radial temperature gradients within the column during Poe’s experiments.  They 




insulated and air bath configurations.  At reduced densities, approaching 1.0, band 
broadening and peak splitting was far greater with the column residing in the air bath versus 
the insulated column, suggesting the radial temperature gradient was mitigated, but the axial 
gradient maintained an influence on the separation. Reducing the particle size only 
pronounced the band broadening issue, thus leading to the investigations the separation 
influence due to the temperature drop across a column.  During some preliminary 
experimentation with sub-2 µm particle stationary phases performed on prototype 
instrumentation, similar peak shape abnormalities were observed and will be discussed 
further in Chapter 2. 
 
 Recent Theoretical Advancements in SFC 1.4.5
In 2010, the collaborative research from the University of Minnesota-Duluth, University of 
Tennessee, Oak Ridge National Laboratory, Rzeszow University of Technology (Poland), 
and Waters Corporation, resulted in significant advance in supercritical fluids theory.  The 
research was focused on explaining the insights of previous works with peculiar results 
regarding the observed efficiency when using neat CO2 in supercritical or subcritical states.  
The recent theoretical research published by Tarafder et al., correlates the critical role of 
density, the design of constant density plots (or isopycnic plots) and the applied use of the 
isopycnic plots to determine optimal operating parameters when using SFC.  The isopycnic 
plots are referred in the context of a pressure – temperature plane (P-T plane).  Tarafder 
successfully explains the previously reported phenomena using the isopycnic plots proving or 




1.5 SFC Technology and Instrumentation 
For the purposes of this research, the general components of SFC focused technologies such 
as stationary phases and instrumentation, are discussed in this section enabling the low 
dispersion system evaluation, systems integration studies, method development strategy 
development and natural products research performed in Chapters 2 through 6.   
 
 SFC Core Components 1.5.1
Instruments used for supercritical fluid chromatography require a core configuration different 
to conventional liquid and gas chromatographic systems (Figure 1.9) illustrates the essential 






Figure 1.9: Core components schematic of the Waters ACQUITY UPC
2
 instrumentation with 

























1.5.1.1 Pump Design 
Pumping mechanisms are designed in one of two approaches as shown in Figure 1.10.  The 
pumping mechanism is a binary high pressure mixing design.   
 Design 1 -  cools the CO2 using an integrated thermoelectric chilling device that 
operates as a heat sink located on the piston delivery component of the pump with 
heat sink cooling coils located at the head of the pump.   
 
 Design 2 - utilizes a chilling device between the CO2 tank and the pumping device, 
typically performed using a glycol-chilling agent.  In both instances, the CO2 is 
cooled to maintain a more dense liquid state.  Liquid CO2 is less compressible than 
supercritical or gaseous CO2; therefore cooling the CO2 fluid to low temperatures 
allows the pumping mechanism to reproducibly compress and control the density of 
the CO2 and delivers the fluid throughout the chromatographic system in a manner 




Although the fluid delivered is in a liquid-like state, super/subcritical properties occur within 
the column once heat is applied.  The design which best controls the temperature, density, 
and compressibility effectively, should yield improvements in baseline noise and 
reproducible elution times.  In theory, Design 1 allows for a more precise electrically 
controlled temperature environment within the pump chamber, thus allowing for a reduced 
baseline drift and reduced baseline noise due to external environment temperature 
fluxuations.  Basically, Design 1 should minimize the amount of density variability of the 
liquid CO2 and allow for a more controlled delivery of the mobile phase.  The improved 
solvent delivery would benefit signal to noise ratio measurements and improve the overall 






Figure 1.10:  Schematic representation of two different commercial designs of pumping 
mechanism delivering liquid CO2. Figure courtesy of Waters Corporation. 
 
 
1.5.1.2 Sample Introduction 
Historically, traditional SFC instrumentation was simply re-purposed HPLC equipment 
which used a single valve injection design Figure 1.11 (A).  This can lead to irreproducibility 
from injection to injection.  As a result, validation of an SFC method was considered a 
challenge.  The injection sequence performed by a re-purposed HPLC autosampler can result 
in difficulties maintaining the physical state of CO2, therefore leading to poor injector 
linearity, accuracy and precision.  Adiabatic expansion of the CO2 liquid would occur and 
vent through the path of least resistance, typically in the path of the needle.  The out-gassing 
of the CO2 from the needle would create positive pressure at the point of sample retrieval and 


























effectively used for quantitative analysis.  In order to maintain the physical state of CO2, only 
full loop injections could be performed.  As a consequence of only performing full loop 
injections, sample was wasted due to loop overfills needed to place the sample properly in the 
loop for injection.   
 
The use of a second auxiliary valve (Figure 1.11 (B)), allows the injection mechanism to 
maintain the CO2 physical state and prevent expansion and expulsion of the gas out of the 
needle.  The auxiliary valve also provides expanded flexibility allowing partial loop 
injections with precision and accuracy.  The dual injection design will vent residual 
pressurized CO2 in the primary sample loop to waste, enabling the sample to enter the loop 
under atmospheric pressure while maintaining the closed circuit of the mobile phase flow 
stream keeping the CO2 mobile phase in a supercritical phase.  The design of the auxillary 
valve also allows for reductions in pressure pulsation resulting in adding to the 
reproducibility of the sampling design when performing partial loop injections.  A single 
valve design would result in positive pressure inside the needle during the sampling from the 
vial due from the depressureing residual CO2 escaping through the path of least restriction.  






Figure 1.11:  Schematic representation of two different injector designs; single (A) and dual (B) 
valve designs used in autosamplers for SFC instrumentation.  
 
 SFC Stationary Phases and Mechanisms 1.5.2
Supercritical fluid chromatography is referred to as a derivative of normal phase 
chromatography.  Normal phase LC (NPLC) is characterized as an adsorption based retention 
mechanism and driven by the solute affinity to the stationary phase.  This is different to 
reversed-phase LC (RPLC), which is characterized by a hydrophobic retention mechanism 
based on the solute partitioning in the stationary phase and the solute elution affinity upon 
increasing organic in the mobile phase.  Many stationary phases can be used with 
super/subcritical CO2 mobile phases.  SFC which is described to have adsorption retention 
mechanisms can also have ionic interactions either with the mobile phase or stationary phase.  
Solute retention can be affected by the addition of an ion-pairing additive increasing the 
polarity of stationary phase and mobile phase [94].  One of the differences between normal 
phase and reversed-phase LC are the opposite polarities of the mobile phases used to elute the 
solute.  In SFC, the mobile phase can remain constant regardless of the type of stationary 
phase; polar or non-polar leading to a ‘stationary phase agnostic’ approach.  Column polarity 
along with the choice of additive [95] can dictate the elution of the solute providing a more 
“unified” approach to chromatography [96]. 












































The industry has primarily adopted the use of chiral stationary phases for the preferred 
analysis of enantiomeric racemates.  Chiral stationary phases are manufactured either with (i) 
a polymer coated with an enantiomeric selector or with (ii) an immobilized enantiomeric 
selector.   In terms of which is more effective, a study by Ghanem et al. concluded the 
polymer coated amylose tris-(3,5- dimethylphenylcarbamate) chiral column provided the best 
separation of the chiral β-blocker probes. However, the immobilized amylose tris-(3,5-
dimethylphenylcarbamate) chiral column provided solvent flexibility such as allowing the use 
of chlorinated organic solvents [97]. 
 
Normal phase columns and columns used for hydrophilic interaction liquid chromatography 
(HILIC) are polar and commonly used for the achiral analysis of polar solutes.  These 
columns are packed with particles such as pure silica and stationary phases with ligand 
functionality consisting of any of the following: diol, cyano, amino, 2-ethylpyridine (2-EP), 
amide, and aminopropyl groups.  Reversed-phase columns are typically non-polar and 
include hydrocarbon chains bonded to silica such as octylsiloxane bonded silica (C8) and 
octadecylsiloxane bonded silica (C18).  Other typical RPLC columns that are used include 
phenyl propyl, phenyl-hexyl and penta-flouro phenyl bonded ligands.  In a paper by West and 
Lesellier, they classify 28 commercially available stationary phases based on three types: 
non-polar, moderately polar and very polar [96].  They evaluated up to 111 solutes using 
linear solvation energy relationships (LSER) and plotted selectivity characteristics of the 
solutes, which allowed for a visual representation of the 28 columns in a five-dimensional 
plot.  They conclude by stating, “SFC is a normal phase and a reversed-phase technique 




the stationary phase, as in reversed-phase LC, then a plot of the logarithm of the retention 
factors (log k) versus the logarithm octanol-water coefficient (logP) would indicate a 
decreased retention as polarity increased.  The reverse is true when plotting logk vs. logP for 
stationary phases which are more hydrophilic than the mobile phase, a similar observation to 
that obtained with normal phase LC.  West et al. noted that when the stationary phase is 
bonded with an aromatic ligand, the logk vs. logP trending for polarity is indiscriminate for 
the solutes tested, thus eluding to retention mechanism influence from other functionality 
from the aromatic ligand [96].  Therefore, their LSER models provide a characterization of 
stationary phases because the equation considers the additional factors that may affect 
retention such as hydrogen-bonding, π-π interactions, and dipole-dipole interactions induced 





 Detection Schemes 1.5.3
Traditional SFC instrumentation has been configured with various types of detection such as 
Ultraviolet (UV/Vis), Diode Array (DAD) or Photodiode Array (PDA), Evaporative Light 
Scattering (ELSD) [98], Flame Ionization (FID) [99], Mass Spectrometry (MS), 
Chemiluminescent Nitrogen (CLND) [100], Fluorescence (FLR) [101], Corona Charged 
Aerosol (CAD) [102], Acoustic flame ionization [103, 104]. 
 
Systems configured with UV based detection (UV, PDA) are one of the most commonly used 
types of detection for pSFC.  Unfortunately, like the other components, the UV based 
detectors have been repurposed HPLC modules.  The flow cells used in these liquid based 
detectors are designed with the refractive index of typical liquids used with LC analysis.  The 
refractive index for CO2 (1.000) is quite different than water (1.333) or methanol (1.330).  
Therefore, the noise observed from a traditional SFC chromatogram would indicate 
curvature, disturbances or drift in the baseline [105, 106].  Sensitivity would also be impacted 
therefore challenging the capability to perform trace analysis, such as impurity analysis of 
pharmaceuticals.   
 
 Back Pressure Restriction and Regulation  1.5.4
The key functionality to using instrumentation with CO2 based mobile phases is the ability to 
maintain conditions that restrict the CO2 liquid or super/subcritical fluid from endothermic 
expansion to the gas state.  Backpressure restriction can be achieved by using either a static 
restriction or variable restriction.  Static restriction is typically performed using a length of 
tubing or capillary that applies a restrictive pressure greater than the critical pressure of the 




therefore, cannot control mobile phase density as mobile phase density changes with 
changing percent modifier and this can greatly impact the separation.  Static restriction lacks 
the flexibility to perform automated approaches toward method development exploring 
pressure as a variable to aid changes in selectivity.   
 
Instrumentation employing CO2 based mobile phases utilizes a more practical approach by 
including a module that can variably control the pressure with software control.  This is 
commonly referred to as an automatic backpressure regulator (ABPR).  The general 
perceptions of the ABPR designs are not favorable by scientists, yet they accept the necessary 
evil as a tradeoff for flexibility.  Reported issues typically cite performance concerns related 
primarily to baseline noise generation.  ABPR modules utilize a “needle and seat” 
construction that is powered by a stepper motor.  The stepper motor applies pressure on the 
seat mechanism using the needle.  The resolution of the stepper motor describes the amount 
of degrees rotation per pulse.  The higher the resolution, then the more refined the stepper 
motor can make small movements.  The benefits of smaller movements by the stepper motor 
are realized in less pulsation and less baseline noise observed in the chromatogram.  
 
Another applied approach to restriction employs a fixed restrictor with the make-up pump 
running a reverse flow gradient.  This allows the ability to keep the amount of modifier 
constant to the second detector in parallel and across the restrictor.  Unfortunately, like the 
static approach, the backpressure cannot be variably controlled, and therefore, mobile phase 
density will vary with changes in modifier.   In order to interface with multiple detectors, a 
flow splitter that allows the control of the column outlet backpressure provides the greatest 





When coupling UV detection to a destructive based detector such as ELSD or MS, a multiple 
connection splitter allows for a fixed leak and introduction of make-up flow when also 
connected to an ABPR or fixed restrictor.  This enables control of the mobile phase density.  
The challenges to this approach are associated with minimizing band spreading when 
comparing the two detector traces (i.e. UV vs. MS), and maximizing sensitivity for the 
detector receiving the fixed leak of flow versus diverting the majority of the sample to waste.  
Schematics of multi-connection splitter configurations are illustrated in Figure 1.12 and 
Figure 1.13.  Figure 1.12 is a commercially available splitter and Figure 1.13 is a splitter 
designed to utilize a lower amount of make-up flow which results in reduced dilution of the 
sample and provides a stable flow when introduced into a MS detector.  
 
Figure 1.12: Schematic of a commercially available splitter from Waters Corporation (Courtesy 















Figure 1.13:  Schematic of a ‘home-made’ splitter designed to minimize make-up flow sample 
dilution when interfaced to MS in order to maximize sensitivity. 
 
1.6 Supercritical Carbon Dioxide Opportunity for Natural Products Research 
As stated earlier, natural product research involves extraction techniques, chromatographic 
separations, and isolation and scale-up purification tools.  Extraction procedures require 
flexibility for constituent solubility and the range of polarity found in natural products.  In 
practice, scientists utilize a variety of extraction techniques such as microwave extraction, 
soxhlet extraction, solvent-solvent extraction and solid phase extraction (SPE) to meet the 
diversity criteria.  Supercritical fluid extraction (SFE) uses carbon dioxide (CO2) as the 
primary solvator and organic solvents (protic or aprotic), as a secondary solvator in order to 
control the extraction solvating strength.  SFE presents an opportunity as a single technique 
capable of spanning a range of solute polarity and matrix complexity just by manipulating 
temperature and pressure variables to maximize diffusion or solubility, respectively.  
Coupling SFE approaches to chromatographic analysis have the potential of simplifying the 
sample preparation process required to achieve a comprehensive representation of natural 
product profiles, thus streamlining the time required to attain results. 
PDA outlet
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High throughput screening strategies can benefit from the implementation of supercritical 
fluid chromatography.  The SFC mobile phases are less dense thus resulting in a greater 
throughput.  Historically, SFC has been highly used in drug discovery primarily for chiral 
screening.  The opportunity for achiral use is growing.  SFC has the capability of using a 
single solvent system in terms of elution solvent and dilution solvent.  Therefore, time 
savings exploring selectivity is enhanced due to the range of chromatographic tools 
compatible with a single solvent system such as polar, non-polar, chiral, and hybrid stationary 
phases.  During recent personal communications with pharmaceutical companies such as 
AstraZeneca (AZ), Janssen and Janssen, Boehringer Ingeheim (BI), GlaxoSmithKline (GSK), 
Sanofi Aventis, Eli Lilly, and Dart NeuroSciences, each laboratory manager of medicinal 
chemistry and supporting separation science divisions indicated a greater use of supercritical 
fluid chromatographic techniques for achiral analysis.  Each group cited the recent 
improvements of commercially available analytical SFC instrumentation in terms of 
robustness and reliability, which are key to supporting the purification activities.   Many of 
these groups mentioned previous HTS screening activities low success rate, yet they all 
acknowledged a current shift in practice to re-screen natural products focused based libraries 
due to recent re-evaluations of natural products and natural products derived drug approval 
history. This new-found knowledge has allowed companies to intelligently build relevant 
HTS libraries to increase the H2L success rate.  Many of the Medicinal Chemistry 
laboratories managers cited an improvement in both cheminformatically and analytical 
performance as a result of these updated technologies.  Although these groups are shifting to 
greater SFC analytical and purification usage, they all commented on the difficulty of 
implementing a common approach or one-dimensional protocol analogous to the reversed-
phase HPLC strategies used in the past two decades.  Basically stating, these organizations 




development strategies to aid optimization decisions and workflows within their processes.  
Currently, a high number of publications cite existing collaborations and continue to grow 
between industry, academia and vendor providers searching to better characterize and 
develop the tools needed to progress supercritical fluid techniques for drug discovery. 
 
In this study, the primary aim of this research is to provide a pragmatic approach and 
expectations when implementing sub-2 µm particle stationary phases for packed column 
supercritical fluid chromatography for the audience of the pharmaceutical industry.  The 
focus of this study is primarily aimed at the pharmaceuticals audience; however, the 
information should act as an applicable roadmap for additional industries such as the 
chemical materials, petroleum, and food research.  The aim will be achieved through a step-
wise phase driven approach of careful experimental design strategies and application 
development which integrates the technologies and strategies which are required to discover 
new molecular entities.  The hypothesis is to prove supercritical fluids as a critical 
requirement for the workflows involved with natural product research and new molecular 
entity discovery.  This hypothesis is inclusive of proving sub-2 µm particle stationary phase 
packed columns coupled to supercritical fluid chromatography has become a robust approach 
that has been theoretically nurtured by academia and implemented with fortitude by both 
instrument and column vendors.  The overall hypothesis relies on natural products acting as 
the vehicle to quickly identify unique chromatographic behavior due to their complexity of 





 The objectives that will help determine the aims of this thesis are categorized below and 
briefly described: 
 
1. Verify the expected theoretical benefits of using sub-2 µm particle stationary phases for 
packed column supercritical fluid chromatography. The requirement of this verification 
includes the assessment of prototype low system volume SFC instrumentation, 
confirming basic van Deemter principles and correlate results to previous and recently 
published findings.  The comparisons of different column formats; sub-2µm and supra-
2µm; the chromatographic efficiency can be reviewed and compared with RPLC trends 
when reducing particle size.  This will help determine if the SFC instrumentation design 
facilitates the use of sub-2 µm particle stationary phases.  These findings will be 
reflected in Chapter 2. 
 
2. The effect of solvents typically used in a synthesis laboratory will be explored to assess 
their effects on chromatographic performance. Attain method development insights and 
strategies which are fit-for-purpose for their intended use in discovery HTS and applied 
pharmaceutical development.  This requires a variety of experimentation such as method 
development of  impurity profiles for related substances and biologically related small 
molecules found in nature such as lipids.  The experiments will be designed to help 
understand and control the primary influential variables that effect selectivity, sensitivity 
and resolution as it pertains to the relationship of the solutes, stationary phase and mobile 
phase.  Careful observations will be required in terms of identifying secondary 
interactions or influence on the chromatographic separation.  The end result should 
conclude a simple-to-implement guide and workflow for the industry to implement sub-2 
µm particle stationary phases for packed column supercritical fluid chromatography. 
 
3. Explore a chemical compound library of intermediates using generic SFC screening 
methodology and correlate chromatographic performance to solute physiochemical and 
structural attributes by use of cheminformatics software provided by ChemAxon.  A 
routine use screening method will be developed to analyze the library.  The 
chromatographic attributes of retention, peak symmetry, peak width, efficiency, peak 
height, and peak area will be recorded for each column that they analyzed with.  These 




logP, logS, polarizabilty, etc) and with the structures number and presence of functional 
groups (i.e; amines, esters, hydroxyl, etc)  .  The compound library subset will be 
selected based on the Lipinski’s ‘Rule of Five’. A key aspect of this study would be to 
attain a system suitability method capable of alerting to system level issues affecting 
chromatographic performance.  By utilizing the informatics tools typically used by 
medicinal chemists and minimizing the occurrence of skewed data entry into the 
informatics modelling, confidence can be achieved when identifying particular outliers 
associated with the structural features physiochemical properties of the solute. 
 
 
4. Develop methodology strategies using the knowledge gained from the previous studies 
exploring solvents, selectivity variables, and instrument interfacing best practices and 
apply them to techniques practiced in typical pharmaceutical industry discovery 
organizations.  High throughput screening of chemically diverse compounds will be 
performed and the results compared with those achieved by reversed-phase LC 
approaches.  The application strategy in this phase will also include the reaction 
monitoring of three pharmaceutical syntheses from building block scaffolds to final 
product.   
 
5. Investigate sub-2 µm particle stationary phase supercritical fluid chromatography 
coupled to mass spectrometry for chemical profiling of chamomile extracts as an 
orthogonal approach to chromatographic techniques like RPLC and GC. The aim of this 
phase is to provide insight for future botanicals profiling workflows.  It entails 
comprehensive profiling techniques to discovering unique chemical markers.  The 
application was designed to be validated by previously reported and known reversed-
phase results to further validate the use of sub-2 µm particle stationary phase 
supercritical fluid chromatography and identify additional benefits of utilizing the 
technique. Aside from providing a continuation of comparative analytical separation 
techniques, the use of multivariate statistical processing of results will be used to profile 
the extracts of authentic natural product reference materials for new chemical entities and 





6. Summarize the investigations and final thoughts from previous chapters but also provide 
future insight regarding the impact of supercritical fluid extraction techniques in relation 
to typically performed solvent-solvent techniques to complete the concept of a fully 
supercritical fluid workflow for sample preparation and analysis of natural products for 
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CHAPTER 2   
2 Investigations of a Low Dispersion Prototype SFC Instrument using 
Sub-2 µm Particle Size Columns 
 
2.1 Introduction  
Limitations in analytical SFC instrument design and column availability have prevented the 
adoption of small particle pSFC[48].  Earlier attempts at implementing sub-2µm packed 
column SFC (pSFC) have resulted in many false starts due to the lack of commercially 
available instrumentation optimized for sub-2 µm particle stationary phase analysis[48, 75, 
92]. As for analytical pSFC, many systems identified in the public domain utilize instrument 
configurations limited by large system volume and extra column volumes which affect their 
ability to achieve optimal chromatographic performance[50, 52, 54, 94, 96].  
 
A new generation of SFC technology was designed by the research, development and 
engineering (RD&E) teams at Waters Corporation.   Their design concepts were targeted to 
address the general issues of traditional SFC commercialized and non-commercialized 
instrumentation regarding baseline stability, chromatographic sensitivity, and instrument 
robustness, specifically in regards to the back pressure regulator mechanism.   The design 
explored the different modules; pump, autosampler, detector, and back pressure regulator 
individually.   Additionally, the initial design when based from the ACQUITY UPLC 
commercialized technologies provides already implemented design changes reducing extra-
column volume and system volume.   The prototype SFC instrumentation underwent much 
iteration of optimization and improvement during this study (Figure 2.1).  Some 




optimized based on the results of the collaborative efforts from others whom received 
prototype instrumentation within the Waters organization.  Additionally, some brief 
discussions about the results that led to optimizing the instrument design is touched upon, but 
the full results will not be shown due to the proprietary nature of the results, specifically 
pertaining to the autosampler modifications to which this author had generated the results. 
 
Figure 2.1:  Initial prototype SFC instrumentation design utilizing modified ACQUITY UPLC pump, 




The prototype SFC pump utilized a modified ACQUITY UPLC binary pump.  The unit was 
modified with an external glycol cooling device engineered to cool the primary and actuator 




from a 50 lb. tank.  This allowed the CO2 gas from the gas cylinder to be converted to a liquid 
state for easier and more consistent delivery by the pumping device.  The B side of the binary 
pump, or modifier side, was not engineered with the glycol cooling mechanism.  At this time, 
the temperatures of the CO2 pump heads were programmed to cool at a maximum of 12 
0
C.   
The engineering group used thermal heat sensing technology to determine the efficiency of 
the cooling device attached to the A side of the pump head.  The addition of insulation 
increased the cooling efficiency but also reduced the number of pressure transducer failures 
due from condensate penetrating to the electronics of the pressure transducer.  Although the 
actual results are proprietary, it was determined additional insulation was required in order to 
cool the pump heads to the targeted temperature.    Cooling to the targeted temperature 
allowed for the CO2 gas to be converted to a liquid state, thus allowing the pumping device to 
more accurately deliver the solvent with minimal variation arising typically associated with 
gas compressibility.   Mixing of the liquid CO2 and modifier were not optimized or explored 
in depth at this point in time.  Also, the pumping algorithms were continuously optimized for 
used with liquid CO2 delivery as more was understood and modeled by the engineering group 
at Waters.  These modifications to the prototype SFC instrument pump algorithms were 
uploaded as new firmware on a weekly basis.  Therefore, the results in this chapter gave 
general assumptions to observations obtained from the results and not assumed to be highly 
reproducible until the SFC instrument design was closer to a commercialization designs.   
The final commercialized pump used for the later chapters in this thesis employed the electro 
thermostatically controlled pump where the two pump heads of the CO2 delivery side are 
controlled at two different temperatures; 6 
0
C for the primary and 12 
0
C for the accumulator, 





The introduction of the sample by the autosampler was another area of concern.  It was 
assumed that the irreproducibility of results and lack of uptake by the industry; such as the 
pharmaceutical industry, was due to the inability to meet suitable accuracy and precision 
results during a validation that were comparable to a 4 or more sigma level of confidence as 
observed with other chromatographic techniques.  Different injection mechanisms such as a 
flow through needle (FTN) injection design, fixed loop injection design, and finally a dual 
valve injection design were explored for the prototype SFC instrumentation.  The majority of 
the investigations explored the flow through needle injection design based on the flexibility 
of this design providing partial loop injection capabilities, a capability not previously 
provided in typical SFC instrument designs.  In summary, the FTN design explored different 
sampling methods that were compared to 5 µL fixed loop injection result used as the 
benchmark.  The final modification to the prototype autosampler utilized a waiting period 
was implemented after an initial decompression followed by a needle flush just before the 
sample was aspirated.  This approach was deemed successful when the optimization of the 
wait and flush times resulted in a retention time %RSD for 6 replicate injections to be less 
than 0.5% and area %RSD to be less than 2%.    
 
The final modifications were to the photodiode array detector.  A series of undisclosed 
modifications were made to the optics bench of the detector.  It was communicated bythe 
Waters engineering team that the optics bench was optimized for the refractive index of 
liquid CO2 rather than for the refractive index of aqueous liquids as typical for RPLC 
detectors.  The flow cell was redesigned using a 10mm path length.  The traditional reduced 





The automatic back pressure regulator was a new design utilizing a higher resolution stepping 
motor with a new interface for the needle and seat valve design.  The larger and updated 
motor technology required an updated CPU and power supply for control needs.  The 
materials used for the needle coatings and seat were an ongoing development project by the 
engineering group at Waters during the investigation within this chapter.  The ABPR 
instrument module was modified with different needle materials during the course of the 
investigation this chapter.   
 
The goal of this investigative study is to determine the feasibility and functionality of this 
prototype low system volume instrument configuration for use with sub-2 µm particle 
stationary phases.  The study is designed to: 
 Determine instrument design feasibility 
 Identify appropriate analyte probes 
 Identify and solve any obscure retention behaviors, and  
 Confirm similar van Deemter behavior to that of sub-2 µm particle column UHPLC 





The experiments within this chapter were performed using a prototype low dispersion SFC 
instrument produced by the RD&E division at Waters Corporation.  There are a multitude of 
changing experimental parameters explored within this study, therefore an explicit 
description of additional experimental variables are referenced within the sub-section text and 





 Analyte probes selection study 2.2.1
2.2.1.1 Materials and preparation 
An 18 component test mixture (Table 2.1) was selected based on availability and prepared as 
1mg/mL stock solutions in methanol.  The working standard mixture was prepared such that 
the final concentration of each analyte was 0.01mg/mL.  This concentration was used to 
achieve a suitable UV signal. 
Table 2.1:  18 components used for test mixture 
Compound name logS 


















The compounds listed in  were purchased from Sigma-Aldrich (Missouri, USA).  .  The 
working mixture was prepared adding 1 mL of stock solution to a 100 mL volumetric flask 
and diluted to volume with methanol.  Acetone (HPLC Grade), acetonitrile (Optima™ 
LC/MS Grade), and methanol (Optima™ LC/MS Grade) were obtained from Fisher 





2.2.1.2  Instrument conditions 
2.2.1.2.1 18 component test mix study 
The analysis was performed using a 2 µL sample injection. The flow rate was maintained at 
1.2 mL/min. Gradient elution was performed using a linear addition of the methanol modifier 
from 2% to 16% over 7 minutes.  The column temperature was set to 45 
0
C. The outlet 
pressure was held constant using the ABPR set to 130 bar (approximately 1885 psi).  A 
Viridis™ BEH hybrid silica column with dimensions 2.1 mm x 150 mm and particle size of 
1.7 µm was used for the separation. Detection of the analytes was measured at a UV 
wavelength of 230 nm. 
 
2.2.1.2.2 Acetone void marker study conditions 
The data was collected using a prototype BEH hybrid silica column with dimensions 3.0 mm 
x 100 mm, with 1.7 µm particle size.  The temperature was maintained at 40
0
C during the 
isocratic elution with 5% methanol modifier introduced into the CO2 mobile phase. 
 
 Peak Distortion Studies 2.2.2
2.2.2.1 Materials and Preparation 
A carbamazepine (Sigma-Aldrich, MO, USA) stock solution was prepared in methanol at a 
concentration of 1 mg/mL.  The working standard solution was prepared using 25 mL of 





2.2.2.2 Instrument Conditions 
The initial exploratory experiments were performed on the prototype low volume SFC 
analytical instrument configured with photodiode array detection.  A BEH HILIC 2.1 mm x 
50 mm; 1.7 µm column was used for the initial van Deemter study and peak distortion 
experiments investigating flow rates and percentages of modifiers.  The temperature was 
maintained at 40 
0
C for each set of experiments.  The back pressure regulator was maintained 
at 130 bar. 
 
 Isobaric versus Isopycnic van Deemter Studies  2.2.3
 
2.2.3.1 Instrument conditions for the van Deemter comparisons 
The mobile phase composition consisted of 95% CO2 and 5% methanol modifier.  Two 
columns were compared: a prototype BEH HILIC column with dimensions 3.0 mm x 100 
mm; 1.7 µm particle size column and a prototype BEH HILIC column with dimensions 3.0 
mm x 100 mm; 5 µm particle size column. Both were maintained at a 40 
0
C.  The total 
system pressure was maintained at 5650 + 150 psi.   
 
2.2.3.2 Instrument Conditions for the Isopycnic flow rate comparisons 
The mobile phase composition consisted of 93% CO2 and 7% methanol modifier.  The 
ACQUITY BEH HILIC column with dimensions 2.1 mm x 50 mm; 1.7 µm particle size 
column was maintained at a 40 
0
C.  The 0.25 mg/mL standard solution of carbamazepine was 





2.2.3.3 Device to measure the pressures and temperatures of the column inlet and outlet 
An electronic pressure and temperature measuring device (Figure 2.2) was constructed to 
measure the difference of these values for the mobile phase as it transitions from the column 
inlet and outlet.  Electronic pressure transducers were used to measure inlet and outlet 
pressures of the column.  The pressure transducers were configured on both sides of the 
column and connected to an electronic board supplied with 110 V analog power supply with 
probes that were connected to a voltmeter.  The pressure transducers transmitted readings that 
were measured in volts and converted to pressure (in terms of psi) using Equation 2.1: 
𝑃𝑟𝑒𝑠𝑠𝑢𝑟𝑒 (𝑝𝑠𝑖) = (6200 ∗ 𝑣𝑜𝑙𝑡𝑎𝑔𝑒) − 4650 
Equation 2.1: Conversion of volts to pressure (psi) 
 
These constants in Equation 2.1 are provided by the transducer manufacturer to convert the 
voltage readback to pressure and can vary 0.75 +/- 0.075 resulting in an output of +/- 465 psi.  
if the readout was equal to zero.  The output measurements are linear and should follow the 
linearity equation of y = mx+b according to the manufacturer of the transducers.  
Measurements were recorded using a multimeter tester manufactured by Fluke Corporation.  
Thermocouples were configured both prior to the inlet pressure transducer and after the outlet 
pressure transducer. The read-back from the thermocouples was recorded using a high 
accuracy J/K Input thermocouple thermometer model HH802U and manaufactured by Omega 










 Investigations with Sub-2 µm Particle Stationary Phases 2.3.1
In the next sections, preliminary exploratory experiments were performed utilizing 
commercially available columns that were current at the time of the prototype SFC 
instrumentation construction.  These columns were Viridis™ BEH and ACQUITY UPLC 
BEH HILIC columns.  It should be noted that the stationary phase consists of the same hybrid 
bridged ethylene base particle.  The Viridis™ and ACQUITY naming was a marketing term 
administered by the manufacturer to denote a classification of column dimensions and scale.  
Viridis™ denoted analytical and preparatory scale column dimensions that consisted of 
(B) 
(B) 




stationary phase particles equal to 5 µm and various lengths and internal diameters which 
were intended for supercritical fluid chromatography applications.  ACQUITY UPLC 
denoted a reference to columns with sub-2 µm particle size stationary phases configured in 
analytical scale columns typically with 2.1 mm internal diameters and various column 
lengths. 
As the chapter continues and the time progressed throughout the year of experimentation, the 
preliminary investigations evolved to studies where prototype BEH stationary phase columns 
with an internal diameter of 3.0 mm were used.  The 3.0 mm i.d. columns were determined 
and formally presented by Jacob Fairchild at the HPLC2012 conference titled “ACQUITY 
UPC
2™: New Capabilities and Possibilities for Separations Science” to be the appropriate 
internal diameter for the prototype analytical SFC system.  In the HPLC 2012 presentation, 
he states the 3.0 mm i.d. column was a good compromise between mitigating dispersion and 
targeting appropriate flow rates which achieve fast linear velocities required to maximize the 
optimal efficiency for the sub-2µm particle size.  At the time of this research, these columns 
were considered prototypes due to the supplier’s procedures to pack and reproducibly 
manufacture the columns had not been validated and refined yet.  However, it should be 
noted that a Viridis™ BEH, an ACQUITY UPLC BEH HILIC, and the prototype BEH 
HILIC stationary phases are all the same base silica particle.  The difference resides in the 
column dimensions and the particle size and follow the process submitted by U.S Patents 





Figure 2.3: BEH Technology particle synthesis based on ethylene bridged bonding provided 
courtesy of Waters Corporation 
 
2.3.1.1 Determination of Suitable Experimental Solute Probes 
Understanding the benefits of columns packed with sub-2µm particle stationary phases 
requires comparisons to traditional, larger particle size columns. A series of van Deemter 
curves were evaluated for each of the different columns with varying particle size using the 
conditions outlined in section 2.2.3.1.  The practical experiments are well documented for LC 
[107-116], however little has been published to date (prior to 2011 when this work was 
performed and presented at HPLC 2011 in Budapest, Hungary) regarding particle size 
efficiency for pSFC with smaller particles [76, 77, 117-119].  To determine the effect of 
particle size on column efficiency for pSFC, various preliminary requirements for the 
construction of van Deemter curves were addressed, including: 
 Explore a selection of analyte probes with different polar, non-polar, acidic, basic and 
neutral properties 
 Empirically determining a probe with k = 4 with Gaussian peak shape 




 Considering sample diluents to mitigate external influences on peak shape and 
efficiency 
 Exploring isobaric vs. isopycnic conditions 
 Determining relative performance of sub-2 µm particles vs. 5 µm particles in pSFC 
 
The critical factors listed above need to be addressed prior to performing the van Deemter 
determinations.  The analyte probe is the key factor for success.  The key characteristics of a 
good chromatographic test mixture for this purpose include:  
1. An unretained/poorly retained analyte for the determination of the void volume 
2. An analyte with appropriate k 
3. An analyte(s) of low molecular weight to facilitate fast mass transfer 
4. Additional probes with a smaller k can facilitate troubleshooting during the 
experiment. 
5. It must exhibit a Gaussian peak shape   
 
In addition to determining appropriate analyte probes, a void marker must be used to 
determine the volume of the column.  This is generally measured chromatographically using 
the retention time of an unretained analyte.   An appropriate void volume marker can be 
defined as a probe with the lowest elution time possible, with a retention time that does not 
change regardless of elution conditions.  It must not be influenced by other internal or 
external variables, such as temperature.  Acetone was determined to be unretained and eluting 
in the injection void of the chromatographic run when injecting the probe during a 5% 
modifier isocratic experiment.  The results in Figure 2.5 show that acetone is unaffected by 
increasing flow rate.  If non-linearity was observed, conclusions regarding the effect of  
frictional heating or adiabatic cooling of the CO2 liquid phase exiting the column as the flow 




𝑃𝑒𝑎𝑘 𝑣𝑜𝑙𝑢𝑚𝑒 (𝑚𝐿) =  [𝐹𝑙𝑜𝑤 𝑟𝑎𝑡𝑒 (
 𝑚𝐿
𝑚𝑖𝑛𝑢𝑡𝑒
)] ∗ [𝑃𝑒𝑎𝑘 𝑊𝑖𝑑𝑡ℎ (𝑚𝑖𝑛𝑢𝑡𝑒𝑠)] 
Equation 2.2:  Calculation for peak volume 
 
An 18 component test mix was prepared and analyzed using the gradient method outlined in 
2.2.1.2.1(Figure 2.4).  The mixture represents a series of acidic, basic, and neutral compounds 
 
Figure 2.4: Prototype SFC instrument analysis of the 18 component test mix. The UV 
































































































































































































































































































Figure 2.5: Elution volume trend plot for acetone for an isocratic 5% modifier elution method. 
Column: BEH HILIC 3.0 mm x 100 mm; 1.7 µm  
 
Based on the results from the experiments shown in Figure 2.4 and Figure 2.5, two analytes 
were selected as appropriate candidate probes in order to construct van Deemter plots. Based 
on the critical factors listed earlier, the analytes chosen were: 
 Acetone - void volume marker (V0) 
 Carbamazepine - Target probe for van Deemter measurement because the retention 
factor was approximately k = 4. 
 
 Peak Distortion Studies 2.3.2
2.3.2.1 Complications from initial van Deemter study 
The van Deemter study was initially performed, but peak distortion was observed for the 






























resulted in peak splitting Figure 2.6).   The prototype instrument back pressure regulator for 
these experiments did not have automated control.  The back pressure had to be manually 
adjusted for each of the flow rates.  Variations in the observed “total system” pressure were 
observed to increase with higher flow rates (Table 2.2).  The peak splitting issue was 
hypothesized to be due to an increased pressure drop and a large density gradient effecting 
the migration of the solute band on column. “Total system pressure” is defined as the 
pressure readback from the pressure transducer monitoring pressure at the pump heads.  This 
readback would be inclusive of all exerting pressures on the instrument, pre- and post- 
column. As the outlet pressure is held constant by the back pressure regulator and the inlet 
pressure increases with increasing flow rate, it can be assumed there is a variation of pressure 






Figure 2.6: Effect of isocratic modifier with decreasing flow rate. 
 
Table 2.2:  Table of observed total system backpressure (Psys) related to flow rate and applied 















0.75 2439 122 1769 
1.00 2720 127 1842 
1.25 2990 127 1842 
1.50 3263 127 1842 
1.75 3568 127 1842 













A similar observation by Professor J.L Veuthy and team showed peak deterioration at low 
modifier strengths in their experiments and presented at the HPLC Symposium in 2010 
(Figure 2.7).   Interestingly, their observations were performed on a larger particle size 
column.   
 
Figure 2.7: Influence of % modifier using a Sunfire 4.6 x 150 mm; 5 µm, 40 
0
C, flow rate was 4.0 
mL/min, BPR=200 bar.  (Courtesy of J.L. Veuthy, U. Geneva) 
 
 
The results of the initial van Deemter attempt combined with the results of Veuthy’s HPLC 
2010 presentation suggest multiple effects causing the peak shape distortion.  A range of co-
solvent percentages were explored in order to determine a suitable retention factor (k) using 
carbamazepine as a standard.  Interestingly, it was found that at very low isocratic additions 
of modifier when using an ACQUITY BEH HILIC column with dimensions of 2.1 mm x 50 
mm, the peak shape deteriorated as the percentage of co-solvent decreased and k increased 





Figure 2.8: Effect of modifier percent on peak shape. 
 
In the initial attempts of the van Deemter study that vary flow rate, it was assumed that 
mobile phase homogeneity of the CO2 and modifier could be the cause of the peak splitting.  
The pressure drop across the column could also be contributing to extreme mobile phase 
density gradients across the column, thus effecting the solute band dispersion.   In Veuthy’s 
results, the peak shape distortion was hypothesized by the author to be related to insolubility.  
The carbamazepine standard was injected and eluted using different percentages of modifier.   
 
Upon a further review of the literature, similar research by Donald Poe et al. reported peak 
shape abnormalities [92].  They concluded the peak shape distortion was due to the effects of 
pressure drop and temperature drops across radial axis the column, which ultimately affected 
the density of the CO2 within the column, inducing band broadening of the solute.  This is 
basically a solubility problem because the solubility is density dependent He proposed that 
























as constant density conditions.  For these experiments, it is understood that the linear 
velocities across the column are not equal between a constant pressure studies (isobaric) 
versus a constant density study (isopycnic). Therefore, in summary, three factors appear to 
affect peak distortion and require investigation: 
 Mobile phase homogeneity 




Mobile phase homogeneity can be explored by experimenting with larger mixers on the 
chromatographic system.  Density variations and pressure drops can be measured with 
temperature and pressure probes on the inlet and outlet of the column.  Solubility issues are a 
bit more difficult to investigate due supercritical properties of the mobile phase occurring on-
column and relating it to the solubility of the solute.  The solubility studies would require 
specialized instrumentation that would not be achievable on the prototype analytical SFC 
instrument and better studied using specialized pressure containment vessels with a viewing 
window to observe for insolubility.   
 
2.3.2.2 Investigating Isopycnic Conditions at Constant Modifier Composition 
The isopycnic conditions resulted in symmetrical Gaussian peak shapes observed at 2.0 
mL/min with an overall observed system pressure measured by the transducers at the pump 
head being held at 4000 pound per square inch (psi), or approximately 275.8 bar.  The 
instrument read backs were in “psi” units, and therefore reported as such.  At the lower flow 
rate where the peak shape was observed to be splitting, the back pressure regulator was 
adjusted to exert an increased pressure on the outlet of the column such that the total system 




in Figure 2.9, the peak shape (and baseline noise) at the lower flow rate was not suitable for 
constructing an optimal van Deemter plot.  
 
 
Figure 2.9: Comparison of carbamazepine under isopycnic conditions at different flow rates. 
 
The successful experiments that produced the original van Deemter generated by Aubin and 
Neue [120] utilized a column with internal diameter (i.d.) of 3.0 mm rather than the 2.1 mm 
i.d. column used in the previous sections of this chapter.  It should be noted that Aubin and 
Neue modeled the empirical data to determine the efficiency benefits of sub-2 µm particles 
for use with SFC.  To understand if the column i.d. was a contributing factor, experiments 
that produced the poor peak shape on the 2.1 mm i.d. column were repeated on a prototype 
3.0 mm i.d. column.  Again, peak splitting was observed for the low flow and low percentage 
modifier conditions.   
 
In an effort to rule out volume and mass overloads, the 0.25 mg/mL carbamazepine standard 
solution was injected at a lower injection volume of 0.2 µL.  Subsequent experiments with a 
Flow = 0.75 mL/min
BPR = 270 bar = ~4000psi
Flow = 2.0 mL/min
BPR = 124 bar = ~4000psi
k = 3.36
N = 1438 ?
Tailing = .813
Assym @ 4.4% = .635




Assym @ 4.4% = .888





diluted standard of 0.1 mg/mL were also explored.  The results yielded the same odd and 
unpredictable peak shapes for the lower flow rates.  Based on these results, it was concluded 
that another effect was contributing to the peak shape distortion. 
 
In previous experiences, mixing has been a point of concern, particularly the miscibility of 
CO2 and methanol modifier.  Therefore, a larger mixer with a 425 µL of volume was installed 
on the pump after the piston heads.  A decrease in baseline noise was observed and pressure 
fluctuations appeared to be lower (Figure 2.10 (a)).  An experiment was performed using the 
larger mixer and 3.0 mm i.d. column using the same instrument conditions from Figure 2.6. 
but with a specific focus on the conditions using the flow rate of 0.75 mL/min and 7% 
methanol modifier composition.  The experiment resulted in a Gaussian and reproducible 
peak shape with the 3.0 mm column ID (Figure 2.10(b)).  The next set of experiments 
explores the larger mixer and larger column i.d. using the experimental conditions used for 
Figure 2.8. The results in Figure 2.10(c) resulted in Gaussian peak shapes down to 3% 
modifier addition.  Although this looked promising, sufficient mixing was thought to solve 
the peak splitting issue due to low flow rate and mobile phase homogeneity.  The results of 
the 2.1 mm i.d. column still looked less than ideal as seen in Figure 2.10(d), therefore mobile 
phase homogeneity is not the only contributor and larger mixers are not the single solution.  
However, it is hypothesized that sufficient (or insufficient) mixing is a major contributing 
factor and a homogenous delivery of mobile phase can be a beneficial contributor to peak 






Figure 2.10: Effect of increased mixing on (a) baseline noise, (b) low %modifier/low flow, (c) 
varied % modifier, and (d) decreased column i.d. 
 
 
2.3.2.3 Investigating the Effect of Mobile Phase Mixing 
The previous experiments suggested mobile phase inhomogeneity with the modifier and 
supercritical CO2 mobile phase at low flow rates.  It was then hypothesized that increasing 
column length would improve peak shape, based on the essential concept that a column is 
essentially another mixing device within the chromatographic system.   Injections of 
carbamazepine standard solution were injected on to the prototype instrument with the 50 µL 
mixer configuration.   
  
a)  Noise Comparison between the 50 µL (red) mixer vs.
425 µL mixer (black)
b) 0.75 ml/min; 7% MeOH;3.0 x 50 mm; 1.7 µm




It was hypothesized the re-insertion of the 50 µL mixer would help differentiate between two 
factors: 
 Peak shape improvement due to an increase in mixing represented by a total increase 
of system volume in addition to increased column length  
 
 Is the peak shape improvement due to an increase of system volume alone?  This 
would represent the effects of more mixing volume thus facilitating better mobile 
phase homogeneity and resulting in more optimal peak shapes.   
 
The investigation explored a longer column of dimensions 2.1 mm x 100 mm; 1.7 µm particle 
size and maintained at a 40 °C.  The stationary phase was consistent with previous 
experiments consisting of ACQUITY BEH HILIC particle.  The 0.25 mg/mL standard 
solution of carbamazepine was used for the 1 µL injections.  The mobile phase composition 
consisted of 93% CO2 and 7% methanol modifier.  The back pressure regulator was set to 
130 bar.  The 50 µl mixer and longer column length resulted in improved peak shapes when 
the percentage of modifier was decreased.  Baseline noise was equivalent to that from the 425 







Figure 2.11: Effect of increasing column length with low volume mixer 
 
 Isopycnic and Isobaric Pressure Study 2.3.3
2.3.3.1 Comparing Column Efficiency using Isopycnic versus Isobaric Backpressure 
Conditions 
Retention factor (k) and column efficiency (N) were investigated using the probe analyte 
carbamazepine under isobaric and isopycnic conditions.  Isobaric conditions use a constant 
backpressure regulator outlet pressure which results in a change in total system pressure and 
changing densities as different flow rates are used.  Isopycnic conditions vary outlet pressure 
inversely to inlet pressure in order to maintain a constant density (as determined by 
measurement of a constant system pressure with changing flow rates). The prototype 
instrument has upper pressure and flow rate limiting thresholds.  The maximum permissible 











instrument setting limit of 6000 psi).  The thresholds determine the design of the achievable 
isopycnic experiments.  For experimental purposes, the maximum pressure observed for the 
highest allowable flow rate determines the set point for total system pressure to maintain 
throughout the isopycnic experiments.  There is concern that there could possibly be a density 
differences between the inlet of the column and outlet of the column, however there is no 
practical method to determine this experimentally during the experimental run of an analyte.  
The measurement readings for the pump pressure transducers, backpressure transducers, 
column inlet and outlet pressure transducers (Figure 2.2) all register the same apparent 
pressure for the entirety of the closed system.  It can be assumed that the average density or 
apparent constant density is maintained by this technique of adjusting backpressure during 
varied flow rates and therefore considered ‘isopycnic’.   
 
The plot of k versus mobile phase flow rate (mL/min) for the two techniques (isobaric vs. 
isopycnic) is used to generalize the combined effect that the variables such as temperature, 
pressure, and density have on efficiency.  The retention factor for carbamazepine changed 
with flow rate in different ways, depending upon the experimental conditions (Figure 2.12).  
When comparing the lower flow rate experiments such as the 0.5 mL/min and 1.0 mL/min 
experiments, it is hypothesized that the decreased density and lower viscosity of the isobaric 
results facilitated increasing solute diffusivity and interactions with the stationary phase.  In 
terms of the isopycnic experiments, the mobile phase density is likely to have been 
maintained closer to ‘liquid’ densities,, thus contributing less to changes in diffusivity of the 
solute with the stationary phase and consequent lower k.   The k decreases with higher flow 
rates for the isobaric conditions, whereas the k increases when the flow rate increases for the 
isopycnic experiments.  In order to hold density constant during the isopycnic experiments, 




measurements of k.  This could be affecting the solubility of the test probe in the mobile 
phase and inhibiting the interaction with the stationary phase.   In terms of the observations of 
the isobaric test results, possible factors decreasing k’ include (a) radial and axial temperature 
and pressure gradients resulting in adiabatic cooling, causing an increased linear velocity as 
the band approaches the column outlet, and (b) performing the experiments too close to the 
critical density.  As the gas expands due to adiabatic cooling, an increased diffusion and 
retention of carbamazepine occurs as per Equation 1.19.  Additionally, since the pressure is a 
function of the density of the mobile phase, the reduced pressure would affect k to decrease. 
 
 
Figure 2.12: Flow rate versus retention factor (k) for isobaric and isopycnic evaluations of 
carbamazepine. 
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2.3.3.2 Isopycnic Comparisons using Different Stationary Phase Particle Sizes 
When the particle sizes are compared under isopycnic conditions, the k’ for the 5 µm particle 
remained relatively constant.  At flow rates above 1.5 mL/min, k increased for sub-2µm 
particles (Figure 2.13).  It is possible that the increased k’ for isopycnic results reflect (a) an 
increase in frictional heating resulting in an increased on-column temperature and therefore 
allowing temperature to play a role as a function in density, and thus consequently increase in 
k [121].  Another explanation could indicate a lower percent molar volume of modifier in the 
mobile phase, causing k to increase. The latter would be very difficult to experimentally 
determine and is unlikely unless an instrument flaw was determined such as a leaking 
modifier pump seal.  System diagnostics were initiated to test the leak rate from the pump 
seals. The test passed according to the instrument diagnostics control panel, therefore the 






Figure 2.13: Isopycnic trend plot comparison for hybrid 3.0 mm internal diameter columns 
packed with 5 µm particles and 1.7 µm particles. 
 
 
2.3.3.3 Isobaric versus Isopycnic van Deemter determinations 
Rajendran et al. have shown that under isobaric conditions, decreases in efficiency are 
observed when operating at lower outlet pressures (130 bar) and low modifier percentages 
(<7%) [91].  The apparent optimal linear velocity for maximum column efficiency for the 3.0 
mm x 100 mm; 1.7 µm column approaches 0.4 cm/sec (Figure 2.14).  The isopycnic plate 
height results in Figure 2.14 suggest the observed optimal linear velocity is 2.2 times greater 
to reach the maximum efficiency when compared to that of the isobaric experiment.  
However, it also seems that the optimal linear velocity was not reached for the isopycnic 
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efficiency for the isobaric experiment was the same as the isopycnic experiment when using 
at a linear velocity of 1.1.  The system pressure read back from the instrument control 
software at these two experimental points were equivalent.  For all practical and research 
purposes, if plate heights are to be used to categorize performance, then the details of the 
experimental conditions and more specifically the average density predicted within the 
instrument which can be guided by the overall observed system pressure and viscosity of the 
mobile phase composition should be considered when comparing and reporting column 
comparisons between commercial suppliers. 
 
 
Figure 2.14: van Deemter curve comparing the efficiency differences while running in an 
isobaric outlet pressure state (classical approach) versus an isopycnic (constant density) state.  
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2.3.3.4 van Deemter plots Comparing Different Isopycnic Settings 
The experiments used for the generation of data for the van Deemter plots in Figure 2.15 
were conducted at 5500 psi and 5700 psi constant total system pressures.  These two 
experiments were performed by two separate analysts.  Any variations which are observed 
might be influenced by the fact that the two systems are prototype instrumentation and 
manufacturing controls are not established.  These variations have the potential to have a 
greater impact than those of the separate analysts’ technique towards the analysis, therefore 
the results of this experiment are purely qualitative.  It is undetermined if the decreased plate 
height observed for the sub-2µm particle column experiments was caused by the increase in 
total system pressure.  A difference of 200 psi does not appear to have a great effect on 
column efficiency for the larger particles for the two experiments. It is interesting to observe 
a decrease in efficiency for the 5 µm particles as the linear velocity increases beyond 0.2 
cm/sec, a comparable trend to typical RPLC results.  This trend is not observed for the sub-2 
µm particle column experiments, thus suggesting the instrument pressure and flow limitations 
are inhibiting the capability to determine the optimal linear velocity and maximum efficiency 
attainable for that column when using this instrument.  Regardless of the limitation, the sub-2 
µm particles yielded greater column plate counts than larger particles.  Interestingly, the 
overall set of results show similar trending for both the sub– and supra– 2 µm particles for the 







Figure 2.15: Van Deemter plots comparing two separate experiments on two prototype 
instruments. 
 
2.3.3.5 Comparison to Previously Published Results 
The recent works of Tarafder, Guiochon, Ranger, Kaczmarski, and Poe have provided 
information that facilitates the understanding of super-/sub-critical fluid compressibility [68-
74].  Their series of publications have provided estimates about the viscosity variation when 
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variations when plotted versus density.  The design and use of their isopycnic plots provide 
the most practical way of identifying problem zones and determining why variations in 
efficiency have occurred for a given set of experiments.  In their reports, a series of isopycnic 
plots were constructed for CO2 with the addition of 5%, 10%, 15%, and 20% modifier which 
result in different critical temperatures and critical pressures.  
Based on their reports, the data presented here can be correlated and superimposed on their 
plots to determine the relative effects of temperature and pressure changes exerted during 
previously mentioned experiments.   Figure 2.15 indicated a slight increase in efficiency with 
a 200 psi difference in pressure.  When plotted on the isopycnic pressure – temperature plane, 
the density of the fluid changes slightly (Figure 2.16).  The operating parameters from Figure 
2.8 were plotted on the CO2 + 5% modifier isopycnic plot indicating a density drop of 
approximately 0.06 g/mL and a pressure drop approximately 140 bar at the highest flow rate 
and 46 bar at the lowest flow rate.  These results can now be used for future experiments to 
investigate an allowable range of density differences without affecting chromatographic 
fidelity. Another conclusion, suggests that as the mobile phase density approaches 0.84 g/mL, 






Figure 2.16: CO2 + 5% methanol modifier isopycnic plot (reproduced with permission from A. 









In conclusion, the investigation of sub-2 µm particle columns yielded a vast amount of 
practical approaches to consider when developing SFC methodologies.   The higher density 
CO2 yields more robust results, but at the cost of higher pressures.  Acetone was determined 
as a suitable void marker to calculate retention factors for the probe analyte carbamazepine.  
The retention factor should be kept constant when experimentally determining accurate plate 
counts for varied particle sizes.  Isobaric conditions may be suitable for plate count 
determinations for practical purposes, but isopycnic experiments could indicate the potential 
maximum efficiency for a given column.  Either technique, isobaric or isopycnic would be 
appropriate to compare columns; however the experiments must be consistent when 
compared.  The apparent plate counts yielded by using an isobaric outlet pressure are not 
represented accurately due to the changing density as pressure is increased with increased 
modifier, and thus generating a larger pressure drop across the column.  The van Deemter 
plots prove that sub-2 µm particles yield a better plate count than larger particles regardless 
of experimental approach.  Insight to the phenomenon might be explained using the isopycnic 
plots published by Tarafder [68, 69, 72, 74].  
 
 It was clearly evident that further experiments outside of the scope of this preliminary 
evaluation using prototype instrumentation and columns should be repeated on final design 
instrumentation to improve confidence in the conclusions regarding the observed 
chromatographic phenomena.   In terms of utilizing this system in practice, these experiments 
and investigations described within this chapter provided a basis of some expectations of 
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CHAPTER 3   
3 Exploring Method Development and Optimization Variables 
In the previous chapter, the prototype low volume supercritical fluid chromatography system 
was proven to take benefit of the sub-2 µm particle stationary phases.  The prototype 
instrumentation was refined and a pre-commercialized instrument was provided by Waters 
Corporation.  The final instrument design was commercialized and introduced at the 
Pittsburgh Conference in 2012 and marketed by Waters as UltraPerformance Convergence 
Chromatography™ (UPC2).  Waters defined “Convergence Chromatography” as a category 
of separation science that provides orthogonal and increased separation power, compared to 
liquid or gas chromatography, in order to solve separation challenges.  The term Convergence 
Chromatography was derived from J. Calvin Giddings concepts of a ‘unified 
chromatography’, a term used by Giddings to describe the unification of liquid, supercritical, 
and gas chromatography [122]. Instrument design is important to understand and defines a 
basis for general expectations of the results to come once it’s employed for analytical 
determinations. The practicality of the instrument design can be better understood when 
methodology variables are taken into consideration.  In the next two chapters, ‘one factor at a 
time’ (OFAT) and multivariate approaches are explored to determine the variables that effect 
chromatographic separations, information rich data, and interfacing with mass spectrometry.  
In addition, these chapters highlight the importance of troubleshooting techniques that help 
distinguish system related effects versus chemistry related effects based on experimental 
observations and reason that could cause retention time drift, peak splitting, peak distortion, 
and ionization efficiency.  More importantly, evidence of the various retention mechanisms 
affecting the selectivity, retention and resolution of analytes; but more specifically, 
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structurally related small molecule (>1500 Da) analytes analogous to those observed in 
natural product profiling 
 
3.1 Introduction  
Many new chemical entities can either be extracted and purified from natural product sources 
or synthesized based on previous characterization and understanding of the natural product 
moiety.  The chromatographic screening analysis of new chemical entities relies on 
appropriate sample preparation and methodology variables which do not adversely affect the 
chromatographic results and interpretation of the data.  Techniques which provide selectivity, 
specificity, and orthogonality deliver insight about the underlying chemistry of the 
compounds under investigation, or the chemical reactions creating the molecules.     
 
Synthetic reactions are carried out using a wide range of solvents the properties of these 
solvents could well effect the performance of the chromatography when loaded onto the 
system, a well-known effect in HPLC.  Documented knowledge of the effect of sample 
diluent on supercritical fluid chromatography is not as well characterized. When analyzing 
reaction mixtures, in an ideal scenario, the chemist would favor injecting the reaction mixture 
directly onto a chromatographic instrument without any dilution. However, when considering 
the high concentration of a reaction mixture, this is not always practical, and simple dilutions 
are therefore recommended.   In many cases, when analyzing a reaction by reversed-phase 
LC, the sample aliquot must also be diluted with a suitably comparable RPLC injection 
solvent to minimize detrimental effects on observed chromatographic peak shape [123-127].  
It is normal practice to dissolve the analyte in a solvent with an eluotropic strength 
significantly lower than the strength of the chromatographic elution solvent thus allowing the 
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analytes to be focused on the head of the LC system and produce a sharp LC peak [18].  In 
RPLC the scientist would ideally dilute the sample in water, as it is a weak eluter, however 
DMSO is often used to ensure analyte solubility.  DMSO’s strong eluotropic nature is often 
circumvented by employing a low injection volume for these HTS applications.  By the 
definition above, a non-polar solvent such as hexane would be an optimal diluent for 
supercritical fluid chromatography due to its low eluotropic strength compared to that of the 
methanol elution solvent (typically referred to as co-solvent or modifier). However, using 
hexane can be challenging for the analysis of polar compounds due to its immiscibility with 
the polar component of the solvent and solubility of the analyte.  
 
Using CO2 as a primary mobile phase for chromatographic separations provides an 
orthogonal approach, aiding discovery of unknown impurities when compared to reversed- 
phase LC.  While method development strategies in liquid and gas chromatography are well-
defined, that is not the case for CO2-based chromatography.  Although to say they are not 
well defined, that is not to say they are not well understood.  West and Lesellier have 
published the most extensive research in this field of SFC and analyte retention [54, 55, 96, 
128-135], however there is a need for a well-defined, strategic approach for method 
development in SFC. In order to streamline this process, a systematic approach to achiral 
SFC method development requires research and additional practical examples from the 
pharmaceutical industry to validate the feasibility of the technique.   
 
In pharmaceutical development it is important to understand the impurity profiles of the 
potential drug substance material in order to allow accurate assessment it toxicological 
profile.  Assessing the purity of the sample allows pharmaceutical companies to make 
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decisions during drug development and commercialization of the drug.  Impurity profiles are 
dictated by route synthesis pathways, raw material quality from vendors, final drug quality 
and safety, finished product shelf life, and also provide intellectual protection from 
counterfeiting.  Orthogonal comparisons of the chromatography profiles provide the ability to 
make the best educated decisions throughout the entire drug discovery, development and 
commercialization process. 
 
In this chapter, the following investigations explore the applied use of newer technologies 
composed of sub-2 µm particle size achiral stationary phase columns and the optimized 
analytical scale low volume pre-commercialized SFC instrumentation for the task of complex 
sample analysis.  The pre-commericialized instrument differed from the prototype in many of 
the modules.   The pump was no longer cooled using Design 2 in Figure 1.10 and utilized the 
thermostatically controlled schematic in Design 1 of Figure 1.10.  The prototype utilized an 
initial design of the back pressure regulator that was controlled by manual entry of specific 
code to apply pressure settings.  The pre-commercialized backpressure regulated was 
controlled through the software control console, optimized for appropriate materials that 
prolong the robustness of the needle and seat components, and included additional static 
pressure regulation to stabilize pressure irregularities of the dynamic regulation of 
backpressure.  The photodiode array detector optics bench was modified during the 
experiments performed in section 3.3.3 in order to reach the sensitivity required to perform 
impurity analysis profiling.  The particularity of the details pertaining to many of these 
changes are proprietary to the manufacturer and thus not described in greater detail.   
The sub-2 µm particle columns are primarily explored because they provide the 
potential for greatest increases of efficiency, sensitivity and resolution.  The dispersion of the 
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protoype and commercial instrument were calculated to be about 25 µL
2
 at 2 mL/min.  This 
compares with other binary high pressure mixing UHPLC systems (1 µL
2
), quaternary low 
pressure mixing UHPLC (10 µL
2
), the first commercially available UHPLC systems (16 
µL
2
), and traditional HPLC systems (40 µL
2
) [136]. The question now is “Which column 
format?, Should  2.1 mm i.d, 3.0 mm i.d. or 4.6 mm i.d. be used?”.   The presentation 
reported 3.0 mm i.d. column formats are the best compromise between mitigating dispersion 
effects and maximizing the utilization of the instrument based on the upper pressure and flow 
rate limits of the instrument.  However, it was reported the 2.1 mm i.d column format is 
minimally affected by the slightly higher extra column volume yielding very high efficiencies 
and a fast analysis [136].    
Due to the importance of mass spectrometers role in aiding the identification of new 
chemical entities in natural product profiles, confirmation of reaction synthesis completions 
and high throughput screening for potential lead candidates, experiments which explore the 
optimization of the interface with mass spectrometry detection were investigated.  A short 
study was designed to obtain a better understanding of peak distortion effects when using 
polar and non-polar organic diluents for sample preparation specifically during reaction 
synthesis.  Generally, the analytical methods performance is the critical aspect to successfully 
identifying, characterizing, quantitating and controlling new chemical entities for further 
development.  In an effort to build SFC methodology expectations, changes in method 
variables affecting selectivity and resolution will be investigated using One Factor at a Time 
principles (OFAT). This will be applied to a commercially available compound and 
amphipathic compounds commonly found and associated as the matrix of natural products.  
Results of the study will provide guidance when performing synthetic chemical reactions 
common to the earlier stages of the medicinal chemistry workflow.   
 




The experiments within this chapter were performed using a pre-commercialized low 
dispersion SFC instrument.  Due to the nature of changing method development variables 
with an aim to deliberately alter selectivity, there are a multitude of changing experimental 
parameters explored within this study.  Therefore an explicit description of all the 
experimental variables will not be included in this experimental section, but rather referenced 
within the sub-section text and figure captions where appropriate.   
 
 Diluent Study  3.2.1
3.2.1.1 Diluent study materials and preparations 
HPLC grades of methanol, acetonitrile, tetrahydrofuran, and 2-propanol were purchased from 
Fischer Chemical (New Jersey, USA).  n-Heptane and n-hexane was purchased from VWR 
International (Pennsylvania, USA).  Reagent grades of dimethylsulphoxide, N,N-
Dimethylacetamide,  N-methylpyrrolidone, an dimethylformamide were purchased from 
Fischer Scientific (New Jersey, USA).    The probe analyte 4-hydroxybutylbenzoate (4-HBB) 
(Sigma Aldrich, MO, USA) was prepared as a 0.2 mg/mL solution in a range of polar and 
non-polar solvents as shown in Table 3.1. 
  




Table 3.1: Diluents used in the study 
Heptane/IPA 9:1 Tetrahydrofuran (THF) 
Heptane/IPA 7:3 N,N-Dimethylacetamide (DMA) 
Methyl-t-butyl ether (MTBE) Dimethyl sulfoxide (DMSO) 
Methanol N-methyl pyrrolidone (NMP) 
Acetonitrile Dimethylformamide (DMF) 
2-Propanol (IPA)  
 
3.2.1.2 Diluent Study Instrument Conditions 
The separations were performed using the columns outlined in Table 3.2 on an ACQUITY 
UPC
2
 system configured with PDA detection (Waters® Corporation, MA, USA).  Each of the 
columns outlined in Table 3.2 were acquired from Waters Corporation (Milford, USA).   
Each column was maintained at 45 
0
C to minimize any external environment effects such as 
varied room temperature.The analyte was eluted isocratically at 2.0 mL/minute with a mobile 
phase composition of 97% medical grade CO2 and 3% methanol.  The backpressure was 
maintained at 2000 psi.  The injection volume was 2.0 µL while the samples were maintained 
at 18 
0
C in the autosampler. Detection was monitoring at a single wavelength 254nm and a 
wavelength range from 210 nm to 500 nm.     
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Table 3.2: Columns and dimensions for diluent study 
Stationary Phase Dimensions 
ACQUITY UPC
2
 Chrarged Surface Hybrid 
(CSH) Flouro Phenyl,  
3.0 mm x 100 mm; 1.7 μm 
ACQUITY UPC
2
 BEH silica,  3.0 mm x 100 mm; 1.7 μm 
ACQUITY UPC
2
 BEH 2-Ethyl Pyridine,  3.0 mm x 100 mm; 1.7 μm 
ACQUITY UPC
2
 High Strength Silica 
(HSS) C18 Stable Bond (SB), , *This column 
showed no retention so it was eventually 
excluded from the study. 
3.0 mm x 100 mm; 1.8 μm 
 
 
 Mass Spectrometry Interfacing Investigations 3.2.2
3.2.2.1 MS Interface Materials and Preparations 
Acetonitrile (Optima™ LC/MS Grade), 2-propanol (Optima™ LC/MS Grade), and methanol 
(Optima™ LC/MS Grade) were obtained from Fisher Scientific (New Jersey, USA).  The 
analytical reference standards clopidogrel hydrogensulfate, lidocaine, tolbutamide, 
omeprazole, alprazolam, warfarin, and ranitidine hydrochloride were purchased from Sigma-
Aldrich (Missouri, USA). The mobile phase and make-up flow additives were formic acid 
and ammonium hydroxide and purchased from Sigma-Aldrich (Missouri, USA). A seven 
component mixture was prepared to a concentration of 100 ng/mL for each component and 
diluted in methanol.  A working mixture solution composed of a concentration of 100 ng/mL 
for each of the seven reference standards listed above; clopidogrel hydrogensulfate, lidocaine, 
tolbutamide, omeprazole, alprazolam, warfarin, and ranitidine hydrochloride diluted in 
methanol and labeled as ‘MS Test Mix’. 
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3.2.2.2 Mass Spectrometry  
The optimization investigation experiments were performed using a Waters Xevo TQ-S triple 
quadrupole mass spectrometer (Waters Corporation, Manchester, UK) and controlled using 
Masslynx™ V4.1 software (Waters Corp., Milford, USA).  The experiments were performed 
using positive ES ionization mode.  The multiple  reaction monitoring(MRM) transitions for 
each compounds was determined by infusion of standards of each analyte.  Infusion could not 
be performed with SFC mobile phase flow due to issues with the on board MS/MS valve 
compatibility for use with supercritical fluid solvents.  Leaks would occur.   The 
optimizations of temperature and gas flows were determined using a series of injections at 
varied conditions.  This experimental record pertains to investigations and therefor references 
to MS conditions are noted in the experimental results of the pertain sections in this chapter. 
 
 Method Development One Factor at a Time (OFAT) Investigations 3.2.3
3.2.3.1 Metoclopramide and related substances materials preparations  
Methanol was purchased from Fisher Scientific (Pittsburgh, PA, USA) and USP grade CO2 
from (AirGas, MA, USA).  Formic acid and ammonium formate (Sigma-Aldrich, St. Louis, 
USA) were used in the mobile phases.  Standards of metoclopramide and related substances 
(LGC, UK) were used for the method development experiments.  A resolution solution; 
defined as a mixture of the API and related substances,  was prepared with metoclopramide 
and eight related impurities, as shown in Table 3.3.  The impurities were prepared at 0.1% 
w/v % concentration of the metoclopramide standard.  The metoclopramide was prepared by 
weighing approximately 100 mg of standard and each of the impurities were prepared by 
weighing approximately 10 mg of standard and dissolved in 100mL of methanol.  The 
resolution solution was used for the chromatographic method development. Investigations of 
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impurity C and impurity F standards were prepared in methanol and explored at 0.1 mg/mL 
concentrations.   
 
Table 3.3:  List of metoclopramide impurity standards, peak designation, masses, and European 
Pharmacopoeia labels. 




1 4-amino-5-chloro-2-methoxybenzoic acid 201.6 (EP C) 
2 4-(acetylamino)-2-hydroxybenzoic acid 195.2 (EP H) 
3 4-amino-5-chloro-N-2-(diethylaminoethyl)-2-
methoxybenzamide N-oxide 
315.8 (EP G) 
4 4-amino-5-chloro-N-2-(diethylaminoethyl)-2-
hydroxybenzamide 
285.8 (EP F) 
5 4-(acetylamino)-5-chloro-N-2-(diethylaminoethyl)-2-
methoxybenzamide 
341.8 (EP A) 
6 Methyl 4-(acetylamino)-2-methoxybenzoate 223.2 (EP D) 
8 Methyl 4-(acetylamino)-5-chloro-2-methoxybenzoate 257.7 (EP B) 
9 Methyl 4-amino-2-methoxybenzoate 181.1  
 
3.2.3.1.1 Instrumentation Configuration for Metoclopramide Analysis 
 
A Waters ACQUITY UPC
2
 (Waters Corporation, Milford, USA) equipped with a binary 
solvent management system capable of four solvent selection for the modifier delivery 
mechanism, Convergence Manager (CCM) to variably control the outlet backpressure of the 
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system, four column management system controlled by a Waters CM-A and CM-Aux.  
Detection was achieved with a Waters UPC
2
 photodiode array detector (UPC
2
 PDA) and a 
Waters ACQUITY SQD mass spectrometer using electrospray ionization (ESI+/-) switching.  
Full scan data was collected with a range of 150 – 1200 Da.  The cone voltage was set to 20 
V and the capillary voltage set to 3.0 kV.  The source temperature was set to 150 
0
C and the 
desolvation temperature set to 500 
0
C.  The desolvation gas flow was set to 1000 L/hr.  The 
system control and data acquisition were undertaken using Waters Empower 3® CDS.  The 
eluent was split using the Waters UPC
2
 splitter (as described in Chapter 2) via post PDA 
detection but before the CCM allowing for a leak of flow to the MS probe.  The splitter was 
modified to eliminate use of the make-up pump flow by taking out the first tee splitter in the 
UPC
2
 MS splitter containment device while re-plumbing for the flow from the PDA directly 
to the second tee splitter in the MS splitter device. 
 
 Amphipathic Analysis Investigations 3.2.4
3.2.4.1 Amphipathic Solution Materials and Preparations 
Samples and standards were purchased from Avanti Polar Lipids.  Stock 1 and Stock 2 were 
Brain (porcine) extracts except for lysophosphatidylcholine (LPC) and phosphatidylglycerol 
(PG) which were egg (chicken).  Stocks were prepared in 50:50 chloroform/methanol. 
Working lipid mixtures were prepared to the specified concentration.   
 Stock 1:  Ceramide, SM, (0.05mg/mL) and  PG, PE, PC, (0.1mg/mL)   
 Stock 2: LPC, LPE, (0.05mg/mL) 
 Mix 1:  1:1 of [mix 2] and [mix 3] 
 Mix 2:  Phosphatidylcholine (PC) acyl chain length 5 component mix (0.1 
mg/mL): 14:0/14:0, 16:0/16:0, 17:0/17:0, 18:0/18:0, 23:0/23:0 
 Mix 3:   Phosphatidylcholine (PC) Saturation 3 component mix: 18:1(Δ9 
cis)/18:1 (Δ9 cis), 18:2(Δ9,12 cis)/18:2 (Δ9,12 cis), 18:3(Δ9,12,15 cis)/18:3 (Δ9,12,15 
cis) 
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3.2.4.2 Instrument Conditions for the Amphipathic Experiments 
The chromatography was performed using an ACQUITY UPC
2
 system coupled to an 
ACQUITY single quadrupole (SQD) mass spectrometer.  CO2 was used as the super critical 
fluid as mobile phase component A.  A modifier co-solvent was used as mobile phase B 
which consisted of 2 g/L ammonium formate dissolved in methanol.  The column for the 
analysis was a 3.0 x 100 mm UPC
2 
BEH column with 1.7 µm particles.  The injection volume 
was optimized for 1 µl.  The samples were eluted with an optimized flow rate of 1.9 mL/min.  
The column temperature was optimized and maintained at 60 
0
C. The peaks were eluted 
under gradient elution initially beginning with 15% modifier.  The modifier was increased to 
50% over 3 minutes and held at 50% for another 2 minutes.  Prior to the next injection, the 
gradient was re-equilibrated at initial conditions for 2 minutes.  General re-equilibration times 
recommended from column manufacturers for RPLC utilizing gradients that extend from 5% 
to 95% organic are 8-10 column volumes.   For this UPC
2
 method, the gradient is increased 
to only 50% elution modifier.  It assumed an equilibration of 5 column volumes at initial 
conditions equating to 1.86 minutes for equilibration time, would be suffice.  The time for 
equilibrating 5 column volumes for this method was calculated by Equation 3.1: 
𝑇𝑜𝑡𝑎𝑙 𝑉𝑜𝑙𝑢𝑚𝑒 𝑓𝑜𝑟 𝐸𝑞𝑢𝑖𝑙𝑖𝑏𝑟𝑎𝑡𝑖𝑜𝑛 (𝑉𝑒𝑞𝑢𝑖𝑙)
= (𝜋𝑟2𝐿)(#𝑜𝑓 𝑟𝑒𝑐𝑜𝑚𝑚𝑒𝑛𝑑𝑒𝑑 𝑐𝑜𝑙𝑢𝑚𝑛 𝑣𝑜𝑙𝑢𝑚𝑒𝑠 (𝐶𝑣))







= 1.86 𝑚𝑖𝑛 
Equation 3.1: Calculation of equilibration volume as defined by 5 column volumes and 
calculation of re-equilibration time 
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The re-equilibration time was verified by observing the pressure profile displayed on the 
instrument software diagnostic console panel.  The diagnostic console for monitoring 
pressure indicated that the total system pressure after the re-equilibration was equal to that of 
the total system pressure at the start of the gradient profile.  The matching total system 
pressures are a good indication of appropriate re-equilibration time. The back pressure was 
regulated using the automated backpressure regulator to maintain isopycnic conditions.  The 
initial back pressure setting was 3000 psi which resulted in an overall system pressure of 
5600 psi.  For the isopycnic versus isobaric comparisons, the back pressure was automatically 
decreased to 1500 psi over the 3 minute span of the programmed gradient of the automatic 
backpressure regulator and held at 1500 psi for 2 minutes.  This allowed the observed overall 
system pressure to be maintained at approximately 5600 psi + 30 psi for the duration of the 
analysis.  System control and data collection was achieved using Empower® 3 CDS. 
 
3.3 Results 
 Diluent Study  3.3.1
The goal of this study was to obtain a better understanding of peak distortion effects when 
using polar and non-polar organic solvents for analysis with the ACQUITY UPC
2
 System 
based on the experimental reasoning specified in Table 3.4. The study included a range of 
solvents (Table 3.1) that span a range of polarities and relative eluotropic strengths.  Results 
of the study provided guidance for diluent selection when performing synthetic chemical 
reactions in a medicinal chemistry laboratory.Table 3.4: Diluent effects experimental 
reasoning and design 
Question? Importance? Test Case 
What is the injection range 
for common diluents at 
each end of the polarity 
spectrum? 
To understand loadability 
and strong solvent effects on 
peak shape to aid scale-up 
processes. 
Effect of injection volume 
with polar vs. non-polar 
diluents on a silica column 
Are the results different for 
different columns? 
To understand expected 
retention for low k’ analytes 
Effect on different columns 
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to aid method selection 
Are other diluents 
retained? and how would 
they interfere with the 
results 
To understand the 
interferences when this 
technique is implemented in 
a medchem environment 
Investigated DMA, DMF, 
NMP, etc. 
What if the optimal diluent 
results in poor solubility?  
To understand what the 
limitations and expectations 
when compositional diluent 
mixtures are used 
Systematic exploration of 
increasing addition of 
problematic diluents with 
optimal diluents. 
 
A test probe analyte with a low retention factor (k) is good to study the effect of diluents 
when injected because it will be more susceptible to peak distortion effects.  4-hydroxy butyl-
benzoate (4-HBB) was chosen as a suitable probe analyte because of its high solubility in the 
solvents used in the study and low retention factor.  Different injection volumes were 
investigated to evaluate loadability and strong solvent effects on peak shape. Comparisons of 
the chromatographic peak shape obtained for the non-polar diluent of heptane/IPA (9:1) and 
the polar diluent DMSO are shown in Figure 3.1.   Peak distortion was observed for the probe 
analyte on all columns when DMSO was used as the diluent for injections greater than 2 µL.  
Conversely, the peak shape of the probe analyte was Gaussian when heptane/IPA (9:1) was 
employed as the diluent. However, when the injection volume was increased to 5 µL, peak 
distortion occurred irrespective of diluent.  It is hypothesized that either strong solvent effects 
or the mass load of the sample is the major contributor to peak shape distortions at the larger 
injections rather than the eluotropic strength of the diluent. In both cases, mass overload and 
strong solvent effects, the peak touchdown point would be the same as injection volume is 
increased, yet the liftoff point of the peak would shift to an earlier time point.  Mass 
overloading is historically seen as a ‘shark fin’ peak shape whereas the tailing factor would 
be measured and represented as a larger positive integer, which is not seen in the 
chromatograms in Figure 3.1.  The 2 µL and 5µL injections of DMSO, the mass analysis of 
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the hump at the beginning of the probe peak indicated retention interference of the DMSO 
solvent.  It was concluded that DMSO is retaining on the column but is also contributing to 
strong solvent effects at the larger injection volumes which are contributing to the distortion 
of the peaks.   
  




Figure 3.1: Peak distortion comparisons of 0.2 mg/mL 4-HBB standard between polar solvent 
DMSO and non-polar solvent heptane/IPA 9:1 for 0.5 μL, 2 μL, and 5 μL injection volumes on 
an ACQUITY UPC
2
 BEH, 3.0 mm x 100 mm; 1.7 µm column. 
 
Reaction synthesis commonly uses a wide range of polar solvents such as DMA, DMF, NMP, 
and DMSO.  These solvents were used as diluents and compared to the non-polar diluent 
heptane/IPA (9:1) for the same analyte probe 4-HBB. Each injection resulted in peak shape 
distortion for the 4-HBB probe. The injections using the DMA and DMF diluent showed 
retention of these diluents on the column interfering with the 4-HBB probe analyte.  A similar 
result was observed for NMP, however NMP exhibits low absorbance at 254 nm. Therefore 
extra considerations should be adhered to when using NMP as a diluent at lower wavelengths 
5 µL DMSO 
2 µL DMSO 
0.5 µL DMSO 
5 µL Heptane/IPA 
2 µL Heptane/IPA 
0.5 µL Heptane/IPA 
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as a possible diluent, yet the peak width was observed to be greater than the peak width for 
the injections of the heptane/IPA (9:1). 
 
The experiment performed for Figure 3.2 was repeated by injecting the 4-HBB probe analyte 
on the CSH Fluoro-phenyl column. The extent of the 4-HBB peak distortion was observed to 
be much more severe for this column when compared to the results obtained on the 
ACQUITY UPC
2
 BEH column (Figure 3.1).  
 
Figure 3.2: CSH Fluoro-phenyl UPC
2
/UV results showing peak distortion of 4-HBB for polar 
solvents DMA, DMF, NMP, and DMSO including the non-polar solvent heptane/IPA (9:1).   
 
Further investigations to help explain this phenomenon would have to consider solubility 
compatibility and loadability studies.  However for the purpose of this chapter and future 
work described in this thesis, the goal of attaining general expectations regarding sample 
diluent retention interferences and effects on peak shape due to strong solvent effects and 
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increasing injection volume has been achieved allowing us to begin general HTS experiments 
and reaction monitoring of pharmaceutical compounds. 
 
 Optimizing the Mass Spectrometry Interface 3.3.2
3.3.2.1 Effects of MS probe exit solvent plume instability 
Prior to beginning any analysis, the instrument was set-up at initial conditions of 5% modifier 
at a flow rate of 1.5 mL/min with a make-up flow of 0.2 mL/min.  The modifier composition 
was 100% methanol.  Make-up flow is defined as the post-column addition of solvent used to 
aid ionization of the analytes in the mass spectrometer.  For this experiment, the composition 
of the make-up flow was 100% methanol with 0.1% formic acid.  The gradient program was 
initiated to increase to 30% modifier over 7 minutes.  Blank injections of methanol were 
performed to monitor the baseline.  Baseline ripples or excessive baseline noise was observed 
and highlighted in the blue circle of Figure 3.3.  Upon further investigation of a subsequent 
injection, the ripples coincided with pulsation of the spray as it exited the mass spectrometer 
probe.  The ripple was not observed during single ion recording nor detected in the PDA 
chromatographic trace.  As the modifier composition increased, the gradient, the ripple 
disappeared indicating that the effect was due to poor nebulization at low organic solvent 
compositions.   In an effort to mitigate the increased baseline noise and probe pulsation, 
make-up flow rates were increased to 0.6 mL/min until the gradient composition increased to 











Figure 3.3:  Evidence probe plume pulsation (circled in blue) in MS TIC during a blank 
injection 
 
3.3.2.2 Investigating capillary voltage parameters 
Capillary voltages were explored in order to understand their effect on sensitivity for the 
probe analytes in the mixture described in section 3.2.2.1.  The optimal capillary voltage for 
the majority of the compounds resulted in a value of 1.0 kV as seen in the plot shown in 
Figure 3.4.  The make-up flow consisted of 0.2% ammonium hydroxide in methanol with a 
flow rate of 0.4 mL/min.  The analysis was performed using an ACQUITY BEH column with 
a flow rate of 1.5 mL/min and gradient elution programmed at a starting composition of 2% 
modifier increasing to 45% modifier over 5 minutes.  The modifier was prepared with 0.2% 
ammonium hydroxide in methanol. 




Figure 3.4:  Investigating capillary voltage for basic and neutral pharmaceutical compounds 
 
Interestingly, different optimal capillary voltages were observed for the analysis of 
Phosphatidylglycerol (PG) and Phosphatidylethanolamine (PE) lipids (Figure 3.5).   The 
optimal capillary voltage was observed to be 4.0 kV for these amphipathic compounds.   It 
was concluded, the capillary voltage optimal parameters are analyte dependent and not 







































Figure 3.5: MS TIC sensitivity comparisons of Phosphatidylglycerol (PG) and 
Phosphatidylethanolamine (PE) lipids when varying capillary voltage 
 
3.3.2.3 Investigating mass spectrometry desolvation parameters 
Desolvation temperature was briefly investigated.  According to the results plotted in Figure 
3.6, ranitidine hydrochloride was the only compound that increases in sensitivity with higher 
desolvation temperature.  It is assumed that the mass spectrometer requires more heat at the 
point of elution of ranitidine due to the higher amount of modifier, or liquid present in the 




























Figure 3.6:  Investigating desolvation temperature 
 
3.3.2.4 Investigating the effects of post column addition solvent composition and flow rate 
Three different post column addition solvent compositions were investigated.  Acidic and 
basic additives in methanol and isopropanol were chosen.  Additionally, four different post 
column addition flow rates were explored.  The results in Table 3.5 suggested isopropanol 
was a better ionization solvent than methanol, specifically when the basic additive is used.   A 
flow rate of 0.2 mL/min worked well for the compounds eluting in the middle of the gradient 
elution program.  However, early eluting peaks ionized better at higher post column addition 
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Table 3.5: Table of results post column addition make-up flow rates effect on peak area 
 
 
During the execution of other experiments that will be discussed in Chapter 4, particular 
observations pertaining to post column addition were observed and included in this section of 
Chapter 3 due to the relevance to this section.  For the experiments that were investigated in 
Chapter 4, water was explored as a post-column addition solvent additive as part of the 
methodology for the QC check analysis that was periodically performed throughout the HTS 
cheminformatics study.  The blue box represents analytes that benefit from the addition of 
5% water / 95% methanol as the post column solvent.  The green box represents similarities 
of base and weak base addition.  The red box represents the benefits of strong base addition 




Clopidogrel Lidocaine Tolbutamide Omeprazole Alprazolam Warfarin Ranitidine
Composition Rate
0.2% Ammonium Hydroxide in Methanol
0.2% NH4OH in 
Methanol
0.1 8761 542871 517700 135327 654177 1224909 1100792
0.2 8418 547265 618103 132973 711599 1234078 962816
0.3 9613 506205 655874 131585 644136 1260202 864364
0.4 8188 465379 593954 117559 614515 1200658 759458
0.2% Ammonium Hydroxide in Isopropyl Alcohol
0.2% NH4OH in 
Isopropanol
0.1 16154 562763 654389 137596 683221 1328870 1134824
0.2 46801 541635 740471 147503 709307 1405293 994782
0.3 51675 655067 723001 136335 697943 1376285 890588
0.4 41527 824640 657317 130456 665118 1296238 849088
0.2% Formic Acid in Isopropyl Alcohol
0.2% Formic Acid in 
Isopropanol
0.1 22667 584204 355010 84938 508417 929392 1040988
0.2 26018 460535 321338 86027 525280 1028658 909494
0.3 17018 479268 322825 81374 492126 989344 820017
0.4 19893 627858 300963 74636 484784 906409 756484




Figure 3.7:  MS TIC comparison of different post-column addition ‘make-up’ flow compositions 
for an unknown mixture of analytes.  The blue box represents benefits of water addition.  The 
green box represents similarities of base and weak base addition.  The red box represents the 
benefits of strong base addition to the make-up flow. 
 
3.3.2.5 Comparison of MS sensitivity for full flow versus split flow 
In order to perform this experiment appropriately, the pressure profile of the system in 
presence of the MS splitter device and automatic back pressure regulator device must be 
determined.  For the analysis of the MS Test Mix using the conditions described in section 
3.3.2.2., the observed starting pressure was determined to be 2600 psi with a max pressure of 
4200 psi.  Based on these pressure determinations, a transfer line designed to by-pass the MS 
splitter can be made such that they match the pressure profile.  The pressure profile was 
varied based on the transfer line dimensions.  The transfer line is the tubing connecting the 
outlet of the column (or UV flow cell) to the MS which continues to maintain an appropriate 
amount of backpressure so as not to compromise the phase change composition in the mobile 
phase as it pertains to the liquid CO2 converting to gaseous CO2.  This configuration also by-
passed the automatic back pressure regulator; which is a variable pressure regulating device, 
test QC-Diol NH4OH MU
Time
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to a more static pressure regulating device.  The transfer line in this instance was also 
designed to maintain an average density of mobile phase similar to that of the mobile phase 
used for the system using the splitter and back pressure regulator.  The results observed show 
a consistent increase in sensitivity when allowing the full flow of mobile phase into the mass 
spectrometer (Figure 3.8). 
 
 
Figure 3.8:  Comparison of sensitivity with MS splitter versus full flow into the MS without 
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 One Factor at a Time (OFAT) Method Development Investigations 3.3.3
3.3.3.1 Systematic Screening 
The method development process employed systematically screened columns, modifiers, and 
modifier additives to achieve the best separation for the analytes under test.  The initial 
configuration screened four UPC
2
 columns with four modifiers.  A “modifier” is the strong 
solvent mobile phase component that facilitates elution of the analytes increasing in polarity.  
The four modifiers used were:  i) methanol, ii)methanol with 0.5% formic acid, iii) methanol 
with 2 g/L ammonium formate, and iv) methanol with 0.5% triethylamine.  The screening 
process was performed with a generic 5% to 30% B gradient over 5 min, holding at 30% for 
1 min before returning to the initial composition.  The total screening time was achieved in 
just over two hours.  The methanol with ammonium formate provided the best overall peak 
shape compared for each column, as shown in Figure 3.9. The peak tracking during the 
method screening process was achieved by reviewing the MS spectra provided by the mass 
spectrometer.  The selectivity (α) for the more polar analytes varied greatly.  Since the same 
screening method was utilized for these comparisons, the results of changing selectivity were 
hypothesized to be primarily related to the stationary phase – solute interactions.   
 
The structures of metoclopramide and the related substances are given in Table 3.6.  It was 
clear the first three components; impurituies B, 9, and D, did not change selectivity during the 
column screening most likely due to neutral or polarity likeliness.  Interestingly, as the 
polarity increased and the increased composition of modifier was required to elute the polar 
compounds, the selectivity of the analytes changed dramatically for each of the column 
comparisons.  Impurity F, Impurity A and metoclopramide increased retention on the HSS 
C18 SB column, concluding more hydrophobic and possible stearic retention mechanisms 
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between the stationary phase ligand and the diethyl (propyl)amine side chain which many of 
the other impurities did not have.  Impurity A and Impurity C changed elution order on the 
BEH 2-EP column which was concluded as a result of the greater amount of aliphatic amine 
functionality of Impurity A versus Impurity C.  Impurity A has 2 secondary amines and 1 
tertiary amine within the structure.  Impurity C has 1 primary amine within the structure.  The 
number of amines could possibly be related to the pKa of the BEH 2-ethylpyridine stationary 
phase.  The shift in retention selectivity might also be attributed to solubility.  Primary 
amines are more soluble in water and highly polar funtional groups, thus resulting in a greater 
retention time on the silica columns.  The greater retention of Impurity A could be explained 
by increased hydrogen bonding with the silanols of the stationary phase.  Impurity H has a 
carboxylic acid and hydroxyl group locate 5 and 6 on the benzene ring.  The same hydrogen 
bonding retention mechanism could also explain the increased retention of Impurity H on the 
highly polar BEH column.    Impurity C splits into 2 peaks.  The retention mechanism for 
impurity C is hypothesized to be related to pi-pi interactions with the fluorine electron shells 
of the CSH pentafluorophenyl stationary phase and the conjugated bonds of the analyte 
structure. If the mixture consisted of constitutional (structural) isomers, separations of the 
isobaric species could be observed.  This will be investigated later in the chapter.  Because so 
many retention mechanisms are recognized with this technique, it becomes very difficult to 
deduce the dominating retention mechanism within a given separation or comparison of 
separations screened across columns with different properties. 
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Metoclopramide 300.14  
 
Impurity A 342.16  
 
Impurity B 258.05  
 
Impurity C 200.03  
(negative ion) 
 
Impurity D 224.09  
 
Impurity F 286.13  
 
Impurity G 316.14  
 












Figure 3.9: Column screening results with peak tracking confirmed by MS.  The modifier (B) 
was methanol with 2g/L ammonium formate.  5% to 30% B over 5 min and held at 30% for 1 
min. 
 
Based on these results, the UPC
2
 2-EP stationary phase was the optimal column of choice 
providing Gaussian peak shapes and greatest average resolution for the majority of the 
analytes.  The UPC
2
 CSH Fluoro-Phenyl column provided good selectivity and peak shape, 
with impurity C unexpectedly separated into two peaks. Additionally, the impurity F 
appeared to separate as a number of peaks on the 2-EP column.   However, this is suspected 
as being due to a stability issue for that particular compound. 
 
3.3.3.1.1 MS Investigation of reference standard Impurity C 
During the screening process, two peaks were separated during the injection of the impurity 
C standard using the ACQUITY UPC
2
 CSH Fluoro-phenyl column.  This phenomenon was 


































































*Imp “H” is a 






CHAPTER 3  
127 
 
not observed with the other stationary phases.  MS spectral analysis of the two peaks showed 
similar spectra.  The MS spectra in Figure 3.10 indicates possible dimerization of the analyte.  
Based on this information, it was determined the two peaks were related to each other rather 
than the second peak being a contaminant.  The rapid determination of this relationship 
provided direction for scoping future analysis by MS/MS and accurate mass MS.  The data 
generated with higher MS resolving techniques or MS fragmentation capabilities to 
discriminate closely related structures will be more useful in determining the purity of the 
standard.   
 
Figure 3.10: MS spectral analysis of EP impurity C for the doublet peaks observed when using 
the UPC
2
 CSH Fluoro-phenyl stationary phase. 
 
3.3.3.1.2 Investigation of Impurity F working standard solution stability 
The peak shape of impurity F was observed to degrade over time during the method 
development process (Figure 3.11).  Unknown peaks would appear in the chromatogram 
within the course of seven days of investigative analysis.  In addition, the color of the 
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standard solution changed from a clear solution to a solution with a brownish tint.  MS 
interrogation revealed the masses listed in Table 3.7.  The masses were correlated to those 
found to be significant to the UV trace (not shown) between retention time 2.0 minutes and 
3.5 minutes.  XIC of m/z = 330 and m/z = 296 resulted in multiple peaks. 
 
Table 3.7: Table of masses found in the degraded standard solution of metoclopramide EP 
impurity F.   






EP Impurity F 2.92 286   
Unknown 1 2.27 344 + 58 methoxylation + 
methylation 
Unknowns 2 & 4 2.30 & 
2.61 
330 + 44 methoxylation 
Unknowns 3 & 6 2.68 & 
2.89 
296 + 10 hydrolysis + two 
methylations 
Unknown 5 2.86 356 + 70 unknown 
Unknown 7 3.11 252 - 34 Loss of Cl
-
 
Unknown 8 3.29 258 - 28 Loss of two CH3 groups 
 
The working standard was prepared in methanol and left standing when left standing 
unprotected from light for 1 week.  Many of the impurity peaks were products of methylation 
or methoxylation.  Based on this information, methanol as a diluent has the potential to be 
problematic for compounds susceptible to these methylation and methyloxidative degradative 
reactions.  As a result of these observations, the working standard solution shelf life has been 
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decreased to 3 days until a suitable diluent study can be performed.  Further studies would 
have to be explored to determine if colder storage conditions would increase the shelf life of 
the solution.  For all practical purposes for this investigation, 3 days shelf life was suffice.   
The unknown peak #8 in Table 3.7 with m/z = 258 has the same mass of methyl 4-
(acetylamino)-5-chloro-2-methoxybenzoate which is commonly referred to as “impurity B”.  
This unknown peak found in the impurity F working standard was determined not to be 
identical to EP impurity B due to differences in retention time, whereas impurity B eluted 
approximately at 0.48 minutes.  The other impurities origins were still undetermined.  They 
were hypothesized to be products of solution instability with methanol rather than degradants 
present in the reference material.  
  
 
Figure 3.11: MS ESI+ TIC of a degraded standard solution of metoclopramide EP impurity F.  
 




















































































Impurity F: [M+H] = 286
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3.3.3.1.3 Effect of Gradient Slope 
In reversed-phase LC, gradient slope is a common tool to manipulate the chromatographic 
separation, specifically in terms of increasing resolution between a critical pair of peaks. 
Using the UPC
2
 2-EP stationary phase, the gradient slope was decreased by extending the 
overall gradient run time.  The change in slope had little to no effect on the chromatographic 




Figure 3.12: Normalized x-axis overlay metoclopramide analyzed with extended 12- and 35-
minute gradient run times flattening the slope compared to the 6-minute screening experiments. 
The original gradient was used; 5% to 30% B. 
 
3.3.3.1.4 Effect of Different Elution Solvents 
Inducing a shallower gradient did not increase resolution between peaks.  To increase 
resolution, a less polar aprotic organic solvent (acetonitrile) was mixed at different 
compositions with methanol, the stronger elution solvent.  The addition of acetonitrile 
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within the retention time windows of 2.8 minutes and 3.5 minutes, as well as the effecting the 
separation of the peaks with the metoclopramide API and the later eluting impurity peaks 
between the retention window between 3.8 and 5.0 minutes in Figure 3.13.  Based on these 
observations, this technique proves to be a powerful tool when developing methods. 
 
Figure 3.13: Highlighted in this overlay, the addition of acetonitrile to the composition of the 
modifier increased the resolution of the later eluting analytes. 
 
3.3.3.1.5 Effect of Additive 
The effect of additives can either enhance or mask analyte interactions with the stationary 
phase, thus impacting peak shapes. The metoclopramide impurities have many different side 
group functionalities. The related impurities shown in Table 3.3 and Table 3.6, indicate 
amines, carboxylic acids, and hydroxyl groups. Therefore, choosing a suitable additive is 
challenging.  Individual standards of each of the impurities were explored during the 
additives screening. Formic acid achieved acceptable peak shape for impurity H; however, 
the chromatographic performance of the other related substances; for example when 
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compared to Impurity F which did not improve significantly.  Increasing the concentration of 
the formic acid yielded further improvements in peak shape for impurity H, as shown in 
Figure 3.14A.  Unfortunately, the peak shape for impurity F was compromised, as seen in 
Figure 3.14B.   Conversely, when 2 g/L of ammonium formate was used as the additive, the 
peak shape for impurity F was suitable and the peak shape for Impurity H was compromised.  
 
Figure 3.14: Peaks with hydroxyl (or polyphenols) functionality such as impurity H tend to 
benefit from the use of only formic acid, as shown in Figure 3.14A.  Optimal peak shape 
observed for compounds with primary, secondary, and tertiary amine functionality trend from 
the use of ammonium salt-based additives as with impurity F, shown in Figure 3.14B 
 
: 2-EP : 50:50 MeOH ACN 2% formic acid 
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Combining formic acid and ammonium formate provided the benefits of each additive, 
resulting in optimal peak shape for the entire separation. The results of the formic acid, 
ammonium formate, and combination of additives in the modifier for the expired sample are 
shown in Figure 3.15.  By using the expired sample in this comparison, it was observed that 




Figure 3.15: Injections of an expired metoclopramide sample performed with different additive 
compositions in the modifier. Combining ammonium formate with formic acid in terms of a 
“buffer-like” system provided the best peak shape for all analytes in the sample.  The modifier 
used was 50:50 methanol/acetonitrile. 
 
 Analysis of Amphipathic Compounds 3.3.4
The following sections explored the effects of acyl chain length and saturation for a set of 
lipid single moieties which are commonly found in natural products.  The experiments 
explored two stationary phases; the ACQUITY UPC
2
 BEH which exploits polar retention 
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mechanistic behavior and the ACQUITY UPC
2
 HSS C18 SB to promote hydrophobic 
mechanistic behavior.  The hypothesis of utilizing the polar and non-polar stationary phase 
was based on the premise of promoting hydrophobic retention interactions such as those 
observed when using RPLC, as previously reported by West[134].  For the analysis of lipids, 
insights could be attained for class and species separations. Both results will be compared to 
understand dimensionality and selectivity resulting from the distinctly different mechanisms 
provided by each stationary phase. 
 
3.3.4.1 Effect of Acyl Chain Length 
The PC acyl chain length Mix 2 was used for the comparison of the two stationary phases. 
The separation of the different chain lengths via the BEH column resulted in a retention 
window range of 0.2 minutes, whereas the elution order increased with decreasing length.   
The HSS C18 SB material resulted in an increase in selectivity. A retention window of 
approximately four minutes for the separation of the five analytes was observed.  Increasing 
retention is proportional to increasing chain length. Unfortunately, the peak shape obtained 
using the C18-based stationary phase is less desirable with increased tailing proportional to 
increasing chain length (Figure 3.16).  The poor peak shapes are due to the increased 
interaction with competing polar and non-polar retention mechanisms between the stationary 
phase and amphipathic analyte. 
 









 C18 SB stationary phases. 
 
3.3.4.2 Effect of Acyl Chain Saturation 
The PC acyl chain saturation mixture (Mix 3 in section 3.2.4.1) was used to explore the effect 
that double bonds have on retention in an effort to identify trends with retention and lipid 
chain length..  The BEH column continued to maintain a narrow retention window separation 
for the probe analytes. The elution order increases with increasing degrees of unsaturation 
(Figure 3.17).  Retention is similar to the acyl chain length experiment such that retention 
decreases in respect to molecular weight.  The HSS C18 SB column provided increases in 
separation for the probe analytes with reverse elution order to that observed on the BEH 
column, as was also observed in the previous experiments. Again, peak shape is not as 
favorable on the hydrophobic C18 stationary phase to that observed on the polar BEH 
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stationary phase, hence leading to a hypothesis of increased analyte - stationary phase 
interaction activity for the hydrocarbon based ligand perhaps due to an increased occurrence 
of hydrogen bonding between the ligand and the solute.   
 
Figure 3.17: Comparing the effect of acyl chain saturation on retention between ACQUITY 
UPC
2
 BEH vs. ACQUITY UPC
2
 C18 SB stationary phases. The 18:0/18:0 data points were added 
from the acyl chain length experiments to illustrate agreement with each trend 
 
3.3.4.3 Isopycnic vs. Isobaric Conditions 
Injections of Mix 1 (from section 3.2.4.1) were performed to explore any differences when 
running an isobaric experiment versus an isopycnic experiment.  The automatic backpressure 
regulator pressure value was set isobarically to 1500 psi.  The isopycnic conditions were 
generated using a reverse pressure gradient from 3000 psi to 1500 psi so as to match the 
pressure generated by the increase of %B.  The overall system pressure of 5600 psi was 
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maintained across the pressurized system, hence constant density.  The MS ESI+ single ion 
recording (SIR) traces of the isobaric (red) and isopycnic (black) UPC
2
 automatic 
backpressure regulator settings were overlaid (Figure 3.18).   For the isopycnic conditions 
during the solvent gradient resulted in the faster elution of the first four peaks with slightly 
greater peak heights, suggesting an apparent reduction in dwell volume or more efficient 
mixing due to the higher applied pressure and mobile phase density during the programmed 
gradient. However, the peak widths were observed to be in a range of 1-2 seconds wider than 
the isobaric conditions when integrated and measured by the chromatographic software.  The 
isopycnic conditions during the 50% co-solvent hold resulted in identical peak shapes.    
 
Figure 3.18: Isopycnic results in black versus isobaric results in red.  Gradient occurs during 
the first 3 minutes only.  Increased density earlier in the gradient decreased retention for these 
polar analytes. 
 
3.3.4.4 Column lifetime investigations 
Retention times were observed to be shifting with shorter elution times over the course of two 
weeks of using the developed methodology for the class separation of lipids.  The 
methodology that was originally developed used a modifier composition of 100% methanol 
with 2 g/L ammonium formate.  The separation was performed on a 3.0 mm x 100 mm; 1.7 





 BEH column held at 50 
0
C in the column oven.  The flow rate was 2.0 mL/min 
programmed with a gradient elution of the modifier from 5% to 50% over 12 minutes.  The 
backpressure regulator was maintained at 1600 psi.  The phenomenon was observed on two 
systems and four columns over time prompting an investigation.  A sampling of 200 
injections of the lipid Mix 1 was performed.  A new mobile phase was prepared after 100 
injections.  It was observed for injection #200 of the lipid mix 3, the polar lipids eluting later 
had decrease in retention time from 8.56 minutes for phosphatidylcholine (PC) during 
injection #10 to 6.59 minutes during injection #200 (Figure 3.19).  Additional to the retention 





 resulting in a 54% decrease in sensitivity.  Resolution of many peaks 
was also observed to decrease between injection #10 and injection #200 (Figure 3.19).   
 
 
Figure 3.19:  MS ESI+ TIC of the separation of lipids Mix 1 showing the retention drifting, loss 
of resolution and loss of sensitivity over 200 injections. 
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Figure 3.20:  Trend plot for calculating the difference and percent difference between injection 
#1 and injection #236. 
 
Based on these findings, communications were relayed back to the Consumables Group 
organization in Waters Corporation.  They further researched the phenomenon and 
determined evidence of silyl ether formation (SEF) equilibrium reactions between the 
alcohols on the particle of the surface and in the mobile phase solvent [137].  Their findings 
stated the silanols of the column can be hydroxylated to their original state upon exposure to 
water.  The regeneration of the column was attempted using this recommendation, however 
this was not achieved.  Therefore, an alternative approach was used to mitigate the decaying 
chromatographic performance by utilizing a similar buffered mobile phase used in the 
method development experiments in section 3.3.3.1.5.  The results of using the modifier with 
ammonium formate and formic acid additive stabilized the retention time shifts and 
CER RT Drift:  Δ = -0.291 min,   %Δ = -14.6%
PG RT Drift:  Δ = -1.188 min,  %Δ = -23.4%
PC RT Drift:  Δ = -2.537 min,   %Δ = -28.3%
Sample injection #
1 236
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minimized any further decreases in sensitivity, except in the case when it was determined that 
the sample stock solutions had degraded Figure 3.21. 
 
Figure 3.21: Overlay comparison of injections performed over 13 days of injections using the 
mobile phase with both additives composed of 1 g/L ammonium formate and 1% formic acid 
 
3.4 Conclusions 
The general objective of this chapter was to attain general observations and expectations of 
sample preparation techniques, mass spectrometry optimization guidelines, and varied 
method development variables effects on chromatographic performance when utilizing SFC.  
The diluent study revealed retention of typical solvents used in chemical synthetic reactions 
that may result as problematic interferences if determining yield of a reaction intermediate or 
final product.   
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*The stocks of these 
peaks were deemed 
no good after review 
of the solution
Inj. 1, Day 1
Inj. 5, Day 6
Inj. 10, Day 13
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The investigation of the effect of method development variables on peak shape and retention 
was correlated to some of the properties of the impurity structures.  The analysis of 
metoclopramide provided a nice example of solute diversity due to the impurities structure 
functionality of amines, hydroxyl groups, esters, and carboxylic acids. The primary method 
variables that influenced selectivity, resolution, and peak integrity were stationary phase, 
modifier elution strength, and additive composition, respectively.  The addition of additives 
resulted in better peak shapes and the addition of weaker elution solvents in the modifier 
aided resolution between analytes.  The addition of a weak acid with its conjugate base as 
additives in the modifier to create ‘buffered-like’ properties to the mobile phase aid and 
improve the peak shape for the majority of peaks for the metaclopramide separation.  The 
method development process uncovered multiple (stationary phase – analyte) interactions 
during the comparison of the column screening process. This was clearly observed with the 
hypothesized pi-pi interactions of the PFP stationary phase and Impurity C splitting into two 
peaks and with the example of 2-EP pKa properties affecting the elution order of basic 
solutes differing in primary, secondary, and tertiary amine functionality.  Further research, in 
addition to and guided by those previously published need to be explored in the next chapter 
[54, 81, 94, 96, 128-132, 135, 138-140].  Understanding the influence of these interactions 
with method variables will help build an appropriate method development approach.    
 
Lastly, the observation of the silyl ether formation (SEF) poses a problem in regards to 
column stability, as well as method repeatability and robustness.  Although there seems to be 
an approach published to regenerate a deteriorated column, the results of these studies 
suggest using a ‘buffered-like’ modifier composition to prevent retention time shifts and 
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CHAPTER 4  
4 Cheminformatic Investigation of Solute Physiochemical and Structural 
properties affecting SFC Chromatographic performance 
In the previous chapter, sample diluent, columns, and mobile phase effects were explored to 
determine the susceptibility to interferes and adverse effects on peak shape.  Additionally, 
“One Factor at a Time” (OFAT) principles explored methodology parameters that manipulate 
selectivity, sensitivity, and resolution of the packed column supercritical fluid 
chromatographic results. The aim of this present chapter is to explore a diverse compound 
library of intermediates and final compounds and employ a multivariate approach to 
visualize, confirm or identify additional factors that could potentially affect SFC 
chromatographic results. 
 
4.1 Introduction  
Many new chemical entities can either be extracted and purified from natural product sources 
or synthesized based on previous characterization and understanding of the natural products 
structural composition..  The screening analysis of new chemical entities relies on appropriate 
sample preparation and method variables for analysis which do not adversely affect the 
chromatographic interpretation of the data.  Diluent studies provided knowledge of solubility 
and interferences whereas if chosen inappropriately can affect the discovery of a positive 
‘Hit’ for a new lead candidate.  Additionally, natural product profiling experiments yield a 
high number of new chemical entities that are explored for drug-likeliness[141-147]. 
Cheminformatic data interpretation tools are commonly used to distill information from large 
screening data sets based on physiochemical properties and their susceptibility to reacting 
with targeted diseases.  The cheminformatic tools for chemical library management and 
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assessments utilize digital representations of molecules referred to as ‘languages’ for 
describing molecular patterns referred to as SMILES and SMARTS.  SMILES (Simplified 
Molecular Input Line Entry System) is a line notation (a typographical method using 
printable characters) for entering and representing molecules and reactions.  SMARTS is a 
language that allows you to specify substructures or describe molecular patterns using rules 
that are straightforward extensions of SMILES.  In fact, almost all SMILES specifications are 
valid SMARTS targets. Using SMARTS, flexible and efficient substructure-search 
specifications can be made in terms that are meaningful to chemists [148].  If the 
cheminformatic tools can provide direction towards lead candidates, could the 
cheminformatic tools provide insight to chromatographic trends and behavior based on 
knowledge of physiochemical or structural attributes of the entire chromatographic system 
which involves solutes, stationary phases and mobile phases?  Each of these factors, diluent 
choice, methodology, and data visualization and interpretation play important roles in the 
success of moving forward with lead candidates. 
 
General perceptions exist within the scientific community familiar with pSFC suggest a 
correlation between logP and pSFC retention of analytes.  Other reports have explored 
physiochemical attributes to predict ‘best use’ columns for screening exercises and method 
development activities[55, 128, 132-135, 140, 149, 150].  Examples investigate SFC 
retention behavior correlations with analyte pKa, polarizability, dipole-dipole moment values, 
and hydrogen donor-acceptor properties.  The authors de la Puente et al. has explored these 
concepts from a discovery HTS objective.  West and Lessellier have explored Linear 
Solvation Energy Relationships (LSER) with an objective to provide method development 
guidance.  In each instance, the authors typically investigate correlations using a list of test 
probes which are commonly purchased by chemical standards and reagent providers.  Many 
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of the correlations are in regards to retention, yet equally important chromatographic 
attributes which are ignored in these reports are peak symmetry and peak widths.     
 
Medicinal chemists utilize cheminformatic tools to sort through extensive compound 
libraries; internally and externally provided, and filter the libraries to build smaller targeted 
libraries aimed to explore in vitro activity towards chosen therapeutic targets [151-155]. 
Since medicinal chemists currently utilize these tools to manage the creation of HTS libraries 
based on physiochemical properties, with the addition of chromatographic results within the 
cheminformatic tools could allow for trends and correlations to be rapidly identified.  The 
trends and correlations could aid in predicting chromatographic behavior and thus aid in 
building better screening methods. Examples of similar research in this area has been 
explored with an objective of developing analytical SFC/MS screening protocols [140]. The 
authors construct trend plots for 55 compounds versus physiochemical characteristics such as 
pKa, dipole moment, and electron density to help generalize column selection for SFC/MS 
HTS.  The research described in this present chapter was designed to expand on previously 
reported results by incorporating structural functionality and library diversity for drugs 
exhibiting drug likeliness.   
 
In this chapter, the following investigations explore the applied use sub-2 µm particle size 
achiral stationary phase columns and the optimized analytical scale low volume SFC 
instrumentation.  Post purification QC; (commonly referred to as library QC in the 
pharmaceutical industry), typically utilize 96, 384, or 1536 well plates of compounds 
dissolved in dimethyl sulfoxide (DMSO). A cheminformatic tool provided by ChemAxon 
will be used to investigate trends with the supercritical fluid chromatography 
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chromatographic peak attributes in relationship to the physiochemical and structural 
chemistry of the molecules using SMILES and SMARTS notations for describing molecular 
patterns. The study will explore a compound library and cheminformatics tools will be 
explored to visualize physiochemical and structural functionality parameters based on 
SMILES/SMART notations and modeled against retention times, peak width and USP peak 
tailing values. The objectives of these following experiments were to investigate a diverse, 
yet drug-likeliness set of compounds as defined by Lipinski’s ‘Rule of Five’ that would 
similarly exist within pharmaceutical company compound libraries.  The acquired 
compounds theoretically exist as building blocks or scaffolds that can be used as 
intermediates for further targeted HTS screening and catalysis studies thus creating additional 
new molecular entities.  For large dataset screening, it is prudent to routinely test for system 
performance or system suitability.  A system suitability test can defend the validity of system 
performance influence, positively or negatively, with the conclusions of the investigation.  
Therefore, an appropriate system suitability test mix and procedure had to be developed to 
support the investigative observations of the compound library plate. The objective of this 
preliminary experimental plan was to record the chromatographic attributes for each of the 
analytes as they are analyzed on different columns using a generic screening method.  Once 
the chromatographic attributes were entered into the cheminformatic software, general 
observations and trends were explored when plotting chromatographic attributes versus 
physiochemical or structural functionality of the analyte. 
 




 Cheminformatics Experimental 4.2.1
A chemical library was purchased (ChemBridge, San Diego, USA).  Physiochemical 
parameters were predicted values calculated within the cheminformatic software based on 
structure.  SMILES notations were used to calculate the quantity of structural functional 
groups such as ketones, aldehydes, primary amines, secondary amines, tertiary amines, 
halogens, conjugated oxygen containing groups, carboxylic acids, phenols, and enols.  . The 
selected compounds were also filtered based on Lipinksi’s ‘Rule of Five’ which evaluates the 
drug likeness of a chemical compound with a certain pharmacological or biological activity 
described with physiochemical properties that would make it a likely orally active drug in 
humans[156].  The dataset filters include compounds with a water-octanol partition 
coefficient (logP) less than 5, no more than 5 hydrogen bond donors, no more than 10 
hydrogen bond accepters, and a molecular mass less than 500 Da.  Cheminformatic modeling 
was performed using Instant JChem and JChem for Office.  (ChemAxon, Budapest, 
Hungary).   
 
 Cheminformatic System Suitability Test Mixture 4.2.2
A QC test solution was used to determine system performance during the course of the 
extensive compound screening.  The test solution consisted of a mixture of analytes (Table 
4.1) designed to elute over a gradient of 0% to 50% modifier composed of 100% methanol or 
methanol with additives to improve peak shape.   
   
Table 4.1 Compounds and concentrations for the system suitability test mixture performed 
during the cheminformatic correlations experiments 






(mg/mL in MeOH) 
benzophenone 182.2179 C13H10O 0.1 
glybenclamide 494.0035 C23H28ClN3O5S 0.25 
4-hydroxybenaldehyde 122.1210 C7H6O2 0.25 
carbamazepine 236.2686 C15H12N2O 0.25 
sulfanilamide 172.2049 C6H8N2O2S 0.25 
procaine 236.3101 C13H20N2O2 0.25 
protryptyline 263.3767 C19H21N 0.25 
metoclopramide 299.7964 C14H22ClN3O2 0.25 
 
 Instrumentation Parameters for the Cheminformatic Study 4.2.3
The system suitability separations were initially performed using various columns outlined in 
Table 4.2 on an ACQUITY UPC
2
 system configured with PDA detection (Waters® 
Corporation, MA, USA).  The column was maintained at 45 °C.  Gradient elution was 
performed using a linear addition of the modifier from 5% to 50% over 5 minutes.  The 
backpressure was maintained at 2000 psi.  The injection volume was 2.0 µL while the 
samples were maintained at 18 °C in the autosampler. Detection was monitoring at a single 
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Table 4.2  Columns and dimensions explored for system suitability study 
Stationary Phase Dimesions 
ACQUITY UPC
2












 HSS C18 SB, , *This column 
showed no retention so it was eventually excluded 
from the study. 
3.0 x 50 mm; 1.8 μm 
 
 
The final separations were performed using a 3.0 mm x 50 mm ACQUITY UPC
2
 1.7 µm 





 Corporation, MA, USA). Gradient elution was performed using a 
linear addition of the modifier from 5% to 50% over 15 minutes.  The modifier composition 
was 15 mM ammonium formate dissolved in 100% methanol and spiked with 10 mL of 
formic acid.  The achiral columns were maintained at 50 
0
C.  The backpressure regulator was 
maintained at 1800 psi.  The system injected 1.0 µL of sample.  The post column make-up 
flow prior to the entry into the MS composed of 0.1% ammonia in methanol flowing at 0.4 
mL/minute.  The mass spectrometer was an ACQUITY SQD2 (Waters
®
 Corporation, MA, 
USA).  The experiment was performed using positive ESI mode.  The cone voltage was set to 
25 V and a capillary voltage set to 3.0 kV 





 Development of the chemometric analysis system performance test  4.3.1
A variety of acids, bases and neutral compounds were screened and evaluated using a generic 
UPC
2
 method.  The method conditions used a 5% to 50% modifier gradient elution profile 
flowing at 2.0 mL/minute over 6 minutes.  The temperature was maintained at 45
o
C with a 
backpressure setting of 1800 psi.  The method profile allowed for an assessment of analyte 
elution diversity. The analytes were also chosen in terms of peak shape.  A selection of test 
probes with Gaussian peak shapes and tailing peak shapes were chosen.  Tailing analytes 
were selected as part of the final test mix to determine if any silanol interaction activity 
changes within the column over time.  The resulting system suitability test mix is listed in  
Table 4.1.  
 
The system suitability test mix was injected and screened on the four different achiral UPC
2
 
columns listed in Table 4.2.  Methanol was screened initially, but the chromatograms resulted 
in severely tailing peaks and peak splitting.  Retention time shifts were also observed over 
time for the later eluting peaks on all four columns.  Examples are shown for the BEH results 
in Figure 4.1 whereas the worst peak distortions were observed for protryptyline, procaine, 
and metoclopramide eluting respectively and retention times were confirmed by mass upon 
review of the MS spectra.  The elution order for protryptyline and procaine swapped for the 
BEH 2-EP column; however the peak shapes were less abnormally distorted. The polar 
analytes did result in severe tailing on the BEH 2-EP column shown in Figure 4.2.  System 
pressure was observed to increase on each column over time from 5171 psi to 5946 psi over 9 
hours of injections, whereas Figure 4.3 shows the pressure increase for the BEH 2-EP 
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column.  This can be observed when SEF is occurring on-column. It is unclear what is 
causing the peak shape distortion and retention time shifts on the BEH column, but it is 
hypothesized that the column chemistries are altering over time effecting the active silanol 
sites and possible the properties of the ligand.  The basic properties of the BEH 2-EP column 
could be contributed to improved Gaussian peak shapes for the polar, yet basic analytes 
protryptyline, procaine, and metoclopramide.  It was observed that the polar analytes shifted 
while the more neutral analytes eluted with a consistent retention over the 16 hours.  Another 
hypothesis would suggest solubility issues with the analytes and thus causing precipitation on 
the head of the column, thus creating changes in the mobile phase density.  Additionally to 
that  hypothesis, suspicion of the operating conditions within the sub-optimal conditions 
outlined in the Tarafder and Poe publications due to the similarity of the peak anomalies 
reported [68-74, 80, 92].  The later hypothesis is not as suspect due to the high composition 
of modifier in the gradient profile where the problematic peaks are eluting.  Solute 
precipitation is moderately suspected as the issue. However, when solutes crash out due to the 
mobile phase upon injection and onto the inlet of the column filter frit, the system pressure 
would return to normal when the filter frit is replaced.  The return to initial pressures did not 
occur when the filter frit was replaced.  Although the replacement of the column frit could 
alleviate pressure issues that may be caused by precipitation building at the head of the 
column, the frit replacement does not exclude the possibility of precipitation within the 
column bed. 
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Due to the problematic issues occurring with chromatographic peak shape and retention time, 
the modifier was changed from 100% methanol to 100% methanol spiked with 10 mM 
ammonium formate and 1% formic acid based on the previous method development 
experimentation performed and discussed in Chapter 3.  The peak shape and retention time 
shifts previously observed with the system suitability test mix dramatically improved for all 
columns.  The final methodology for the system suitability test mix was chosen with UPC
2
 
BEH 2-EP results shown in Figure 4.4.  The UPC
2
 BEH results were excellent in terms of 
peak shape and reproducibility; however the separation lacked any critically resolved pairs to 
be used as a diagnostic. Additionally,  the last eluting peak retained in a range of 45-48% of 
the gradient elution profile.  The UPC
2
 2-EP has two critical pairs of tightly resolved peaks 
and less retention for the last eluting polar metoclopramide peak.  The resolution of the first 
critical pair of peaks; 4-hydroxybenzaldehyde and carbamazepine, decrease with increasing 
column injections, while the resolution increased for the second critical pair of glybenclamide 
and sulfanilamide.  It is believed this is due to column equilibration steady state issues that 










0.00 0.60 1.20 1.80 2.40 3.00 3.60 4.20 4.80 5.40 6.00
CHAPTER 4  
154 
 
equilibration readiness may impact critical pair separations positively or negatively in terms 
of resolution based on the properties of the analytes shifting in retention time.  For this 
particular system suitability mixture, it was believed to be advantageous to have two sets of 
critical pairs of analytes showing increases and decreases in resolution, thus utilizing any 
changes in observed resolution due to slight issues with column or system equilibration. 
These two criteria allow for quick determinations of system or column performance issues 
and allows for unpredicted late eluting retention of highly polar compounds that may exist in 
the screening plate.   
 
It has been previously shown that the high pKa properties of a BEH 2-ethylpyridine column 
provides the best peak shape for the analysis of alkaline pharmaceutical compounds [157].  
For this cheminformatic investigation, utilizing the 2-EP column; in combination with a 
modifier with additives, is a suitable choice for controlling unexpected influences affecting 
peak shape during the preliminary screening experiments with the compound library.  The 
basic properties of the column and the buffering-like capabilities of the additive based 
modifier typically yields Gaussian peak shapes for basic, acidic, and neutral analytes. 
Therefore, it is hypothesized utilizing this particular column and modifier combination will 
mitigate complications in questionable data inputs into the cheminformatic software assisting 
with the trending analysis, thus simplifying the data analysis. 
 




Figure 4.4: System suitability test mix results performed using the UPC
2
 2-EP column and 
ammonium formate/formic acid methanol modifier conditions. 
 
 Design of Physiochemical and Structural Correlations  4.3.2
SMARTS notations were used to create the compound structural descriptors and the 
physiochemical descriptors and calculated for each compound in the cheminformatic 
software. SMARTS notations were either created or downloaded as templates from the 
internet [158] in order to calculate the number of functional groups per compound such as 
aldehydes, carboxylic acids, enols, however, the compounds procured by the vendor and 
tested were found not have some of these structural attributes.  The compounds in this library 
sample plate were found to have a variety of ketone, esters, ethers, halides and hydroxylated 
functionality described in Table 4.3.  The calculated values were tabulated in a single table 
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of descriptors (y) was plotted against the chromatographic results (x) for each compound.  
Additional plots were created to visualize third and fourth dimensional descriptors to identify 
additional trends.  When added, the third and fourth dimensional descriptors are represented 
by color and size of the data point in the plots.   
Table 4.3:  Table of descriptors using for the cheminformatic multivariate trend investigations 
Chromatographic Result 
Descriptors 
Functional group using 
SMART pattern descriptors 
Physiochemical 
descriptors 
Stationary phase -COOH clogP 
Tailing # of –OH  log 
Retention time -OH due only from carboxylic 
acids 
logSw 
Peak doublet or splitting -OH from phenol groups H bond accepters 
Peak width # of Primary amines H bond donors 
 # of Secondary amines Rotational bonds 
Other Descriptor labels # of Tertiary amines tPSA 
Molecular formula aldehydes  
Molecular weight Ketones, esters, ethers  
stereochemistry halides  
 Intramolecular h-bonding  
 
 
 Results of Chromatographic, Physiochemical and Structural Correlations  4.3.3
Using the same method developed for the system performance test, 300 compounds 
purchased from ChemBridge Inc. were injected.  Retention times and tailing factors were 
recorded and plotted in the cheminformatic software.  Descriptors for each of the analytes 
were generated by the ChemAxon software once the ChemBridge SDF file of compounds 
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was imported.  It was clear after the first set of experiments and data entry, the method 
needed to be extended to 10 minutes to allow for more discrimination in retention times 
between the analytes when performing the cheminformatic correlations. 
 
Trends were not observed when plotting the physiochemical descriptor values [such as 
rotational bonds (RB), hydrogen bond acceptors (Hacc) and donors (Hdon), topical 
polarizable surface area (tPSA), logarithm of the distribution coefficient (logD), and 
molecular weight] against the retention time or peak tailing chromatographic results attained 
on the UPC
2
 2-EP column.  Similarly, correlations were not observed for functional group 
descriptors when plotting the number of primary amines, secondary amines, and tertiary 
amines against the retention time or peak tailing chromatographic results attained on the 
UPC
2
 2-EP column.  Interestingly, the most notable correlation expectation is retention time 
in relationship to clogP of the analyte, yet Figure 4.5 shows no observable correlation 
between clogP and retention time.  With the close relationship to clogP, the log solubility of 
water (LogSw) was plotted versus retention time (Figure 4.6).  No trend was observed, yet 
the data point size was included to represent the tailing factor of the peak and a slight 
relationship or trend can be identified with this peak shape attribute.  The larger the data 
point, the greater the tailing value. 




Figure 4.5:  cLogP versus BEH 2-EP retention time results for the 300 compounds where the 
colors are represented by stereochemistry and the size of the point is represented by molecular 
weight 




Figure 4.6: LogSw versus BEH 2-EP retention time results for the 300 compounds where the 
colors are represented by stereochemistry and the size of the point is represented by the BEH 2-
EP tailing factor results. 
 
As stated, trends rather than conclusive correlations were observed in some instances.  Based 
on the discovery of a relationship to tailing and LogSw, a plot of clogP versus BEH 2-EP 
tailing showed a relationship with clogP values greater than three (Figure 4.7).  Out of 300 
compounds, 69 had a clogP value greater than 3.0.  About 23% of those compounds had 
tailing factors greater than 1.5.  The majority of compounds with a tailing factor of 3.0 or 
greater contained an ether group, hydroxyl group or both.  In 50% of those instances, the 
compound also had a pyrrolidine-based ring structure in the molecular scaffold.  Due to the 
results experienced with the system suitability test mix where the later eluting peaks were 
observed to have greater tailing factors, BEH 2-EP tailing results were plotted versus BEH 2-
EP retention times (Figure 4.8).  Although there seems to be a tailing factor and clogP 
correlation, there also seems to be a correlation between later eluting peaks and tailing 
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factors.  Yet, there was no conclusive evidence between retention time and clogP.   The 
tailing versus retention time plots could be an indication of a poorly performing system at 
high modifier compositions of the gradient.  If so, the system suitability test mix did not 
indicate this to be an issue.  Additionally, system level diagnostic tests provided by the UPC
2
 
software diagnostic tools indicated the system was working properly.  The assumption is that 
neither the system suitability mix nor the diagnostic level testing can identify the issue with 
enough accuracy.   Newer tools will have to be developed that will indicate issues, whether 
column related or system related, that are acute to higher organic modifier compositions in 
the overall mobile phase. 
 
 
Figure 4.7: cLogP versus BEH 2-EP tailing results for the 300 compounds where the highlighted 
yellow colors are represented by clogP values > 3.0.   The greater the size of the data point was 
represented by greater retention. 
 




Figure 4.8: 2-EP tailing results versus BEH 2-EP retention times for the 300 compounds where 




The results from this cheminformatic study highlight the importance of having a system 
suitability test with test probes capable of identifying subtle changes in chromatographic 
separations resulting from the system to reach steady state equilibrium.  The system 
suitability text mix is suitable to determine slight changes in column performance for the 
UPC
2
 2-EP column.  It looks to be suitable for the UPC
2
 BEH column, but for different 
purposes that might be suitable for method development or training activities.  The 
development of the test mix allowed for proper decisions when moving forward with a 
method for the cheminformatic study of correlating chromatography associated with analyte 
properties.  The cheminformatic analysis revealed little to no correlations or trends between 
many of the physiochemical or structural attributes of an analyte to that of the retention of 
that analyte by supercritical fluid chromatography.  Interestingly, there seems to be some 
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trends related to tailing factors.  In future investigations, it is recommended to design 
experiments with n ≥ 10 constituents with each of the structural attributes, specifically 
focused on ethers, hydroxyls, ketones, and pyrrolidine structural functionality.  Expanding 
the investigation to newer column technologies would also be recommended as future work. 
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CHAPTER 5  
5 UPC2/MS Applied to Pharmaceutical Drug Substance Reaction 
Synthesis Monitoring 
The aim of Chapters 3 and Chapter 4 focused on providing insight to scoping experimental 
planning and chromatographic expectations when utilizing sub-2µm particle columns on the 
optimized pSFC instrumentation technologies.  The scope highlighted considerations 
pertaining to the sample preparation considerations, methodology, interfacing with 
destruction detection devices and diagnostic system performance approaches.  These 
applications are focused on the typical procedures and workflows practiced in the lead 
optimization and process development groups employed in the pharmaceutical or chemical 
material industry.  The application investigates the reaction synthesis monitoring of three 
small molecules chosen either for their unique stereochemical properties and relationship to 
derived natural product entities.  The reasoning for this investigation was due in part of 
proving the sustainability of the technique and novel technology design improvements for use 
by the industry in terms of post discovery of a new chemical entity.  The examples in this 
chapter show the benefit of a high efficiency separation using the SFC approach when 
compared to UHPLC, the effectiveness to determine recovery values, the ability to 
troubleshoot synthetic route issues, and an approach to streamline chiral and achiral screening 
on a single chromatographic system.  One of the highlights demonstrates the optimized SFC 
instrument as a tool for a column agnostic screening approach to aid process optimization of 
a synthetic reaction during the clopidogrel experiments.   
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5.1 Introduction  
Implementing a novel technology into the everyday workflow of a pharmaceutical 
environment must be cautiously thought through, especially when it involves the fast paced 
discovery laboratory.  Instrument requirements include robustness, ease of use, and 
throughput and are assessed through a comprehensive evaluation in order to determine the 
usefulness and ‘fit for purpose’ implementation [159].  A comprehensive investigation should 
explore the different facets of the medicinal chemistry workflow, from single sample reaction 
monitoring submission, purification, HTS library QC, and reaction optimization [160, 161].  
The synthesis of the natural product derived drugs begins with basic molecular scaffolds 
which can be attained or synthesized.  For example, the scaffolds are typically coupled with 
additional molecular functionality to create small molecule building blocks which are 
analyzed and recovered by liquid chromatography coupled to mass spectrometry [162].    
Understanding the route synthesis of drug candidates facilitates the expedition of optimizing 
reaction rates, product yield, product purity, and thus the overall synthetic process as lead 
compounds progresses from discovery, through to early development. 
 
Multiple “walk-up” systems typically analyze greater than 40,000 samples per month in an 
analytical high throughput pharmaceutical discovery laboratory [163].   Utilizing these walk-
up LC/MS systems, chemists routinely and rapidly obtain molecular weight information of 
their samples, monitor reaction progress, purify target analytes, and evaluate the purity of 
resulting intermediates and products.  The simple workflow enables a chemist to login to the 
computer system, assign an identification code to the sample, and select from a menu the type 
of LC/MS experiments to be performed.  The automated sample analyses can be performed 
rapidly using short LC columns and fast gradients, typically with runs of 5 minutes or less.   
The evolution of walk-up LC/MS environments has occurred industry wide in recent years.  
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In fact, dedicated open-access software packages are now available from most instrument 
manufacturers [164-166].   
 
Chromatography instrument configurations include variations with analytical scale and 
chromatographic separation technique, such as walk-up purification and supercritical fluid 
chromatography, respectively.  Packed column supercritical fluid chromatography (pSFC) 
has proven usefulness within discovery research by providing orthogonal techniques to those 
commonly practiced, such as thin layer chromatography (TLC) and reversed-phase liquid 
chromatography (RPLC) [140, 167-174].  Purification scale pSFC provide the ability to 
purify achiral and chiral compounds with fractions that require less dry down time than the 
commonly used purification scale liquid chromatographs[175].   Yet, the challenges with 
supercritical fluid chromatography reside with the lack of robust supporting analytical scale 
instrumentation, efficient screening workflows, and analyte solubility challenges particularly 
with scale-up purification applications [140].  Additionally, the poor performance of 
analytical scale pSFC supporting technologies traditionally contributed to the pitfalls of wider 
adoption and use of pSFC for purification.   
 
In this chapter, the following investigations explore the applied use of newer technologies 
composed of achiral and chiral sub-2µm particle size stationary phase columns, optimized 
analytical scale low volume SFC instrumentation, and a novel ‘zero user interfacing’ compact 
single quadrupole mass detector for a walk-up high throughput screening environment.  This 
optimized pSFC instrumentation is analogous in design and use to that of ultrahigh-
performance LC (UHPLC) with extra-column volumes measuring approximately 30µL and 
system volumes measuring less than 400 µL.  Pharmaceutical syntheses were performed for 
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imatinib, rosuvastatin, and clopidogrel.  The reactions for each synthesis were monitored, and 
scaled up as part of the process of investigating this technology in a ‘real world’ synthetic 
environment.  Purification was performed for various stages of the pharmaceutical API 
synthesis experiments, however the purification overviews will be excluded from this chapter 
to maintain focus on the analytical evaluations of the sub-2 µm particle stationary phases and 
low bandspread analytical supercritical fluid chromatography system.  It is hypothesized that 
liquid chromatography might be required as an appropriate path and vice versa, therefore 
comparisons to reversed-phase LC will highlight these specific instances.   
 
Chiral analysis is an important part of drug discovery and natural product research [176-183].  
It would be difficult to ignore the implications that a low-bandspread pSFC instrument would 
have on the chiral analysis activities which are typically columns with particle sizes greater 
than or equal to 2.5 µm.  Although the focus of this thesis is achiral, chiral chromatography 
will be performed and evaluated.  The diversity each case study provides a suitable example 
for investigating the applicability, benefits and challenges of implementing packed column 
SFC/MS, and the newly developed chiral column technologies.  The combined results are 
aimed to provide a comprehensive assessment of overall feasibility, robustness, and 
flexibility currently questioned by the pharmaceutical discovery and development 
organizations.  Hypothetically, the investigations discussed in these studies should build 
scientific confidence in the approach, define guidelines for use, and add to the existing 
knowledgebase about packed column supercritical fluid chromatography use in the public 
forum.   
 




The compounds were chosen based on them meeting a combination of the following criteria: 
 Relevance pertaining to overall number of prescriptions and worldwide revenue,  
 Compound complexity for achiral and chiral conformations, 
 Diversity of reaction schemes and solvents used,  
 Relationship to natural products (derived, extracted, or synthesized.)    
 
Imatinib met the criteria for solvent diversity in terms of organic solvents required for 
synthesis, clopidogrel met the criteria for chiral attributes and rosuvastatin met criteria for 
natural product origins.   Interestingly, statins are derived from the natural product discovery 
compactin, commonly known as mevastatin, which was isolated from the mold of Penicillium 
citrinum by a Japanese biologist Akira Endo in the 1970s.  Although not marketed as a 
therapeutic drug to treat cholesterol, Merck filed the first cholesterol reducing statin referred 
to as lovastatin, a derivative of mevastatin. Rosuvastatin is classified in this family of 
therapeutics[184, 185].   The overall aims of including these ‘applied use’ investigations were 
to assess the applicability of a low volume instrument with sub-2µm particle stationary phase 
pSFC as a valuable solution for reaction monitoring activities performed in medicinal 
chemistry.  
The chiral analysis investigates the synthesis of clopidogrel and rosuvastatin.  Specifically, 
rosuvastatin is derived from a class of six-membered heterocyclic ring compounds, 
specifically pyrimidine scaffolds, reported to lead to a high percentage of top marketed drugs 
[183].  The therapeutic form of rosuvastatin is a (3R,5S) diastereomer enantiomer and 
requires enantiomeric determinations.  The rosuvastatin asymmetric synthetic route includes 
a multi-step synthetic pathway including commonly practiced reaction mechanisms such as 
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cyclocondensation, dehydrogenation, and modified Wittig reactions, thus leading to an 
enantiomeric product with the potential for a variety of impurities with each reaction 
intermediate. 
 
 Reaction Schemes 5.2.1
5.2.1.1 Rosuvastatin Reaction Scheme 
The synthetic route developed by Hirai and Watanabe [186, 187] was followed for the 
asymmetric synthesis of rosuvastatin calcium (Figure 5.1).  A key intermediary step of this 
synthetic pathway uses an aldehyde functionalized pyrimidine intermediate that allows the 
introduction of a modified Wittig reaction (R8) known as a Horner-Wadsworth-Emmons 
(HWE) reaction to lock in the E-alkene stereochemistry of the rosuvastatin intermediate.  By 
locking in the E-alkene stereochemistry as part of the reaction scheme, the protecting group 
provides access to a high purity yield of the desirable (3R, 5S)-rosuvastatin enantiomer by 
desilylation of the intermediate (R9) followed by a Narasaka reduction (R10), thus producing 
the resulting rosuvastatin (3R, 5S) enantiomeric methyl ester.  The methyl ester (R10) 
intermediate follows a two-step process via saponification producing a sodium salt form of 
the rosuvastatin free base (R11) which is then converted to the calcium salt form (R12) which 
is more commonly used for formulated products.  Aliquots from the reaction mixtures were 
diluted in methylene chloride or methanol and submitted for each reaction monitoring time 
point. 




Figure 5.1:  Reaction scheme for route synthesis of rosuvastatin calcium expanded to illustrate 
the reaction stages (R(#)) monitored by UPC
2
/MS and UPLC/MS 
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5.2.1.2 Reaction Scheme for Imatinib  
Zimmerman’s synthetic route (Figure 5.2) was followed for the synthesis of imatinib [10].  The 
aldol product (Stage A) undergoes a condensation reaction with guanidine (Stage B) in basic 
media to give the 2-aminopyrimidine (Stage C). After generating the functional pyrimidine 
core a Pd/C catalyzed hydrogenation of the nitro group to the amine group was performed 
(Stage D).  The acid side chain was prepared from 4-(chloromethyl)benzoic acid and 
condensed with 1-methylpiperazine (Stage E) and converted to the acid chloride using SOCl2 
(Stage F).  Amide formation with 4-chloromethylbenzoyl chloride and a direct displacement 
of the benzylic chloride with pyridine (Stage G) completes this synthesis of imatinib. 
  





Figure 5.2:  Reaction Scheme for the synthesis of Imatinib expanded to illustrate the reaction 
stages A thru G monitored by UPC
2
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5.2.1.3 Reaction Scheme for Clopidigrel 
The reaction scheme for clopidogrel is outlined in Figure 5.3.  The preparation of clopidogrel 
began from 2-chlorobenzyl cyanide building block [188].  Bromination of the 2-chlorobenzyl 
cyanide intermediate using bromine at elevated temperature produces the α- bromo cyanide 
compound (Stage V), which was condensed with tetrahydro-thieno pyridine (synthesized via 
coupling an amino thiophene and dioxane compound (Stage U) in the presence of NaHCO3 to 
obtain the functionalized cyano intermediate (Stage W).  The obtained cyano compound was 
converted into the racemic carboxylic acid intermediate (Stage X) which was methylated to 
yield the racemic clopidogrel (±) (Stage Y). The requisite isomer of clopidogrel was 
separated from the racemic compound using L - camphorsulfonic acid as resolution agent 
(Stage Z), thus the obtained CSA salt was treated with NaHCO3 followed by H2SO4 to yield 
clopidogrel. 




Figure 5.3:  Reaction scheme for the synthesis of clopidogrel expanded to illustrate the reaction 
stages (x) monitored by UPC
2
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 Reaction Monitoring Analysis 5.2.2
5.2.2.1 Achiral pSFC Screening 
The reactions were monitored using ACQUITY UPC
2
 configured with a PDA (Waters Corp., 
Milford, MA, USA), column manager and two auxiliary column managers increasing the 
column screening capability to 6 columns with independent temperature control.  The system 
was also coupled to ACQUITY QDa (Waters Corp., Milford, MA, USA) for mass 
measurements with positive and negative polarity electrospray ionization mode (ESI+).  The 
ACQUITY QDa was used in ‘standard mode’ with a 0.1 µm aperture.  The system was 
configured with the stationary phases shown in   
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Table 3.2 with the internal diameter and length dimensions changed to 3.0 mm x 50 mm 
respectively for rapid screening. Gradient elution was performed using a linear addition of the 
modifier from 0% to 50% over 2.5 minutes at a flow rate of 2.0 mL/min.  The modifier 
composition was 15 mM ammonium formate dissolved in 100% methanol and spiked with 10 
mL per liter of formic acid.  The achiral columns were maintained at 50 
0
C.  The 
backpressure regulator was maintained at 1885 psi.  The system injected 0.5 µL of sample.  
The post column make-up flow prior to the entry into the MS composed of 0.1% ammonia in 
methanol flowing at 0.4mL/minute.   
 
5.2.2.2 Chiral pSFC Screening  
The chiral analysis was performed using the same system configuration described in section 
5.2.2.1 using the chiral columns listed in Table 5.1.  The immobilized Chiralpak columns 
were used for the reaction monitoring screening and the Waters Trefoil columns were used 
for optimization experiments.  The chiral screening columns were maintained at 35 
0
C with a 
flow rate at 1.5 mL/minute.  The rosuvastatin enantiomeric excess experiments in section 
5.3.3.3 explored the newly commercially available Trefoil chiral columns (Waters, MA, 
USA) finalizing on optimized parameters utilizing the ACQUITY UPC
2
 Trefoil CEL1 
column.  The optimized conditions used a 1.4 mL/minute flow rate with an isocratic elution 
profile of 20% modifier and 80% CO2.  The elution modifier composition was 
methanol/isopropanol (1:1) with 20 mM ammonia additive. 
 
5.2.2.3 Achiral Reversed-Phase LC Screening Analysis 
The separations were performed using a 2.1 mm x 50 mm; 1.7 µm ACQUITY UPLC BEH 
C18 column using an ACQUITY Ultra Performance LC Chromatography™ (UPLC) System 





 Corporation, MA, USA). The column was maintained at 40 ºC and eluted with a 
linear acetonitrile – aqueous gradient over 1.0 minute at 800 µL/minute, starting at 5 % 
acetonitrile and rising to 95 % over the course of the gradient. The aqueous mobile phase was 
either 0.1 % v/v formic acid for low pH screening or 0.1 % v/v ammonium hydroxide for 
high pH screening. The column eluent was directed to the mass spectrometer for analysis. 
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Table 5.1: List of chiral columns used 
Stationary Phase Dimesions Manufacturer 
Chiralpak IA  2.1 x 150 mm; 3 μm 
 
Chiral Technologies Inc, PA, 
USA 
Chiralpak IB 2.1 x 150 mm; 3 μm 
 
Chiral Technologies Inc, PA, 
USA 
Chiralpak IC 2.1 x 150 mm; 3 μm 
 
Chiral Technologies Inc, PA, 
USA 
Chiralpak ID 2.1 x 150 mm; 3 μm 
 
Chiral Technologies Inc, PA, 
USA 
Chiralpak IE 2.1 x 150 mm; 3 μm 
 
Chiral Technologies Inc, PA, 
USA 
Chiralpak IF 2.1 x 150 mm; 3 μm 
 
Chiral Technologies Inc, PA, 
USA 
ACQUITY Trefoil Amy1 2.1 x 150 mm; 2.5 μm 
 
Waters, MA, USA 
ACQUITY Trefoil CEL1 2.1 x 150 mm; 2.5 μm 
 
Waters, MA, USA 
ACQUITY Trefoil CEL2 2.1 x 150 mm; 2.5 μm 
 








Three active pharmaceutical ingredients (API) were synthesized by the organic chemist staff 
at Prime Organics, Inc (Waltham, MA, USA).  Each reaction was monitored and assessed in 
terms of identifying any benefit of employing the pSFC technology.  Particular examples 
were observed and are highlighted within the next sections. 
 
 Monitoring the Synthesis of Imatinib by UPC2/MS 5.3.1
An intermediate step for the synthesis of imatinib requires a condensation coupling reaction 
between N-(2-methyl-5-nitrophenyl)guanidine (C8H10N4O2; mass = 194 Da) and  (2E)-3-
(dimethylamino)-1-(pyridin-3-yl)prop-2-en-1-one (C10H12N2O; Mass = 176 Da) in the 
presence of hydroxide and isopropyl alcohol to produce the intermediate product N-(2-
methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine. In Zimmerman’s approach, the 
nitro pyrimidine intermediate was added to ethyl acetate and reduced to produce 6-methyl-
N1-[4-(pyridin-3-yl)pyrimidin-2-yl]benzene-1,3-diamine (C16H15N5; mass = 277 Da) in the 
presence of 10% palladium on carbon (Pd/C) to catalyze the reaction.  These previously 
described reactions will be reviewed in the following sections 5.3.1.1 to 5.3.1.3. 
 
5.3.1.1 Monitoring the Condensation Reaction 
The reaction was monitored using ACQUITY UPC
2 
coupled to ACQUITY QDa with positive 
and negative polarity electrospray ionization mode (ESI+).  Detection of the intermediate 
product eluting at 0.66 minutes and an unknown impurity peak eluting at 0.94 minutes was 
observed on an ACQUITY UPC
2
 2-EP column in the negative mode total ion 
chromatographic trace (TIC).  Initial assumptions presume the unknown at 0.94 minutes 
observed with ESI- m/z = 304 Da suggests a reduced by-product impurity with origins to the 
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intermediate product observed at ESI- m/z = 306 Da.  By employing an additional experiment 
performed using an elevated MS cone voltage, in-source collision induced dissociation (CID) 
occurs, thus creating fragmentation.  The CID experiment will confirm or disprove the 
hypothesis of the origin relating the intermediate product via common fragment analysis.  
Interestingly, the higher applied voltage confirmed an unlikely event of reduced by-products 
and relationship to the intermediate product. The MS ESI- spectra did not result in any 
common fragment ions nor did it result in any form of fragmentation pattern trends (Figure 
5.4). 
 
Figure 5.4: UV/MS chromatographic traces of the nitro pyrimidine intermediate and spectral 
analysis comparison of the intermediate product and unknown by-product performed at cone 
voltage = 80 V.  Maxplot is defined as photodiode array  data collection for a range of 200-400 
nm for these experiments. 
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The unknown by-product did not result in catalytic inhibitions of further reactions, but the 
importance of this observation illustrates the requirement to couple chromatography with a 
mass detection device.  Infusion approaches typically performed on standalone benchtop MS 
instrumentation would not have been as simple to characterize the unknown chemical entities 
which are structurally similar or isobaric related species to the targeted synthetic products 
[189, 190].  Additionally, standalone approaches would impede the detection of potentially 
genotoxic impurities (PGI) at earlier stages of the development process, thus affecting the 
efficiency of the production of drug at industrial scale.   
 
5.3.1.2 Interpreting the Nitroso-intermediate Formation 
There were difficulties repeating Zimmerman’s synthesis approach as reported in literature.  
The insolubility of the nitro pyrimidine inhibited the progress of the reaction and therefore 
the dilution solvent was altered to a ratio of 2:1 ethyl acetate to ethanol rather than 100% 
ethyl acetate.  The data confirmed the positive affect of adding ethanol to the solvent to 
enhance solubility of the starting materials.  Upon review of the chromatography, the results 
showed peak co-elutions and peak ‘bridging’ between the run time of 0.55 minutes and 1.1o 
minutes.  The bridging from one intermediate peak to another major intermediate peak during 
a reaction mechanism is analogous with on-column degradation of solutes observed in 
literature [191] or during the production of structurally unstable intermediates.  The 
observation in Figure 5.5 results in peculiar chromatography during the production of the 
nitroso intermediate.  The extracted ion chromatogram (XIC) for the nitroso intermediate 
indicated the related isobaric species with m/z = 292 Da  The ‘bridging’ in this instance is 
hypothesized as an indicator that reaction is not quenched and possibly occurring while on-
column and .  The starting material (m/z = 308 Da), the product intermediate (m/z = 278 Da), 
and various unknown peaks were identified using the MS spectra extracted from MS ESI+ 
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chromatographic traces.  The major unknown peaks observed were m/z = 282 Da and two 
isobaric peaks with m/z = 292 Da.  It was determined from the MS data, the two isobaric 
peaks observed with m/z = 292 Da were chromatographic observations of nitroso-based 
intermediates as the nitro pyrimidine converts to the amine based intermediate product 
(Figure 5.5).  The conversion results show two peaks due to the ambiguity of which 
conjugated oxygen was reduced from the nitro- functional group.  Monitoring the time points 
of this reaction provided insight to the reaction chemistry behavior and kinetics during the 
entire reaction.   
 
 
Figure 5.5: Hydrogenation reaction UPC
2
/MS traces showing the intermediate by-product 
conversion of the nitro functionality to the nitroso- functionality and finally to the amine 
functionality and confirmed by MS 
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5.3.1.3 Reduction Reaction:  Facilitating Identification and Elucidation of Over-reduced 
Impurities  
Kinetic plots were constructed from the UV data and reviewed for the hydrogenation reaction 
time points (Figure 5.6).   The kinetic plots also revealed peculiarities concerning impurity 
formation as the nitroso- intermediates are consumed, thus affecting the overall purity and 
yield of the final intermediate product.  When performing Pd/C hydrogenation reactions, it is 
common to observe reductions of additional unsaturated conjugated nitrogens which are 
difficult to control within the reactant solution.  After the reaction was completed and worked 
up, several over reduced species were observed.  Post reaction analysis of the MS data 
identified the unknown impurity with m/z = 282 Da, however additional peaks were observed 
in the MS ESI
+
 TIC with observed m/z = 284, m/z = 567 Da and another isobaric species 
with m/z = 282 Da (Figure 5.7).    The impurities are hypothesized to be over-reduced species 
related to the final intermediate as +6 [H], +4[H], and a dimerized over-reduced species.    
The sample was washed several times in an effort to isolate the desired product and eliminate 
the catalyst filtrate.  The reaction was performed several times with different additions of 
ethanol and reduction catalyst, however eliminating the over-reduced impurities was 
unsuccessful, although controlling them was moderately successful.    
 




Figure 5.6: Hydrogenation reaction kinetic plot showing a relationship between the nitroso 


















Hydrogenation reaction kinetic plot 
SM m/z=308 Intermediate #2 m/z=292 Impurity 1 m/z=282
Intermediate #1 m/z=292 Product m/z=278




Figure 5.7: UV/MS chromatographic traces of a hydrogenation reaction mixture time point 
showing the complete reaction profile of starting material, intermediate product, intermediate 
by-product, and over-reduced impurities (highlighted in the rectangular box). 
 
In-source collision induced dissociation was performed to determine the location of the over-
reduction.  The hypothesis assumes two scenarios, reduction of the pyridine ring or reduction 
of the pyrimidine rings (Figure 5.8).  A seasoned organic chemist may instinctually know the 
likelihood of where the over-reduction could occur, however the experienced organic 
synthetic chemists should rely on the analytical data to help interpret, direct, and control the 
stages of a chemical reaction to confirm assumptions. 




Figure 5.8: Possible sites accounting for observations of over-reduced species in the SFC/MS 
data. 
 
Review of the MS spectra and fragmentation pattern from the in-source CID experiments 
confirmed the reduction of the pyridine ring.  Fragments with m/z = 200 Da and m/z = 214 
Da account for the presence of unsaturated bonds in the pyrimidine structure of the product 
intermediate scaffold (Figure 5.9).  
 




Figure 5.9:  MS spectral confirmation of the pyridine ring reduction for impurities peaks 
eluting at 1.02 minutes and 1.14 minutes. 
 
 Achiral and Chiral Screening of Clopidogrel Racemates by UPC2 5.3.2
During the initial start of monitoring the synthetic reactions of clopidogrel, the occurrence of 
process impurities during the synthesis of reaction step ‘U’ were observed in the UPC2/MS 
screening data but not in the UPC
2
/UV data (Figure 5.10).  It was unclear how they would 
affect the synthesis downstream.  Therefore, parallel reactions with different starting 
materials were explored in order to determine conditions to optimize the synthetic route.  The 
oligomers were identified in the MS trace but not observed in the UV trace.  The monomer 
has a mass of 74 Da, therefore it was determined that it was a by-product formed from the 1,3 
dioxolane starting material used in reaction step ‘U’ (Figure 5.11).  It was also determined 
adjustments were required to the gradient methodology to be more specific to this compound.  
The generic 0% B to 50% B modifier screening gradient was adjusted to 0% B to 20% B 
modifier gradient elution to allow for a better separation of the oligomers and greater 
retention of the intermediate reaction products.  With this, an additional set of shallow 
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gradients were added to the open access walk-up methods for purposes of accounting for 
hydrophilic compounds.  These shallow gradient methods were used for the clopidogrel and 
rosuvastatin reaction monitoring experiments. 
 
 
Figure 5.10: Overlay of UPC
2
/ MS total ion chromatogram results for the final clopidogrel 
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Figure 5.11: Oligomer by-product 
 
Analyzing the reaction with the adjusted method and moving forward with the impure 
oligomerized starting material for the clopidogrel synthesis step ‘W’, the oligomers were still 
observed with less interference, and two new unknown impurities were observed in the UV 
and verified by mass spectrometry as m/z = 179 Da and m/z  = 329 Da (Figure 5.12). 
 
 
Figure 5.12: Overlay of UPC
2
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In an effort to improve the synthetic route, alternative starting materials based on a bromo-
ester material (SM2) rather than a bromo-nitrile starting material (SM) were explored.  The 
thiophene-based material was purchased rather than synthesized to determine if the additional 
peaks were a result of the chromatographic technique.  A systematic experimental plan was 
formulated to better control the process impurities.  The single experimental changes are 
underlined and described below. Single experimental changes were employed to control the 
influence of multiple changes upon final conclusions: 
1. Substitute the bromo-ester SM2 for the bromo-nitrile SM and use the synthesized 
thiophene-based SM1 
2. Use the bromo-ester SM2 and synthesized thiophene-based SM1 with dioxane to 
alter the boiling point and reaction kinetics 
3. Use the bromo-ester SM2 and a purchased thiophene-based SM1 to eliminate the 
occurrence of the oligomers. 
4. Revisit the bromo-nitrile SM2 using the purchased thiophene-based SM1  
 
5.3.2.1 Investigating the bromo-ester starting material 
Upon substitution of the bromo-nitrile starting material with the bromo-ester starting 
material, the over reduced species and unknown impurities were eliminated.  The oligomers 
were still present, but that was to be expected because the impure thienopyridine -based 
starting material rich with oligomers was still being used (Figure 5.13). Although the bromo-
ester starting material showed promise, the yield was not optimal.  The use of dioxane in 
place of THF allowed for a lower boiling point thus providing improved reaction kinetics 
decreasing the rate from 22 hours to 3.4 hours with a 29% increase in yield (Figure 5.14). 
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Figure 5.13: Bromo-ester starting material results for clopidogrel reaction step ‘W’. 
 
 
Figure 5.14: Reaction kinetics comparison of the bromo-ester SM adjustment with dioxane 
versus THF as the reaction solvent system. 
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5.3.2.2 Effect of pure thiophene-based starting material 
The purchased thienopyridine starting material was used for both approaches and compared 
to the original data.  In Figure 5.15, comparisons of the bromo-nitrile based approach were 






/MS comparison of synthesized versus purchased thienopyridine starting 
material used in the clopidogrel reaction step ‘W’.   
 
5.3.2.3 Chiral and Achiral Screening of Clopidigrel Synthesis 
Chiral and achiral separations can be accomplished with the same solvent system used for the 
sample diluent mobile phases without swapping instruments.  A different chiral column was 
needed to separate the chiral enantiomers of the product for the clopidogrel intermediate 
reaction step ‘W’,  The achiral UPC2 BEH 2-EP column provided the best results based on 
the number of peaks separated and peak shape in comparison to the other achiral columns 
screened.  The entire set of immobilized chiral technologies columns was screened.  Chiral 
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column ‘A’ (Chiralpak ID) in Figure 5.16 which successfully separated the enantiomers of 
the intermediate reaction product, failed at separating the enantiomers of the starting material.  
Whereas, the chiral column ‘B’ (Chiralpak IB) labeled in Figure 5.16 successfully separated 




Figure 5.16:  Overlay of UPC
2
 UV chromatograms for the achiral and chiral screening results 
for clopidogrel reaction step ‘W’.  Achiral column = UPC2 2-EP, Chiral column A = Chiralpak 
ID, and Chiral Column B = Chiralpak IB. 
 
5.3.2.4 Optimized Synthetic Reaction for Clopidogrel 
The final synthetic route summarize in Figure 5.17, the revised reaction scheme provided a 
45% increase in yield and 11x reduction in synthesis time. 
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 Monitoring the Asymmetric Synthesis of Rosuvastatin 5.3.3
5.3.3.1 Comparisons to Reversed-Phase LC/MS  
During the reaction monitoring of the rosuvastatin intermediate synthetic step (R8) in Figure 
5.1, we achieve a clear separation of the starting materials by ACQUITY UPC
2
 utilizing a 
generic 2.5 minute screening method (Figure 5.18).  It is common for analytical laboratories 
to screen high and low pH mobile phases in an effort to promote selectivity as they search for 
impurities within their process.   When comparing the results obtained by a low/high pH 
reversed-phase screening, the UHPLC separation is achievable, but not ideal.  The UHPLC 
run time may seem faster, however it should be noted that the high/low pH screening utilized 
a generic UHPLC screening method that was recommended by a peer at GSK.  The objective 
was to employ screening methodology conditions which are generally used in the industry 
and compare it with a general screening method for UPC
2
.   The methods were only 
optimized for fit for purpose and not scaled geometrically to account for the two different 
column formats.   The experiment was purely qualitative.   As the reaction continues, the 
product intermediate (PDT) is clearly separated from the starting materials when reviewing 
the UPC
2
 results.   When comparing to UHPLC, the product was co-eluted with starting 
material #1 (SM1).  The elution of starting material #2 (SM2) is not easily identified by 
UPLC due to co-elution with the product intermediate (PDT), regardless of selectivity 
manipulations provided by pH (Figure 5.19).  The improvements observed by a sub-2 µm 
particle stationary phase pSFC approach aided the quantitation of the intermediate yield and 
purity.  
 




Figure 5.18: Separations of rosuvastatin starting materials for reaction step R8 performed using 
ACQUITY UPC
2
 and UPLC with high and low pH mobile phases 
 
 
Figure 5.19:  Reaction monitoring separations of rosuvastatin R8 reaction step after 90 minutes 
performed using ACQUITY UPC
2
 and UHPLC with high and low pH mobile phases 
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5.3.3.2 Achiral Rosuvastatin Intermediate (R8-R11) Reactions Monitoring 
The reaction monitoring of the earlier steps indicated the presence of a variety of related 
impurities, most of which were purged by chemical clean-up involving simple filtering, 
organic washes or recrystallization of final intermediates.  In Figure 5.20, the selectivity of 
UPC
2
 provided a better approach for monitoring the modified HWE reaction (R8) when 
compared to the UHPLC reversed-phase low/high pH screening results.   Upon review of the 
next reaction steps, some process impurities were observed during the desilylation (R9) of the 
intermediate, yet the final intermediates were calculated to be approximately 90% pure.   The 
achiral chromatographic monitoring of the final stages (R10, R11) of the reaction scheme 
indicated the final products were relatively pure and free of major impurities, yielding 90% 
and 98% purity, respectively (Figure 5.20).  The conversion to the calcium salt (R12) is not 
monitored by chromatographic techniques, but rather verified by a simple QC check to verify 
completion.   
 






/PDA chromatographic results overlay of intermediates R9, R10, and R11 
final analysis time points.  Wavelength was recorded at 254 nm.   
 
5.3.3.3 Rosuvastatin Enantiopurity Determination 
Enantiopurity, often measured as percent enantiomeric excess (%ee), reflects the relative 
amount of one enantiomer to another of a chiral compound.  In the case for diastereomers, the 
purity results are typically reported as a ratio of the observed diastereomers (d.r.).  For 
stereoselective synthesis, where the configuration of the desired stereocenter is controlled 
using reagents and catalysts with an objective to yield a single enantiomer or diastereomer, 
the purity is typically reported as %ee or %de, respectively.  Usually, the impurity is the less 
desirable enantiomer, which can alter efficacy or even toxicity. Enantiomeric determinations 
are a necessary analysis for all chiral drug candidates, particularly important for enantiopure 
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formulations.  The enantiopurity of the rosuvastatin final product is expected to be relatively 
high, above 95% purity, based on the reaction scheme described in Figure 5.1.  No major 
impurity peaks were observed in the chromatographic screening results of the final reactions 
(R11 and R12), therefore the expected risk of diastereomer impurity interferences in the final 
rosuvastatin product would be minimal.  However, given the stereochemistry of the heptenoic 
side chain, a variety of diastereoisomer impurities can exist such as (3R, 5R) and (3S, 5S) 
including the (3S, 5R) enantiomer which requires a chiral separation. The original patent 
submission indicates a 10 minute normal phase method utilizing a Chiralpak IB column 
yielding a resolution less than 2 to detect the enantiomeric impurity [192].  In addition to the 
poor separation provided by the patented method, the normal phase chromatography is 
limited due to mass spectrometry incompatibility required for simultaneous identification and 
confirmation during the chromatographic separation. 
 
A chiral chromatographic method was created to resolve rosuvastatin enantiomers using an 
ACQUITY UPC
2
 Trefoil CEL1 2.5 µm column (cellulose tris-(3,5-dimethylphenyl 
carbamate)). The final isocratic method composed of a mixed alcohol co-solvent with a basic 
additive. The resolution between the enantiomers was greater than 2.0, approximately 
measuring Rs = 4.5. The peaks detected by the chiral methodology were confirmed to be 
rosuvastatin enantiomers (m/z = 482.2 Da) as determined by the mass spectrometer.  The two 
diastereomer peaks were integrated and the percent diastereomer excess (%de) was calculated 
using Equation 5.1 as: 
Equation 5.1:  Calculation for percent diastereomeric excess 
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For the 2 µL injection volumes, the d.r was determined to be 98.7:1.3, which was above the 
expected 95% purity threshold. The %de was calculated to be 96.2%.  The peak areas and 
intensities were in good agreement with the mass spectrometer signal, further confirming the 
results obtained (Figure 5.21).  Peak identification was confirmed by spectral analysis of the 
QDa results (Figure 5.22). 
 
   
Figure 5.21: UV and MS chromatographic traces of the Trefoil chiral separation of  ‘R12’ 
rosuvastatin reaction product. 
 
 
Figure 5.22:  QDa MS spectra confirmed with the resulting m/z = 482 Da measurements of both 
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5.3.3.4 Exploring Strong Solvent Effects 
Injection volumes from 1.0 to 9.0 µL were injected to evaluate the injection precision and 
observe any possible injection solvent effects [193].  If peak distortions are observed as a 
result of strong solvent diluent effects, then accurate determinations of the enantiopurity 
would be adversely affected and further method development would be required to mediate 
any peak distortion.  The peak area was linear (peak area R
2
 = 0.9997, which is exceptional 
for a 10 µL loop) with minimal distortion (peak height R
2
 = 0.9999) using 80/20 
heptane/isopropanol as the sample diluent (Figure 5.23). 
 
 
Figure 5.23: Injection linearity exploring injection solvent effects of Rosuvastatin (3R,5S) 
enantiomer. 
  




The reaction monitoring experiments exhibited the unique beneficial orthogonality and 
robustness of the low volume pSFC instrument configured with sub-2µm particle stationary 
phases.  The studies allowed for a variety of observations and guided decision point common 
to responsibilities in a synthetic chemistry and medicinal chemistry laboratory.  The route 
synthesis monitoring of imatinib by SFC/MS guided improved decision management 
affecting greater yield and purity of each intermediate steps and final product.  Observed 
benefits include 8x reduction in synthesis time and 35% higher yield for imatinib.   Impurity 
fate was easily monitored for structurally similar compounds resulting from similar scaffold 
origins by performing supplemental experiments employing in-source collision induced 
dissociation.   
 
The approach facilitated the re-development of the synthetic pathway for clopidogrel.  The 
ability to easily separate the oligomer interferences was unique for the pSFC UPC
2
 
instrument.  Interestingly, as this was the first chiral example performed for this investigation 
the ability to configure the system with chiral and achiral columns provided a stationary 
phase agnostic approach to the screening process.  The solvent system and diluent system did 
not have to be altered to analyze the reactions.  From a traditional LC perspective, this was 
proven to be a great advantage for pSFC because an instrument set-up for reversed phase LC 
analysis would normally have to be converted to a normal phase LC for chiral analysis.  This 
takes either considerable amount of time or a second instrument set-up for normal phase 
chiral chromatography. 
The chiral analysis of the asymmetric synthesis of rosuvastatin using Trefoil CEL1 columns 
provided a very good separation of the enantiomers, while providing improved resolution and 
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mass spectrometer compatibility compared to the patented methodology. Using the nominal 
mass confirmation, determining enantiomeric presence was achieved with high confidence. 
The column methodology was proven to be linear at various injection volumes free from any 
injection solvent effects negatively impacting the purity determinations, thus providing 
greater confidence in regard to the method development of the assay.  
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CHAPTER 6   
6 Investigating Sub-2µm Particle Stationary Phase Supercritical Fluid 
Chromatography Coupled to Mass Spectrometry for Chemical 
Profiling of Chamomile Extracts.  
 
6.1 Introduction 
Chamomile is globally consumed in the form of various tea products.  Essential oils are 
commonly extracted for use in soaps, candles, perfumes and a variety of consumer products.  
The two most popular chamomiles are Roman Chamomile (Chamaemelum nobile) and 
German Chamomile (Matricaria chamomilla, syn. Chamomilla recutita) [194], each 
belonging to the Asteraceae family. While German chamomile is more commonly used  both 
are important medicinal plants, and despite their similar properties, differ chemically [195].   
 
Chamomile contains a wide variety of active constituents and a variety of these have been 
identified differentiating the two popular chamomiles.  The active constituents are contained 
in the essential oil of German chamomile, which comprises, e.g., spasmolytic sesquiterpene 
alcohols such as -bisabolol, chamazulene, farnesene, polyacetylenes and several flavonoids 
[196].  Roman chamomile contains, among other constituents, several SLs, the most abundant 
of which is nobilin, flavonoids, the allergenic -pinene, limonene and bisabolol [195, 197].  
Two spirocyclic polyacetylenes, the isomeric cis- and trans-tonghaosu, have been identified 
from the chamomile flower extracts with the trans isomer being more predominant than the 
cis form [198].  The lipophilic flavone chrysosplenetin/chrysosplenols was identified from 
German chamomile [199].  Roman chamomile is made up mainly from esters of angelic and 
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tiglic acids.  It also contains up to 0.6% of sesquiterpene lactones of the germacranolide type, 
mainly nobilin and 3-epinobilin [200].  
 
The common constituents of German and Roman Chamomiles are based on sesquiterpene 
and derivatives of sesquiterpene.  Sesquiterpene lactones (SLs) are bicyclic molecules 
consisting of a sesquiterpene backbone (15 carbon atoms) in the form of a 10-membered ring 
attached to a five-membered lactone Figure 6.1.   
 
Figure 6.1: Structures of some sesquiterpene lactones:  A. Germacramanolides, B. 
Heliangolides, C+D: Guaianolides, E: Pseudoguaianolides, F: Hypocretenolides, G: 
Eudesmanolides 
 
They represent the main allergen in the flower family Asteraceae.  Arnica, chicory, tansy, and 
chamomile are some important members of this family [201].  They are important 
constituents of essential oils that have many applications in medical, as well as soap and 
perfume formulations.  Often these constituents occur in trace quantities in plants.  Even 
though chamomile extracts are widely used in herbal remedies and cosmetics, the risk of 
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sensitization/elicitation of dermatitis seems to be low based on published reports [202].  
Presumably, cases of sensitization are primarily caused by SLs, but prolonged or repeated 
topical application seems necessary in order to sensitize with the tea because of its lower 
content of allergens [203]. 
 
Effective chromatographic techniques are required for optimal separation, identification and 
isolation of these components.  Gas chromatography is the most efficient chromatographic 
technique for separating volatile mixtures, because of its high peak capacity and the 
availability of universal detection using flame ionization detection (FID). High performance 
liquid chromatography (HPLC) can be carried out when gas chromatography analysis of 
thermo-labile and/or non-volatile polar compounds is difficult to achieve.  Supercritical fluid 
chromatography (SFC) and supercritical fluid extraction (SFE) have also been explored for 
targeted analysis and isolation of matricine in chamomile flower heads, thus streamlining the 
sample preparation workflow via eliminating the hydrodistillation of chamazulene and the 
multiple solvent-solvent extraction processes [204].  
 
Important advances in liquid chromatography instrumentation have resulted in the worldwide 
implementation of sub-2µm particle columns, thus referencing the technique as ‘ultra’ high 
performance chromatography (UHPLC) [112, 205].  The enhanced instrument performance 
and the utilization of smaller particle size stationary phases provide practical benefits of 
reduced analysis time, increased resolution, and increased sensitivity [114, 206].  
Historically, SFC instrumentation has lacked robustness.  The previously reported results 
cited in the introduction of this thesis indicated poor reproducibility and poor sensitivity.  The 
potential benefits of the technique were obvious in terms of reduced mobile phase viscosity 
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allowing for higher flow rates and faster analysis times.  The applicability for chiral analysis 
was also known to be very attractive when compared to traditional normal phase LC 
approaches as demonstrated in Chapter 3, yet the general conclusions in recent decades 
suggested the technique was only suitable for use in academic research projects and never 
accepted as part of any sort of comprehensive workflow outside of the scope of utilizing it for 
unique use applications, preparatory scale isolations and chiral analysis applications.   
 
In this study, a rapid and selective method was developed using sub-2 µm particle columns 
and SFC technology coupled to photodiode array detection (PDA) and MS.  The results 
provided insight for future botanicals profiling workflows. Liquid-liquid extraction 
techniques were performed on two types of authentic chamomile flowers, in which the 
optimal sample extraction procedure was chosen by measuring the maximum peak number 
and reproducibility of the chromatographic process. For comparative purposes, the 
orthogonality of the traditional reversed-phase approaches versus the SFC approach presented 
here was briefly assessed.  Data was processed using multivariate statistical analysis 
techniques including principal component analysis (PCA) and orthogonal partial least 
squares-discriminate analysis (OPLS-DA) to assess differences between the authentic 
chamomile extracts.  Reference standards were acquired and chromatographed in order to aid 
peak identification by comparing their retention time (Rt), mass-to-charge ratio (m/z), and 
spectral analysis of the fragment pattern of the constituents observed in the chamomile 
extracts.  Structures of six of these compounds are shown in Figure 6.2.  The methodology 
was applied to the authentic chamomile flowers and commercial tea products.  Comparisons 
of the authentic flowers and commercial tea products were processed using the same 
multivariate statistical analysis techniques used to assess differences between the authentic 
chamomile extracts. 




Figure 6.2: Structures of the standard reference compounds found in chamomile extracts  
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6.2 Materials and Methods 
 Solvents and reagents 6.2.1
Six standards were used as reference compounds and their structures are provided in Figure 
6.2.  The compounds apigenin, hydroxyisonobilin, 1,10-epioxynobilin, nobilin, cis- and 
trans-tonghaosu were isolated at the National Center for Natural Products Research 
(NCNPR), University of Mississippi, University, Mississippi, USA. The identity and purity 
of these compounds were confirmed by chromatographic (TLC, HPLC) methods and 
spectrophotometric techniques (IR, 1D- and 2D-NMR, ESI-HRMS) by comparison with 
published spectral data.  The purity of these isolated compounds was found to be greater than 
90%.  HPLC grade reagents such as acetonitrile, isopropanol, methanol, hexane, ammonium 
formate and formic acid were purchased from Fisher Scientific (Fair Lawn, NJ, USA).   
Water was purified using a Milli-Q system (Millipore). 
 
 Plant Materials 6.2.2
Matricaria chamomilla L (Syn. Matricaria recutita L.) (NCNPR code #9172, #11680, 
#11681) and Chamaemelum nobile (L.) All. (Syn. Anthemis nobilis L.) (#11577) samples 
were obtained from the cultivated, living collection of the NCNPR Maynard W Quimby 
Medicinal Plant Garden, University of Mississippi. All species were identified by Dr. Aruna 
Weerasooriya of the Maynard W Quimby Medicinal Plant Garden, 300 Insight Park Drive, 
The University of Mississippi. Mississippi, USA. Powder sample of M. recutita (#11781) was 
obtained from Missouri Botanical Garden, Missouri, USA. Powder sample of M. recutita 
(#7539) were obtained from Centre for Research in India System of Medicine (CRISM), 
India. Crushed flowerheads/powder samples of M. recutita (#2802, #9359, #9362, #9364, 
#9365) and A. nobilis (#2061, #9254) were obtained from commercial sources. Sample #9254 
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was identified as A. nobilis and samples #9172, #9359, #9362, #9364, #9365, and #2802 were 
identified as M. recutita by Dr. Vijayshankar Raman, NCNPR, The University of Mississippi, 
University, MS, USA. Tea bags (#9357, #9376, #9383-9391) claiming to contain chamomile 
were purchased online. Specimens of all samples are deposited at the NCNPR’s botanical 
repository, The University of Mississippi, University, Mississippi, USA. 
 
 Sample Preparation 6.2.3
Ten populations of German chamomile (M. recutita), three populations of Roman chamomile 
(A. nobilis), and eleven different commercial tea bags claimed as chamomile were used for 
analysis.  Dry plant samples (about 500 mg) were sonicated in 2.5 mL of solvent.  Four 
solvent mediums were evaluated: MeOH, iso-propanol, hexane and iso-propanol/hexane 
(50/50 v/v).  Each preparation was sonicated for 30 minutes followed by centrifugation for 15 
minutes. The supernatant was transferred to 20 mL scintillation vials.  This procedure was 
repeated four times and respective supernatants combined. The samples were evaporated to 
dryness and reconstituted in 1.0 mL iso-propanol, vortexed, and sonicated for 15 minutes.  
Prior to injection, a 1 mL aliquot was passed through a 0.2 µm PTFE membrane filter and 
collected in 1.5 mL LC/MS certified sample vials.  
  




Two chromatographic techniques were performed and compared for this chamomile profiling 
analysis, namely LC and SFC. 
 
6.2.4.1 SFC Instrumentation 
Supercritical fluid chromatography was performed using a Waters ACQUITY UPC
2®
 system 
(Waters Corp., Milford, MA, USA) including a binary solvent high pressure pump, a dual 
injector design autosampler, dual dynamic/static automatic back pressure regulator, (ABPR), 
column compartment with active heating and column switching control, and photodiode array 
detection (PDA).  The experimental variables explored for the method development process 
are shown in Table 6.1.  Concentrations and compositional mixes were varied as part of the 
method development investigations. All column dimensions were 100 mm × 3.0 mm ID and 
1.7 µm particle size, with the exception of the UPC
2
 HSS C18 SB column which had a1.8 µm 
particle size.   The ACQUITY UPC
2
 BEH 2-EP column was used for the comparisons to the 
UHPLC results. 
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Table 6.1: Experimental variables for the method development investigation.   
Columns Modifiers Additives 
ACQUITY UPC
2



















 Methanol/Isopropanol Trifluoroacetic 
acid (TFA) 
Diethylamine (DEA) 
ACQUITY HSS Cyano Methanol/Acetonitrile Phosphoric acid  
ACQUITY UPC
2
 2-EP  Methanol/ Acetonitrile/ 
Isopropanol 
Citric acid Water 
 
The final methodology for statistical analysis utilized an ACQUITY UPC
2
 BEH 2-EP column 
(Waters Corp., Milford, MA, USA) with dimensions of 150 mm x 3.0 mm, and 1.7 µm 
particle size.  The column and sample temperature were maintained at 50 
0
C and 15 
0
C, 
respectively. The column was equipped with a pre-column filter and frit. The mobile phase 
consisted of CO2 as solvent A and methanol: isopropanol (1:1) containing 0.5% formic acid 
as solvent B.  The mobile phase flow rate was maintained at 1.7 mLmin
-1
.  The gradient 
scheme was set initially at 95% A: 5% B, increasing linearly over 12 minutes to 80% A: 20% 
B and held isocratically for 3 minutes at 20% B.  The total run time for analysis was 15 
minutes.  The backpressure was maintained isobarically by the automatic backpressure 
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regulator [referred to by the instrument manufacturer as the ACQUITY UPC
2
 Convergence 
Chromatography Manager (CCM)] at a pressure of 1500 psi.  The injection volume was 2 µL.  
The photodiode array detection was monitored at a wavelength range from 190 - 400 nm with 
2D wavelength collected at 350 nm.   
 
6.2.4.2 LC Instrumentation 
The separations were performed on a 2.1 mm x 100 mm ACQUITY UPLC
®
 1.8 µm HSS T3 
column using an ACQUITY Ultra Performance LC Chromatography
®
 (UPLC) System 
(Waters
®
 Corporation, MA, USA). The column was maintained at 40 ºC and eluted with a 
linear acetonitrile – aqueous gradient over 1.0 minute at 800 µL/minute, starting at 5 % 
acetonitrile and rising to 95 % over the course of the gradient. The aqueous mobile phase was 
spiked with 0.1 % v/v formic acid. The column eluent was directed to the mass spectrometer 
for analysis following PDA detection. 
 
 Mass Spectrometry 6.2.5
Mass spectrometry was performed using a Waters ACQUITY SQD single quadrupole mass 
spectrometer.  The solvent flow was split post PDA detection, but prior to the MS 
electrospray probe.  The MS electrospray ionization (ESI) source was operated in positive 
ionization (ESI+) mode. The capillary and cone voltages were set at 3.0 kV and 30 V, 
respectively. The temperature of the source and desolvation was set at 150 C and 500 C, 
respectively. The cone and desolvation gas flows were 50 and 800 L h
-1
, respectively.  All 
data collected was acquired in centroid mode using Masslynx
TM
 Version 4.1 SCN 805 
software (Waters Corp., Milford, MA, USA). The post PDA splitter allowed for introduction 
of a make-up flow used to aid ionization.  The make-up flow composed of methanol with 
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0.1% formic acid delivered by a Waters 515 binary pump (Waters Corp., Milford, MA, 
USA).   
 
 Data Analysis 6.2.6
The statistical analysis was performed using replicate preparations and replicate injections of 
each sample using the MS ESI
+
 data. The multivariate analysis of each of the chamomile 
samples were facilitated using Waters MassLynx Software V.4.1 data acquisition whereas 
data processing was performed using the MarkerLynx XS Application Manager (Waters 
Corporation, Milford, USA).   The software was set to analyze a retention time window of 0.5 
- 12 minutes ( 0.1 minutes) and a mass range threshold of 100-700 Da, (+ 0.02 Da).  The 
noise elimination level was set at 10.00%. The resulting fingerprints for each sample were 
statistically compared by principle component analysis (PCA) to search for similar groupings.  
Distinctly different groupings were further compared by orthogonal partial least squares - 
discriminant analysis (OPLS-DA).   
CHAPTER 6  
216 
 
6.3 Results and Discussions 
 Chromatographic method development and optimization 6.3.1
Packed column SFC analysis of chamomile extracts or extracts of natural products with 
components similar to those found in chamomile extracts are rarely published [207]. General 
approaches to SFC method development have been previously reported by Berger et al for 
polymers as well as providing an insight into the use of additives [48, 95].  West et al 
provided an extensive set of results using Linear Solvation Energy Relationship (LSER) 
modeling characterizing stationary phases and mobile phases as it relates to solute retention 
[129, 131].  Each column used during their investigation had different combinations of 
physiochemical properties including hydrophobicity, silanol activity, hydrolytic stability, 
polarity and chemical mechanisms that will affect selectivity and retention of the solutes 
[128, 132, 134, 150].  Their conclusions provided insight and expectations to developing a 
systematic method development approach that could be applied to natural product profiling.  
In these experiments, method development was initially carried out using a “trial by error” 
approach; yet educated by guidance from the previous citations, to gain a better 
understanding of the supercritical fluid chromatographic technique and to validate previous 
reports by West and Berger.  Chromatographic trends addressing selectivity, resolution and 
peak shape were identified following many experiments involving the stationary phase, 
modifier and additives.   
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6.3.1.1 Effect of Elution Solvent and Solvent Blends without Additive 
The elution solvents investigated, typically referred to as co-solvent or modifier, were neat 
organic solvents such as methanol, acetonitrile, iso-propanol, and compositional mixtures of 
each organic solvent.  Injections investigating shallower gradient profiles resulted in minimal 
chromatographic advantages. The retention and selectivity profile of SFC dictates that the 
greatest selectivity changes occur within 0% modifier and 10% modifier, analogous to the 
profile observed for HILIC methodology, another normal phase derived technique.   The 
modifier starting percentage at 1% versus 5% did not result in beneficial increases in 
resolution between peaks (Figure 6.3).  Retention was observed to shift closer to the void 
volume marker as the starting percentage of organic modifier was increased with some gains 
in selectivity.  Addition of a less polar elution solvent such as acetonitrile or iso-propanol to 
the stronger elution solvent methanol resulted in increased retentivity and general 
improvements in resolution between peaks eluting with greater than 10% modifier.  Little to 
no retentivity effects were observed in the early eluting region of the chromatogram, or the 
‘non-polar’ region of the chromatogram.   Unfortunately, the peak shape of many of the later 
eluting (polar) peaks exhibited severe peak tailing for all ‘neat’ modifier experiments.   






 UV chromatograms of Roman chamomile comparing different gradient 
profiles (A) 1% to 40% methanol modifier and (B) 5% to 40% linear gradient over  minutes 
eluted with a methanol modifier. 
 
6.3.1.2 Effect of Elution Solvent with Additives 
The diversity of the solutes in the chamomile extract required an additive to mitigate 
unwanted peak tailing hypothesized as retention mechanism related.  At the same time, the 
objective was to develop a method compatible with mass spectrometry (MS) detection.  The 
MS compatible additives investigated were formic acid, ammonia, ammonium formate, 
ammonium acetate, water, and combinations thereof.  The addition of formic acid visibly 
improved the peak shape for all the tailing peaks.  Ammonium salts such as ammonium 
formate and ammonium acetate further improved the peak shape, however the solubility of 
the salt additive had to be considered when mixtures of modifier were used.  For example, the 
system would overpressure during the equilibration segment at the start of the gradient when 
programmed below 8% modifier with methanol:iso-propanol (60:40) spiked with 10mM 
ammonium formate.  Lower starting percentages of modifier can be used in the gradient 
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program when the composition of the weaker elution solvent in the modifier (e.g.: IPA) was 
decreased, thus decreasing the occurrence of salt insolubility within the flow path.  Formic 
acid as an additive provided similar results to the ammonium formate and ammonium acetate 
additives without the risk of salt precipitation.  During the investigation of formic acid as an 
additive, higher concentrations such as 0.5% rather than 0.1% provided better peak shapes.  
The addition of water at percentages lower than 2%, also provided good improvements in 
peak shape (Figure 6.4).   
 
 
Figure 6.4:  German and Roman chamomile UPC
2
 UV Chromatograms. Conditions: UPC
2
 
column 1.7 µm 2-EP 2.1 x 150 mm; . Flow rate was 1.2 mL min
-1
 at 40 
0
C.  1500 psi 
backpressure. Gradient performed with a slope profile of 5 to 40% modifier.  Co-solvent was 
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The water additive appeared to stabilize retention time instability for repeatable injections.   
Although the results with the water additive observed to be promising, peak tailing increased 
over time affecting the repeatability of the method (Figure 6.5).   Although this phenomenon 
was observed from a general perspective, further investigations regarding water as an 
additive should be explored with controlled experiments outside the scope of this 
investigation to best determine the effect of water on long term column effects.   
 
 
Figure 6.5: Roman Chamomile UPC
2
 UV Chromatogram.  Evidence of increasing peak tailing 
over time highlighted in the rectangular box.  See Figure 6.4 for conditions. 
 
Upon further literature reviews, research (Zhimin et al) showed the use of phenyl columns 
with ethanol elution solvent spiked with 0.05% phosphoric acid improved the peak tailing 
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Additionally, the previously cited investigation of polyphenolic compounds in grape seed 
extracts used a diol stationary phase comparing methanol elution solvents spiked with citric 
acid, formic acid, and triflouroacetic acid (TFA) [207].  A series of untypical and non-MS 
compatible buffers known to suppress ionization were briefly investigated, and these 
produced cluster ions or lacked volatility.  Low concentrations of trifluoroacetic acid (0.05% 
to 0.1%), citric acid (5 mM to 50 mM), and phosphoric acid (0.001% to 0.1%) based 
additives in 100% methanol, provided improvements in peak shape and minimized peak 
tailing.  Each of these additives have ion pairing properties and/or chelating properties 
sequestering secondary retention mechanisms hypothesized as effects from either residual 
silanol or hydrogen bonding with the solutes.  Although these additives are not typically 
suitable for MS, knowing these additives improve chromatographic peak shape enabling UV 
analysis and quantitation when standards are available for the compounds previously 
identified by the MS compatible method. Interestingly, similar conditions to Zhinin’s phenyl 
column and phosphoric acid conditions were performed as part of the chamomile method 
development screening investigation, but initially produced poor results, therefore the 
principles of ion pair reagents and chelating property additives for this methodology was 
further explored.    
 
6.3.1.3 Investigating Phosphoric Acid Additive Effects 
During the previous screening experiments, an injection of the German chamomile using a 
UPC
2
 CSH Flouro-Phenyl column with 0.05% phosphoric acid in methanol was performed with 
a 3 µL injection volume.  The results showed broad peaks in comparison to the other screening 
results (not shown) and poor resolution (Figure 6.6).  Injection overload was hypothesized to be 
affecting the observed outcome of the observed results, therefore reduced injection volumes 
were performed using the flouro-phenyl and phosphoric acid conditions.  The 1µL injections of 
the chamomile extracts resulted in much improved peak shapes and chromatographic 
resolution between peaks ( 
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Figure 6.7).  Unfortunately, upon repeated injections and further method development, 
system pressure would increase over the course of a few days.  A new column was introduced 
and repeated injections performed resulted in the same system pressure failures over less than 
200 injections. The columns were not able to be regenerated with various flush sequences.  
System level diagnostic tests were also performed to evaluate the pump seal quality.  
Interestingly, the diagnostic tests indicated massive leak rates and failures.   Changing the 
pump seals corrected the leak rate failures, thus leading to a hypothesis of phosphoric acid 
detrimentally affecting the integrity of the seal in presence of CO2 based mobile phases. The 
system was set up to run just the mobile phase conditions with a union installed in place of 
the column.  The system would eventually fail the diagnostic leak rate tests performed on the 
pump seals within the delivery of 2 litres of solvent.  Comparisons of 0.005%, 0.01%, and 
0.05% concentration of phosphoric acid each led to the same system level failures on the 
pump component.  The issue was repeatable on a separate system and by a separate analyst as 
a request to better understand any localized issues.  It is unclear why this particular mobile 
phase composition deteriorates the pump seals more rapidly.  It is possible that carbonic acid 
is being produced and working together with the phosphoric acid to produce a more corrosive 
environment attacking the metal components within the system.  The compositional make-up 
of the UPC
2
 instrument components is not documented, therefore making it difficult to 
formulate an efficient investigation. The system was purged from the phosphoric acid in 
methanol modifier and replaced with MS compatible buffers to continue the chamomile 
profiling analysis.  These results indicated the need for caution when developing SFC 
methods for use with natural product extracts.   Extra considerations concerning the injection 
volume and loadability should be investigated.    
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 Effect of Column Temperature 6.3.2
Temperature was observed as a key factor affecting mainly retention time, peak shape and 
signal to noise. The optimization process investigated the effect of column temperature and 
backpressure as exerted by the ACQUITY UPC
2
 CCM.  Increased temperature, (back-) 
pressure, or any combination of each variable resulting in density changes did not yield major 
gains in resolution of the complex chamomile extract chemical profile. The increase in 
temperature allowed for a decrease in overall system pressure, thus allowing for increases of 
flow rate or column length within the allowable upper pressure threshold of the 
instrumentation specification of 41.4 MPa (or 6000 psi as specified by the manufacturer).  
For example, the retention time shifted for the three major constituents, apigenin-7-O-
glucoside, chamaemeloside, and apigenin, found in the authentic Roman chamomile by an 
average of 4 minutes later for a column temperature set to 90 
0
C when compared to the 
chromatographic results obtained when the column temperature was set to 35 
0
C (Figure 6.8).   
 




Figure 6.8: Chromatograms of Roman chamomile methanolic extracts labeled (a), (b), (c) show 
the retention time shift and the increased baseline noise with the increase of temperature for the 
major compounds found in roman chamomile, where peak 1 is apigenin, peak 2 is apigenin-7-O-
glucoside, and peak 3 is chamaemeloside. 
 
The increase in temperature affected the baseline noise thus reducing the measured signal-to-
noise (S/N) values.  This effect was believed to be the result of the rapid supercritical fluid 
CO2 expansion as it exchanged to the gas phase thus creating a greater occurrence of CO2 gas 
in the PDA flow cell.  A column temperature of 50 
0
C provided the optimal choice for 
maintaining a similar experiment to experiment comparison of signal-to-noise across a 
temperature range between 35 
0
C and 50 
0
C.  Therefore, 50 
0
C was chosen in regards to 
suppressing the baseline noise caused by rapid CO2 expansion while maximizing the 
operating parameters of the instrument in terms of the upper pressure threshold.   
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 Summary of Method Optimization 6.3.3
In summary, the final methodology was based on a set of conditions that provided retentivity, 
resolution, and suitable peak shape for the greatest number of peaks detected in the profiles 
while still providing compatibility with MS detection. The trends observed from the dozens 
of experiments performed using the variables outlined in Table 6.1, resulted in confirming the 
general method development workflow proposed in Chapter 3 and proved feasible for 
development of natural product profiling methods.  It was evident that screening columns 
with a set of modifiers and additives maximized changes in retentivity and selectivity of the 
detected peaks in the chamomile extract chromatographic profile.  Initially, six columns were 
investigated, yet the ACQUITY UPC
2
 BEH 2-EP, provided the best option for further 
method optimization in terms of retention of peaks, overall number of peaks detected and 
optimal peak shape, specifically in the later eluting ‘polar region’ of the chromatogram.  
Combining iso-propanol and methanol as the modifier fine-tuned overall increases in 
resolution between peaks.  The addition of formic acid improved peak shape without the risk 
of salt precipitation resulting from imbalances in salt concentration, CO2 composition and 
insolubility with particular weaker elution solvents used in combination with methanol 
modifiers. Based on the optimization of the optimal operating column temperature value, the 
column length was increased to 150 mm allowing for an increase in overall resolution of the 
chemical profile.   
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 Sample preparation optimization 6.3.4
Various extraction media were explored using the developed chromatographic method in 
order to profile the extracts.  The chromatographic comparison of the different extraction 
procedures are shown for M. recutita #9172 in Figure 6.9.  The solvent mixture of 
hexane/iso-propanol (1:1) provided the best balance of polar and non-polar solutes extracted 
while providing optimal peak shape.  The chromatographic comparisons of the A. nobilis 
extractions (not shown) resulted in the same conclusions. 
 
 
Figure 6.9: Comparison of UPC
2
-MS ESI+ base peak intensity chromatogram (BPI) Roman 
chamomile extracts prepared using different solvents (a) isopropanol/Hexane (b) isopropanol, 
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 Chromatographic Technique Comparisons 6.3.5
The orthogonality to reversed-phase liquid chromatography was briefly investigated.  The 
chamomile extracts were analyzed using a generic UPC
2
 0 %B to 35% B gradient elution 
method composed of MeOH and 0.1% formic acid in solvent line B and a generic UHPLC 5 
%B to 95 %B gradient elution method composed of 0.1% formic acid in water in solvent line 
A and 0.1% formic acid in methanol in solvent line B.  Both chromatographic run times were 
35.0 minutes.  The orthogonality between the two chromatographic techniques was 
investigated by tracking the peak elution order of the solutes by UV and MS.  Each peak was 
assigned a nominal peak ID and retention times were recorded for each UHPLC and UPC
2
 
result.  The data was plotted as retention time vs. peak ID to visualize the orthogonality of the 
separation techniques (Figure 6.10).  The UPC
2
 elution profile showed a scattered 
relationship rather than a direct inverse linear relationship to that of the UHPLC technique. It 
is uncertain why this occurs, but the hypothesis assumes that the factors dictating the 
retention mechanisms in the non-polar and polar regions of the UPC
2
 chromatogram shift 
from stationary phase focused to modifier focused.    




Figure 6.10: Comparison plot of peak ID vs. retention time for the UPC
2
 and UHPLC 
chromatography results for the extracts of German Chamomile. 
 
Further interrogation of both datasets showed better chromatographic separation of four 
isobaric compounds with a mass of 474.41 Da:  7-[(3-O-acetyl-β-D-glucopyranosyl)oxy]-
apigenin, 7-[(4-O-acetyl-β-D-glucopyranosyl)oxy]-apigenin, Apigenin-7-O-(6'acetyl) 
glucoside, and Apigenin 7-O-(2''-acetyl-β-D-glucoside).  The UPC2 analysis of German 
chamomile separated the four isobaric peaks for XIC = 475 Da, whereas the UHPLC MS XIC 
m/z = 475 Da only separated three of the isobaric species (Figure 6.11).  




Figure 6.11: Zoomed extracted ion chromatograms (XIC) of m/z = 475 of German chamomile 
methanolic extract.  An additional isobaric peak was identified in the UPC
2
 trace (A) when 
compared to the UPLC-RP trace (B). 
 
 Statistical Analysis 6.3.6
A workflow similar to that published by Plumb et al which outlines pattern recognition for 
pharmaceutical impurity profiling was followed with the exception of using nominal mass 
data in substitution for accurate mass data [209].  The data was processed in terms of pairing 
descriptive information such as nominal mass to charge ratios (m/z) and retention time (Rt) 
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for further statistical analysis.  Initially two plant samples (#9172 and #9254) were checked 
for intra- and inter-day variations.  Intra- and inter-day variation of the analysis was 
determined to be lower than 5%, with a maximum RSD of 4.0%.  The analysis was 
performed three times on three different days and each run was repeated in duplicate.  
Multiple injections showed that the results are reproducible and displayed a low standard 
error.  The additional samples used for the profiling experiments were prepared in the same 
way and injected in duplicate. 
 
Principle component analysis (PCA) is an unbiased clustering technique requiring little prior 
knowledge of a data set and acts to reduce the complexity of the multivariate data without 
losing important information [210].  PCA generates visual plots, a scores plot and a loadings 
plot.  The scores plot summarizes observations in terms of trends, patterns and clusters in the 
dataset as it separates the signal from the noise. The loadings plot correlates the variables 
with the observations in the scores plot.  The numerical
 
value of a loading for a given variable 
of a PC shows how much
 
the variable has in common with that component.  
 
The three authentic extracts of Roman chamomile with distinct sesquiterpenes, were 
distinguished from the ten extracts of authentic German chamomile as shown by the OPLS-
DA scores plot in Figure 6.12, thus confirming the proof of concept that UPC
2
-MS 
methodology is reproducible and information-rich for multivariate statistical analysis.  
Generally, this clustering was observed using the first two principal
 
components (70% of the 
variance was explained). Examination of the scores and loading plots showed as expected 
that the main separation from both flowers were sesquiterpene and flavonoid compounds.    





Figure 6.12: PCA scores plot (PC-1 vs. PC-2) of the authentic German chamomile (GC) and 
authentic Roman chamomile (RC) extracts 
 
A scatter plot (S-Plot) was generated from the OPLS-DA data to further identify differences 
from the two sample groupings.  The S-plot utilizes the mass/retention pairs to aid 
visualization of the variables contribution.  A mass/retention pair contribution is shown in the 
y axis where correlation to the class or group is calculated to a maximum of 1.  The S-plot for 
the German and Roman chamomile data set is shown in Figure 6.13.   
RC
GC




Figure 6.13: Scatter plot (S-plot) of German and Roman chamomile generated from the OPLS-
DA statistical analysis of the dataset 
 
 Mass Spectrometry Analysis 6.3.7
The specificity of the MS data was sufficient in terms of interrogating the data by extracted 
ion chromatograms (XIC).  Peaks were assigned by spiking the samples with standard 
compounds and comparing the retention times and mass.  The UPC
2





 ions typically observed in natural product profiling.  Each 
were observed in ESI
+
  mode with the following observed m/z and Rt values:  m/z = 201 Da 
([M+H]
+
, Rt = 0.95 min), m/z = 201 Da ([M+H]
+
, Rt = 1.22 min), m/z = 364 Da ([M+NH4]
+
, 
Rt = 2.51 min), m/z = 380 Da ([M+NH4]
+
, Rt = 2.85 min), m/z = 380 Da ([M+NH4]
+
, Rt = 
2.99 min), m/z = 378 Da ([M+NH4]
+
, Rt = 3.40 min), m/z = 396 Da  ([M+NH4]
+
, Rt = 4.93 
min), m/z = 380 Da ([M+NH4]
+
, Rt = 6.18 min), m/z = 380 Da ([M+NH4]
+
, Rt = 6.32 min), 
m/z = 396 Da ([M+NH4]
+
, Rt = 8.45 min, 8.95min), and m/z = 271 Da  ([M+H]
+
, Rt = 10.93).   
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The fragmentation patterns observed in the mass spectrum were useful in characterization of 
these compounds.  Sesquiterpenes; composed of chemical markers 3 thru 10 of Table 6.2, 
showed the fragment ion less of 100 Da due to loss of angeloyl or tigloyl group.  For 
example, 1,10 – epioxynobilin has the same observed m/z value as hydroxynobilin.  The 
proposed fragmentation pathway for 1,10-epoxynobilin versus the isobaric counterpart of 
hydroxynobilin  is shown in Figure 6.14.   
 
 
Figure 6.14: Proposed fragmentation pathways for the two isobaric species, (4a) 1,10-
epoxynoblin and (4b) hydroxynoblin. 
 
Components identified as a major contribution to the variance were identified as apigenin, 
1,10-epioxynoblin, hydroxyisonoblin, nobilin, and other unknown compounds (Table 6.2).   
  
(4a) Proposed fragmentation pathway for 
1,10 – epoxynoblin (m/z = 363 Da)
(4b) Proposed fragmentation pathway for 
Hydroxynoblin (m/z = 363 Da)
m/z = 227
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Table 6.2: Qualitative analysis of German (GC) and Roman (RC) chamomile using UPC
2
/MS, 


















M.r. A.n. M.r. A.n. M.r. A.n. 
1 1.10 trans-dicycloether 201 + + + + + + 
2 1.34 cis-dicycloether 201 + + + + + + 
3 2.56 nobilin 347/364→247 - + - - - - 
4 2.75 1,10-epioxynobilin 363/380→263 - + - - - - 
5 3.03 Unknown 1 363/380→263 - + - - - - 
6 3.58 Unknown 2 361/378→261 - + - - - - 
7 5.12 Unknown 3 379/396→279 - + - - - - 
8 5.99 hydroxyisonobilin 363/380→263 - + - - - - 
9 6.36 3-epihydroxyisonobilin 363/380→263 - + - - - - 
10 8.65 
 
Unknown 4 379/396→279 - + - - - - 
11 9.13 Unknown 5 379/396→279 - + - - - - 
12 11.92 apigenin 271 + + + + - - 
 
The unknown compounds are hypothesized as stereoisomers, diastereomers and/or 
enantiomers related to 1,10-epioxynoblin and hydroxyisonoblin based on the common 
fragments observed from in-source fragmentation of the single quadrupole data.  The 
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fragment analysis of hydroxynobilin confirms the loss of -C5H12O4 which would be 
inconsistent with the proposed fragmentation pathway and observed spectra for 1,10-
epoxynoblin (Figure 6.14).   The compounds were identified by comparing their retention 
times and characteristic MS spectral data for the four isobaric compounds with m/z = 363 Da 
and the two isobaric compounds with m/z = 379 Da. The three extracts of the authentic 
Roman chamomile showed the presence of the 6 known compounds (Figure 6.2) and the 5 
new unknown compounds.  
 
Figure 6.15: MS Spectral analysis of (5a) 1,10-epoxynoblin and (5b) hydroxynoblin.   
 
Sodium adduct dimerization is identified with the m/z = 747 Da fragment.   Fragments for the 
ammonium and sodium adducts of 1,10-epoxynoblin are found at m/z = 380 Da and m/z = 
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authenticated and eleven commercial samples of German chamomile showed the presence of 
compounds 1, 2, 11 as listed in Table 6.3.  German chamomile samples also showed the 
presence of chrysoplenetin B (m/z = 375 Da, Rt = 6.34 minutes) and chrysosplenol D (m/z = 
361 Da, Rt = 8.31 minutes).  These two compounds were not observed in the Roman 
chamomile samples.  The in-source fragmentation data confirmed the suggested relationship 
of the unknown compounds with the sesquiterpene lactone derived compounds.  The in-
source fragmentation characterization of the unknown compounds has led to hypothesized 
elucidations of potential structures, however analysis using accurate mass data and true 
MS/MS analysis is required on the isolated compounds to properly identify and report these 
compounds as new chemical features related to chamomile.   Therefore, the unknown 
compounds reported in Table 6.2 will be isolated via preparatory chromatography and 
identified by quadrupole time-of-flight mass spectrometry as future work to support the 
hypothesized compound elucidation data.  The predicted structures are proposed in Figure 
6.16 
 
Figure 6.16: Predicted structures of four of the five unknown chemical entities observed in the 
chromatographic separation profile 
 
 Applied Investigation of Commercial Chamomile Teas 6.3.8
The widespread use and medicinal properties have made chamomile increasingly popular in 
the forms of tea.  The phytochemical profile of these tea samples analyzed showed a similar 
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profile compared to German chamomile. None of the tea samples showed the presence of 
sesquiterpenes, therefore concluding that they are not authentic German or Roman 
chamomile.  However, the PCA dataset indicates the tea samples as a variation of German 
chamomile.  The identification of the eleven chemical markers was reported in Table 6.2; 
however, PCA analysis of the commercial tea sample extracts combined with the dataset of 
the authenticated chamomile extracts was examined.  The scores plot of the entire dataset 
indicated clustering agreement with the qualitative findings in Table 6.3 (Figure 6.17) and 
some very distinct features that clustered tea from flowers in two different quadrants of the 
plot.  This was the effect of the many compounds extracted and detected, thus reflecting the 
potential easily inserting sub-2µm particle size SFC into the workflow of fingerprinting 
herbal medicines.  
 
Figure 6.17: PCA scores plot of the commercial tea samples extracts (black) and the extracts 
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Table 6.3: Qualitative analysis of the authentic chamomile extracts and commercial tea extracts 
for the presence of the 11 chemical marker compounds 
Sample # Compounds # 
1 2 3 4 5 6 7 8 9 10/11 12 
A. nobilis            
2061 + + + + + + + + + +/+ + 
9254 + + + + + + + + + +/+ + 
11577 + + + + + + + + + +/+ + 
M. recutita                        
2802 + + - - - - - - - -/- + 
7539 + + - - - - - - - -/- + 
9172 + + - - - - - - - -/- + 
9359 + + - - - - - - - -/- + 
9362 + + - - - - - - - -/- + 
9364 + + - - - - - - - -/- + 
9365 + + - - - - - - - -/- + 
11680 + + - - - - - - - -/- + 
11681 + + - - - - - - - -/- + 
11781 + + - - - - - - - -/- + 
Tea Samples                        
9357 + + - - - - - - - -/- + 
9376 + + - - - - - - - -/- + 
9383 + + - - - - - - - -/- + 
9384 + + - - - - - - - -/- + 
9385 + + - - - - - - - -/- + 
9386 + + - - - - - - - -/- + 
9387 + + - - - - - - - -/- + 
9388 + + - - - - - - - -/- + 
9389 + + - - - - - - - -/- + 
9390 + + - - - - - - - -/- + 
9391 + + - - - - - - - -/- + 
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In addition to the assessment of RPLC orthogonality, the specific chemical markers listed in 
Figure 6.2 were analyzed by UHPLC/MS, GC-MS, and UPC
2
/MS.  The masses were 
extracted from the total ion chromatograms for each technique. The presence (+) or absence 
(-) of the compounds were recorded per each compound (Table 6.3).  Using UPC
2
-MS, the 
SLs compounds were easily detected from Roman chamomile, but by the other 2 




A sub-2µm packed-column supercritical fluid chromatography-mass spectrometry method 
was studied for the identification of sesquiterpenes and other constituents from chamomile 
extracts. All of the chemical marker compounds were separated within 15 minutes.  German 
chamomile samples confirmed the presence of cis- and trans-tonghaosu, chrysoplenetin, and 
chrysosplenols. Roman chamomile samples confirmed the presence of apigenin, 1,10-
epioxynobilin, hydroxyisonobilin, nobilin, and other SLs. Various extraction techniques were 
evaluated on Roman and German chamomiles, yet extracts using iso-propanol/hexane (1:1, 
v/v) provided a good compromise in solutes extracted and optimal peak shape.  
 
The method optimization indicated that caution should be used when investigating 
temperature as an optimization variable since increases in baseline noise can be observed.  
Increasing the backpressure in coordination with increasing the temperature will maintain the 
density of the mobile phase and minimize the endothermic expansion to the gaseous state, 
thus minimizing the gas in the flow cell contributing to the UV detector noise.  The technique 
does not require any kind of derivatization prior to the analysis.  Dual detection was achieved 
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in series easily by using the post UV detector splitter supplied with the instrumentation which 
allowed for simultaneous UV and mass spectrometry detection with ESI
+
 data collection.   
 
Multivariate statistical analysis approaches including principal component analysis (PCA) 
and partial least squares - discriminant analysis (PLS-DA) were used to correlate the data sets 
and visually differentiate between the chamomile samples. Sesquiterpene lactones, 
dicycloethers and flavonoids are key markers to differentiate Roman and German 
chamomiles.  The PCA dataset of the tea samples indicated a relationship to German 
chamomile, but are not authentic German chamomile.  Sub-2µm particle stationary phase 
SFC in combination with recent state-of-the-art instrumentation is an efficient tool to separate 
and characterize sesquiterpene lactones from chamomile. In comparison to LC and GC, it is 
reasonable to expect LC or GC to separate the 5 unknown compounds in Table 6.2 with 
extensive targeted method development; however, the separation and discovery of the 5 
unknown compounds was easily accomplished using UPC
2
-MS methodology.   In addition to 
the discovery of the unknown compounds, the methodology developed here will be 
implemented for routine quality control testing of chamomile preparations used as herbal 
supplements and tea at the University of Mississippi National center for Natural Product 
Research.   
 
In summary, these results provide the foundation for developing a new workflow for natural 
product profiling using an orthogonal technique to RPLC which combines a simplified 
sample preparation, reliable SFC-based instrumentation capable of reproducible efficient 
data, a systematic method development approach, and statistical analysis that can be used as 
standard protocols for natural product chemical profiling.   
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7 Conclusions and Future Research 
7.1 Final Conclusions 
New chemical entities which are developed as therapeutics resulting from natural product 
drug discovery represent the majority of the small molecule pharmaceutical drugs in the 
marketplace today.  The goal of this research was designed to prove sub-2 µm particle packed 
column SFC; commercially known as UPC
2
, as a viable technique and establish natural 
product drug discovery research as the field with the most to gain from its utilization.  
Interestingly, the technology had to advance prior to attempting chromatographic 
investigations because sub-2µm particle RPLC and HILIC columns employed by UHPLC 
approaches dominated the academic and innovator pharmaceutical community.   
 
A novel instrument design capable of performing separations using today’s evolution of sub-
2µm particle size columns was developed in parallel with this research.  In order to establish 
sub-2µm particle packed column SFC as a beneficial and distinct separations technique, the 
novel UPC
2
 instrumentation was evaluated in terms of system performance and capability to 
harness the theoretical efficiencies of a of sub-2 µm particle size column.  The study showed 
the instrumentation was capable of achieving highly efficient separations with reproducibility 
exceeding those achieved on historical instrumentation configurations. Appropriate mixing of 
the mobile phase was critical to achieving Gaussian peak shapes, but more relevant at low 
flows rates and low percent modifiers.   Interestingly, the study revealed observations about 
column efficiency and retention trends when using isobaric and isopycnic method conditions.  




optimal linear velocity.   The van Deemter plots for the isopycnic results suggest the 
instrumentation pressure and flow rate upper threshold limited the ability to achieve a final 
determination of optimal linear velocity.  If sub-2 µm particle packed column SFC column 
efficiencies are being reported and compared using a van Deemter plot regardless of whether 
an isobaric or isopycnic approach is utilized, then the total system pressure should be 
reported as well in order to make the comparisons fair.   
 
Adoption and implementation of pSFC approaches will be impacted by the amount of 
educational guidance provided by the scientific community.  Method development 
knowledge and detection interfacing techniques are critical components to the education of 
future users, not just hypothesized for pSFC adoption but also evident from HPLC and 
UHPLC adoption.  
 
In terms of discovery based analytics, the majority of metabolomics research utilizes high 
resolution mass spectrometry to identify new chemical features and markers.  The study 
exploring techniques and considerations necessary when interfacing pSFC with the mass 
spectrometer was of critical importance prior to investigating applied approaches for 
synthetic chemistry reaction monitoring and natural product profiling.    Issues such as probe 
pulsation and ionization efficiency must be explored with a critical eye.  The baseline of the 
MS data can alert the user to spray stability. MS tune settings such as cone voltage, capillary 
voltage and desolvation temperatures are fairly easy to automate and investigate for optimum 
parameters. However, the exploration of the post-column addition make-up solvent can be 




the final result.  A mixture of water and ammonia additives in the make-up solvent resulted in 
the best approach to detect the most analytes.  
Factors that affected selectivity in UPC
2
 were explored and seem to have analogous 
behaviour to HILIC.  Column screening impacted changes in selectivity the greatest; however 
these impacts were greater when using columns with a polar ligand and the components of 
interest were highly polar with longer retention times.  The more neutral or non-polar 
compounds did not shift retention times nearly as much as their more polar structurally 
related compounds.  The findings of Caroline West, whereas polar compounds separate well 
on polar columns and non-polar compounds separate well on non-polar columns was verified 
by these investigations.  The observation of columns with π-π retention mechanistic 
capability to separate conjugated compounds that are structurally similar was unique.  The 
general investigations resulted in the following method development strategy: 
1. Perform a generic 5 minute method column screening  
2. Address peak shape with additives, preferably buffered-like additives consisting 
of a strong acid and conjugate base 
3. Explore post-column addition solvents to enhance sensitivity in the MS detector 
(if used) 
4. Utilize the addition of a weaker elution strength modifier to enhance resolution 
between critically resolved pairs 
5. Optimize small selectivity variations with gradient slope, column temperature or 
backpressure settings 
 
The study investigated amphipathic compounds; however mixtures of these compounds 
remain challenging. The benefit of the UPC
2
 approach over HILIC or RPLC approaches 
resulted in moderate predictability of the retention of lipid species and class mixtures.   The 
importance of routine use studies and system suitability methods was paramount.  The routine 
use of the amphipathic method for lipid class separations revealed an issue with column 
degradation during analysis. The Consumables Group at Waters later characterized this 




resulting in a line of newly developed columns in 2014 specifically for use with UPC
2
 
applications designed to inhibit this on-column reaction[137].  This was achieved by utilizing 
a bonding approach which uses a hydrophilic bonding layer connecting the selector to the 
hybrid particle versus using a linker to bond the selector to the hybrid particle.  Although 
these new chemistries were not available for this research, the use of buffered additives 
mitigated the retention drifts caused by SEF when using the hybrid sub-2µm particle 
columns.  This was apparent during the system suitability method that was used as a system 
check during the cheminformatic investigation of structural and physiochemical attributes 
influence on chromatography.  Little was gained from this investigation, but it did prove to be 
a useful approach to visualize the data in a multivariate perspective.   It is difficult to 
conclude if the study proved or disproved perceptions relating solute physiochemical 
properties of logD or logP to chromatographic retention.  This might be due to the basis that 
this study used a modifier and the perceptions of solute logD and logP influence might be in 
the absence of modifier. 
 
The discovery and synthetic chemistry divisions within the pharmaceutical industry rely on 
the results of the analytical methodology to discover ‘hits’.  Although the early discovery and 
medicinal chemistry scientists are not particularly concerned with traditional method 
development as analytical scientists are later in development, the discovery teams are 
cognoscente of method parameters to optimize their data collection of large compound 
libraries.  Routine high throughput screening is driven by a selection of open access methods 
based on retention of the analyte for further purification.   Interestingly, pSFC analytical to 
purification scaling strategies were published in 2014[211].  Many organic solvents, polar 




considerations should be reviewed regarding the diluent interferences of solvents such as 
DMSO and DMF due to their retentivity when using UPC
2
.   
 
Complex extraction techniques are performed to isolate and extract components of interest 
from the matrix of natural products.  The extraction techniques involve many organic 
solvents not amenable to RPLC analysis, thus complicating the workflow to convert the 
extract to an aqueous based diluent better suitable for optimum peak shapes during RPLC 
analysis.  The sample diluent conversion may alter the final sample analyzed due to solubility 
incompatibilities.  The point of analyte solubility was a deliberate concern and point of 
interest in this research in terms of establishing pSFC as the appropriate separations tool for 
drug discovery research workflows, specifically involving natural products.  The 
chromatographic performance from the applied use of sub-2µm particles columns hinged on 
the design and implementation of the novel low volume novel prototype pSFC 
instrumentation through to the final development of the commercialized UPC
2
 instrument.   
The application and use of the technique for reaction monitoring of drug substance synthesis 
and natural product profiling provided the capability to investigate the impact of diluent 
systems and outputs from different extraction techniques.  The impact of these sample 
preparation procedures were less than those observed from compound libraries that were 
diluted in DMSO.  In fact, the impact of the resulting solutions from the reaction monitoring 
and natural product extracts was fairly low due in part to the dilution of the sample which 
was required to minimize detection saturation.  In both studies, the true benefit of the UPC
2
 
approach was illustrated in the comparative data to that of the UHPLC results.   New peaks 
were identified for the chamomile study resulting in previously undiscovered chemical 
entities.  Cleaner separations of the starting materials and intermediate products were 




studies.  The general screening workflow was determined as streamlined due to the stationary 
phase agnostic approach that can be employed when using UPC
2
.  When using the UPC
2
 
instrument when configured with a column switching module, chiral columns, RPLC 
columns, HILIC columns, NPLC columns, and all kinds of hybrid columns could be 
configured on the system without the need to change the mobile phase, wash solvents or 
diluent systems.  To perform these types of separation without a general pSFC or UPC
2
 
approach, either separate dedicated HPLC instruments would have to be configured for each 
separation technique or timely conversion of the instrument to be compatible for each 
technique would have to be performed.   
 
In conclusion, the utilization of the novel and newly commercialized option; UPC
2
, to 
achieve UHPLC-like data for an SFC-based separations technique was a breakthrough for the 
analytical scientific community as reported by researchers at annual conferences since 2012 
to present focused on separation science and include the HPLC symposium, The SFC 
symposium organized by the Green Chemistry Group, Pittcon, International Symposium of 
Chromatography, and various US and EU SFC user group meetings held across the world.  
The performance evaluations, usability assessments, method development strategies and 
applied use examples discussed in this thesis confirm the usefulness of SFC separations and 
validating the need to progress the technologies that enable SFC separations.  In terms of 
which industry would benefit the greatest from the SFC technological advancements; 
specifically UPC
2
, natural product profiling with the aim to discover new chemical entities 
targeted for a therapeutic purpose is recommended as the most appropriate fit.  The analysis 
of natural products and their extracts are simplified due to the amenable diluent and solvent 
systems compatible with the UPC
2
 separations approach, thus simplifying the overall 




synthesis.  The column agnostic approach allows for chiral and achiral analysis on the same 
instrument without any changes to elution solvents and diluents. The use of polar and non-
polar columns to exploit various retention mechanisms for general small molecule 
pharmaceuticals, structurally related compounds, and amphipathic compounds are well suited 
for comprehensive natural product profiling.  The UPC
2
 technology facilitates the scalability 
from analytical analysis to SFC purification of new chemical entity isolations enables time 
and cost savings that benefit high throughput discovery laboratories.  This ease of scalability 
would also facilitate the process of small scale process development through to 
commercialized batch manufacturing of a lead candidate, thus completing the goal of 
bringing new therapeutics to the patient. 
 




The field of studying supercritical fluids, specifically the technique of supercritical fluid 
chromatography has seen ebbs and flows of research activity over the last few decades. pSFC 
has been explored for the analysis of pharmaceuticals, chemical materials, food research, and 
natural products to name a few. The pSFC application previously reported in any of the 
aforementioned foci of interest will usually have a major emphasis on the analysis of chiral 
compounds or highly lipophilic compounds. Unfortunately, aside from chiral analysis studies, 
the scientific community has not indicated a clear reason to use pSFC as the technique of 
choice when analyzing achiral molecules, never mind any mention of which field of 
discipline could best benefit from pSFC.  It is clear that HPLC or GC will be the first option 




any given time will conclude on excellent scientific revelations, but then particular 
limitations inhibiting the widespread use of the technique are commonly raised, namely: 
a. pSFC technology has limitations such as performance, robustness, and ease of 
use. 
b. The theoretical principles that pertain to separation mechanisms and how the 
role of density, role of pressure, and role of temperature influence these 
mechanisms are very complicated and difficult to deduce. 
c. HPLC and GC utilization and analyte coverage is very high 
 
The technology limitations stated in point (a.) are clearly addressed with the introduction of 
the UPC
2
 instrument based on the findings in this thesis.  Academics such as the University 
of Tennessee, Université d’Orléans, University of South Hampton, and University of Genevé 
are leading the charge in characterizing the theoretical principles stated in point (b.).  The 
utilization of HPLC and GC before the use of SFC as stated in point (c.) is a human element 
that takes time to overcome the barrier to change.   Various factors have enabled the scientific 
community to defer the use of pSFC and stick to the tried and trusted technique of HPLC.  
An obvious factor points to technology advancements which enabled HPLC to flourish.  The 
last 2-3 decades, separation technology advancements have primarily focused on HPLC in 
the form of instrumentation and column chemistry.   
A common question and answer session that has been raised at each International Conference 
on Packed Column SFC held by the Green Chemistry Group since 2012 – 2015 throws up the 
following question: 
 What is the universal column for pSFC which would be analogous to the C18 
column for HPLC? …The response by every presenter which is asked this 





The lack of an answer for a universal column is misleading.  In many of the examples 
throughout the investigational studies of this thesis, any column used on the UPC
2
 instrument 
resulted in a good separation in which additional selectivity altering approaches were applied 
to achieve the objectives required of the final method.  These concepts of ‘method 
optimization’ are not unique to pSFC method development and are a necessity in RPLC 
method development as well.  Due to the success of the separations achieved by UPC
2
 when 
using a multitude of columns, the results suggest that every column is a universal column 
when using UPC
2
 assuming you stick with matching the polarity of sample to the polarity of 
the stationary phase concepts that Caroline West recommends.  Based on the column 
screening results from metoclopramide impurities study, lipid class – species separations 
study, the reaction monitoring of the pharmaceutical products study, the compound library 
screening study; the selection of which column could be conceived as the universal ‘SFC’ 
column became irrelevant.  The choice of column became more of an informed judgement 
assessment because the chromatographic attributes that dictate a choice of column (i.e: 
tailing, resolution, efficiency, speed, sensitivity, etc) were not any more discerning than 
RPLC column selection once additives were used from the beginning to address potential 
peak shape issues or column stability.  The practices to address better peak shapes for HPLC 
were the same for those to address peak shapes for SFC.  In HPLC, if the molecule has a 
basic pKa, the utilization of a basic additive in the mobile results in better peak shapes.  In 
SFC, matching the additive to solute pKa has the same benefits; however an additional option 
to facilitate peak shape would be to include choosing a column with pKa properties similar to 
that of the solute.  The ability to utilize an extra selectivity variable should not complicate it’s 
use, but rather simplify the achievement of a successful separation that meets the goals and 
objective of the method’s intended use.  All in all, the time required to optimize the method 




analytical scientist using both techniques.  The application development and investigative 
studies towards this thesis facilitated the learning curve of SFC principles and separation 
expectations helped normalize these two separation experience levels, thus validating the 
time metrics assessment of developing methods for either separations approach. 
  
Additionally, some of the leading practitioners tend to unknowingly complicate and confuse 
willing adopters of pSFC at these conferences. Statements followed by short workshops are 
driven by the following statement: 
 
  “…In practice, the fluid in supercritical fluid chromatography applications is 
not ‘supercritical’.  The fluid is sub-critical due to the use of the organic elution 
modifier.  Based on this fact, what should we rename this technique?  Sub-
critical Fluid Chromatography?  Convergence Chromatography? Unified 
Chromatography? CO2-based Chromatography?...” 
 
One could argue industrial agendas for scientific community recognition if the name were to 
change.  However, for the technique to progress and be adopted by industry, efforts to make 
the technique sound less complicated would be a welcomed path forward.    
 
In terms of the point of universal columns for UPC
2
, there seems to be a popular desire at 
pSFC conferences and workshops for a single column ligand for use with a single separations 
based technique whereas these two tools streamline the ease of use and success of that 
technique for >80% of the separations attempted.  This perception exists as a point of benefit 




single column ligand seems limiting in terms of exploring additional tools to achieve success 
for a challenging and complex separation.  Perhaps that is why there are currently over 300 
C18 branded columns available in the marketplace today, and many separation scientists 
comment: “Not all C18 columns are the same!”, hence perhaps further answering the 
question of why so many are needed.  Knowing there are many C18 columns available, would 
that not complicate the choice of C18 column to use when looking to practice reversed -phase 
chromatography on an LC instrument?  However, analytical chemists do not seem to focus on 
this complexity of column selection for RPLC as a point of contention for using HPLC as a 
technique of choice.   It would be very interesting to hear a delegate in the audience of the 
annual HPLC Conference to ask any presenter how did they know which C18 column to use? 
And how many C18 columns were explored to get the desired separation?” The reality of the 
situation regarding unknown recommendations for a universal SFC column is also true when 
blindly applying the universal column for RPLC separation of analytes, however many times 
the column selection process for RPLC is not very well communicated.   The method 
development story of a successful separation is usually never explained as to why a particular 
C18 column was chosen from the rest of the 300 commercially available C18 columns. A 
presentation or publication might focus on why a C18 column was chosen over a phenyl 
column or shielded column.  Solute polarity is sometimes discussed to justify why a HILIC 
approach was used rather than a RPLC C18 approach.  The scientific conversations regarding 
RPLC method development often focus on the pH of the mobile phase, elution solvent or 
temperature to alter selectivity when needed to achieve a separation.   Interestingly, one 
important factor that is not often addressed is the solute solubility and how the solubility 
dictated the choice of a chromatography technique.  For today’s UPC2, the practice of 
considering the sample solubility may increase the rate of adoption, specifically for natural 




organic solvents used in synthesis and extraction protocols.  Based on the presentations at 
SFC conferences such as the one held by the Green Chemistry Group, adoption is already 
high due to UPC
2
 enabling the supporting analytical component to the SFC purification 
workflow in the pharmaceutical drug discovery divisions in companies such as Eli Lilly, Dart 
Neurosciences, Pfizer, Merck, Novartis and AstraZeneca. 
 
7.3 On-going related research 
The research within this thesis has stimulated the following additional research which is on-
going and beyond the scope of inclusion: 
1.  Investigation of solvent-solvent extraction versus supercritical fluid extraction of 
Garcinia kola nuts.  This research incorporates the comparison of extraction 
techniques and utilizes multivariate statistical profiling techniques based on sub-2µm 
particle pSFC high resolution mass spectrometry data to determine the coverage and 
overlap of each extraction approach.  This research is in collaboration with Dr. 
Worthern and Yasah Vezele from the University of Rhode Island, Department of 
Pharmacy. The initial results have been presented at HPLC 2014 in New Orleans and 
published excerpts in Yasah Vezele’s thesis submitted in partial fulfillment of the 
requirements for the degree of Master of Science in Pharmaceutical Science titled 
“Garcinia Kola: Phytochemical, Biological, and Formulation Studies”.   The research 
is being expanded to identify distinguishing chemical features for the main grouping 
of extraction procedures that are identified as unique by the principal component 
analysis plot.  
 
2. Global lipidomics profiling of cotton seed oil genotypes using sub-2µm particle pSFC 
coupled to mass spectrometry.  The initial results have been presented at HPLC 2013 
as a poster titled: “Application of UPC2/MS for comprehensive and targeted analysis 
of lipids in cotton seed extracts”. This is an ongoing collaboration with Dr. Vladimir 





3. Investigating the purging of the potential genotoxic alerting structures during the 
synthesis of imatinib mesylate drug substance by sub-2 µm particle pSFC and a novel 
miniature MS detector.  Due to the emergence of the ICH M7 guidance focused on 
mutagenic impurities, the MS results of the imatinib reaction monitoring study will be 
re-investigated for the alerting and previously reported genotoxic impurities to 
confirm their elimination from the intermediate and final stages of the synthesis. 
 
7.4 Future Research 
Future research should focus on several areas to further explore the utilization of the pSFC 
approaches investigated within this body of work. Investigations should be expanded to 
incorporate CO2-based workflows inclusive of sample preparation protocols. These could 
include:  
1. Further investigations of optimal mass spectrometry interfacing approaches.  This 
would include investigations towards post-column addition solvents, splitter 
designation and design, and addition of heat to the transfer line restrictor connecting 
to the MS instrument. 
 
2. Investigations of π-π activated ligand bonded columns for the separation of 
structurally related conjugated analytes by pSFC would be a useful tool to discover 
new compounds or develop stronger intellectual property about the markush structure 
of a targeted compound. Markush structures are depicted with R groups, in which the 
side chain can be a structure type, e.g. 'cyclohexyl'.  This more general depiction of 
the molecule, versus detailing every atom in the molecule, is used to protect 
intellectual property [212, 213]. 
 
3. Cheminformatic analysis of a targeted compound library composed of conjugated, 
hydroxylated, or oxygen-based functionality and peak shape should be explored.  A 
number of compounds with these properties resulted in excessive peak broadening.  
The study could be designed to also explore the pi-pi influence when using a penta-





4. The multivariate statistical profiling of natural product collected by sub-2 µm particle 
stationary phase supercritical fluid chromatography and compared to the sub-2 µm 
reversed-phase particle stationary phase coupled to accurate mass spectrometry 
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